<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery - Juthani, VV - 2017 | Cochrane Library</title> <meta content="Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery - Juthani, VV - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010516.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery - Juthani, VV - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010516.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010516.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery" name="citation_title"/> <meta content="Viral V Juthani" name="citation_author"/> <meta content="Albert Einstein College of Medicine, Montefiore Medical Center" name="citation_author_institution"/> <meta content="Elizabeth Clearfield" name="citation_author"/> <meta content="Johns Hopkins Bloomberg School of Public Health" name="citation_author_institution"/> <meta content="Roy S Chuck" name="citation_author"/> <meta content="Albert Einstein College of Medicine, Montefiore Medical Center" name="citation_author_institution"/> <meta content="rchuck@montefiore.org" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD010516.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/07/03" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010516.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010516.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010516.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Phacoemulsification [adverse effects]; Adrenal Cortex Hormones [*therapeutic use]; Anti‐Inflammatory Agents, Non‐Steroidal [*therapeutic use]; Cataract Extraction [*adverse effects, *methods]; Corneal Edema [etiology, prevention &amp; control]; Drug Therapy, Combination; Eye Diseases [etiology, *prevention &amp; control]; Inflammation [etiology, prevention &amp; control]; Macular Edema [etiology, prevention &amp; control]; Postoperative Complications [etiology, *prevention &amp; control]; Randomized Controlled Trials as Topic; Visual Acuity" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010516.pub2&amp;doi=10.1002/14651858.CD010516.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="dLyXbLct";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010516\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010516\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010516\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010516\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","pt","ms","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010516.pub2",title:"Non\\u2010steroidal anti\\u2010inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery",firstPublishedDate:"Jul 3, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Eyes and Vision Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=dLyXbLct&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010516.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010516.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010516.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010516.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010516.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010516.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010516.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010516.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010516.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010516.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>7104 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010516.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-sec-0100"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-sec-0055"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-sec-0092"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/appendices#CD010516-sec-0105"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/table_n/CD010516StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/table_n/CD010516StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/information#CD010516-cr-0002">Viral V Juthani</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/information#CD010516-cr-0003">Elizabeth Clearfield</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010516.pub2/information#CD010516-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Roy S Chuck</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/information/en#CD010516-sec-0115">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 03 July 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010516.pub2">https://doi.org/10.1002/14651858.CD010516.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010516-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010516-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010516-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010516-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010516-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010516-abs-0001" lang="en"> <section id="CD010516-sec-0001"> <h3 class="title" id="CD010516-sec-0001">Background</h3> <p>Cataract is a leading cause of blindness worldwide. Cataract surgery is commonly performed but can result in postoperative inflammation of the eye. Inadequately controlled inflammation increases the risk of complications. Non‐steroidal anti‐inflammatory drugs (NSAIDs) and corticosteroids are used to prevent and reduce inflammation following cataract surgery, but these two drug classes work by different mechanisms. Corticosteroids are effective, but NSAIDs may provide an additional benefit to reduce inflammation when given in combination with corticosteroids. A comparison of NSAIDs to corticosteroids alone or combination therapy with these two anti‐inflammatory agents will help to determine the role of NSAIDs in controlling inflammation after routine cataract surgery. </p> </section> <section id="CD010516-sec-0002"> <h3 class="title" id="CD010516-sec-0002">Objectives</h3> <p>To evaluate the comparative effectiveness of topical NSAIDs (alone or in combination with topical corticosteroids) versus topical corticosteroids alone in controlling intraocular inflammation after uncomplicated phacoemulsification. To assess postoperative best‐corrected visual acuity (BCVA), patient‐reported discomfort, symptoms, or complications (such as elevation of IOP), and cost‐effectiveness with the use of postoperative NSAIDs or corticosteroids. </p> </section> <section id="CD010516-sec-0003"> <h3 class="title" id="CD010516-sec-0003">Search methods</h3> <p>To identify studies relevant to this review, we searched the Cochrane Central Register of Controlled Trials (CENTRAL), which contains the Cochrane Eyes and Vision Trials Register (2016, Issue 12), MEDLINE Ovid (1946 to December 2016), Embase Ovid (1947 to 16 December 2016), PubMed (1948 to December 2016), LILACS (Latin American and Caribbean Health Sciences Literature Database) (1982 to 16 December 2016), the <i>meta</i> Register of Controlled Trials (<i>m</i>RCT) (<a href="http://www.controlled-trials.com/" target="_blank">www.controlled‐trials.com</a>; last searched 17 June 2013), ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>; searched December 2016), and the WHO International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/search/en" target="_blank">www.who.int/ictrp/search/en</a>; searched December 2016). </p> </section> <section id="CD010516-sec-0004"> <h3 class="title" id="CD010516-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials (RCTs) in which participants were undergoing phacoemulsification for uncomplicated cataract extraction. We included both trials in which topical NSAIDs were compared with topical corticosteroids and trials in which combination therapy (topical NSAIDs and corticosteroids) was compared with topical corticosteroids alone. The primary outcomes for this review were inflammation and best‐corrected visual acuity (BCVA). </p> </section> <section id="CD010516-sec-0005"> <h3 class="title" id="CD010516-sec-0005">Data collection and analysis</h3> <p>Two review authors independently screened the full‐text articles, extracted data from included trials, and assessed included trials for risk of bias according to Cochrane standards. The two review authors resolved any disagreements by discussion. We graded the certainty of the evidence using GRADE. </p> </section> <section id="CD010516-sec-0006"> <h3 class="title" id="CD010516-sec-0006">Main results</h3> <p>This review included 48 RCTs conducted in 17 different countries and two ongoing studies. Ten included studies had a trial registry record. Fifteen studies compared an NSAID with a corticosteroid alone, and 19 studies compared a combination of an NSAID plus a corticosteroid with a corticosteroid alone. Fourteen other studies had more than two study arms. Overall, we judged the studies to be at unclear risk of bias. </p> <p><b>NSAIDs alone versus corticosteroids alone</b> </p> <p>None of the included studies reported postoperative intraocular inflammation in terms of cells and flare as a dichotomous variable<i>.</i> Inflammation was reported as a continuous variable in seven studies. There was moderate‐certainty evidence of no difference in mean cell value in the participants receiving an NSAID compared with the participants receiving a corticosteroid (mean difference (MD) ‐0.60, 95% confidence interval (CI) ‐2.19 to 0.99), and there was low‐certainty evidence that the mean flare value was lower in the group receiving NSAIDs (MD ‐13.74, 95% CI ‐21.45 to ‐6.04). Only one study reported on corneal edema at one week postoperatively and there was uncertainty as to whether the risk of edema was higher or lower in the group that received NSAIDs (risk ratio (RR) 0.77, 95% CI 0.26 to 2.29). No included studies reported BCVA as a dichotomous outcome and no study reported time to cessation of treatment. None of the included studies reported the proportion of eyes with cystoid macular edema (CME) at one week postoperatively. Based on four RCTs that reported CME at one month, we found low‐certainty evidence that participants treated with an NSAID alone had a lower risk of developing CME compared with those treated with a corticosteroid alone (RR 0.26, 95% CI 0.17 to 0.41). No studies reported on other adverse events or economic outcomes. </p> <p><b>NSAIDs plus corticosteroids versus corticosteroids alone</b> </p> <p>No study described intraocular inflammation in terms of cells and flare as a dichotomous variable and there was not enough continuous data for anterior chamber cell and flare to perform a meta‐analysis. One study reported presence of corneal edema at various times. Postoperative treatment with neither a combination treatment with a NSAID plus corticosteroid or with corticosteroid alone was favored (RR 1.07, 95% CI 0.98 to 1.16). We judged this study to have high risk of reporting bias, and the certainty of the evidence was downgraded to moderate. No included study reported the proportion of participants with BCVA better than 20/40 at one week postoperatively or reported time to cessation of treatment. Only one included study reported on the presence of CME at one week after surgery and one study reported on CME at two weeks after surgery. After combining findings from these two studies, we estimated with low‐certainty evidence that there was a lower risk of CME in the group that received NSAIDs plus corticosteroids (RR 0.17, 95% CI 0.03 to 0.97). Seven RCTs reported the proportion of participants with CME at one month postoperatively; however there was low‐certainty evidence of a lower risk of CME in participants receiving an NSAID plus a corticosteroid compared with those receiving a corticosteroid alone (RR 0.50, 95% CI 0.23 to 1.06). The few adverse events reported were due to phacoemulsification rather than the eye drops. </p> </section> <section id="CD010516-sec-0007"> <h3 class="title" id="CD010516-sec-0007">Authors' conclusions</h3> <p>We found insufficient evidence from this review to inform practice for treatment of postoperative inflammation after uncomplicated phacoemulsification. Based on the RCTs included in this review, we could not conclude the equivalence or superiority of NSAIDs with or without corticosteroids versus corticosteroids alone. There may be some risk reduction of CME in the NSAID‐alone group and the combination of NSAID plus corticosteroid group. Future RCTs on these interventions should standardize the type of medication used, dosing, and treatment regimen; data should be collected and presented using the Standardization of Uveitis Nomenclature (SUN) outcome measures so that dichotomous outcomes can be analyzed. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010516-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010516-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010516-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010516-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010516-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD010516-abs-0005">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD010516-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010516-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010516-abs-0003" lang="en"> <h3>Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery </h3> <p><b>Review aim</b> <br/> The aim of this review was to find out if topical non‐steroidal anti‐inflammatory drugs (NSAIDs) (alone or taken in combination with topical corticosteroids) or topical corticosteroids alone are better for controlling eye inflammation after cataract surgery. Cochrane review authors collected and analyzed all relevant studies to answer this question and found 48 studies. </p> <p><b>Key messages</b> <br/> It is unclear whether NSAIDs or corticosteroids are better at treating eye inflammation after cataract surgery. There were many combinations of drugs and dosing regimens in the included studies. The majority of the studies did not provide data on inflammation. </p> <p><b>What was studied in this review?</b> <br/> Cataract surgery is one of the most commonly performed eye surgeries. Eye inflammation is common after cataract surgery. If left untreated, this inflammation can cause many complications. NSAIDs or corticosteroids are typically used to control swelling after cataract surgery. These drugs work differently, so comparing their effects is necessary. Cochrane review authors compared the effectiveness of NSAIDs (alone or in combination with corticosteroids) versus corticosteroids alone for controlling swelling after cataract surgery. </p> <p><b>Main results</b> <br/> We included 48 randomized controlled trials from 17 different countries. Fifteen studies compared an NSAID with a corticosteroid. Nineteen studies compared an NSAID plus corticosteroid versus a corticosteroid alone. Fourteen other studies had more than two study arms, with different combinations of NSAIDs and corticosteroids. </p> <p><i>In comparing participants who received an NSAID with those who received a corticosteroid:</i> </p> <p>• it was unclear whether the number of cells, which were a sign of inflammation inside the eye, was higher or lower </p> <p>• there was less flare (another sign of inflammation inside the eye, in which a beam of light becomes visible passing through the eye fluids, like the beam of a searchlight) in the back of the eye in the group that received only an NSAID </p> <p>• it was unclear whether there was a higher instance of swelling of the cornea, the clear window at the front of the eye which becomes misty if swollen, one month after surgery </p> <p>• there was a lower risk of developing cystoid macular edema (fluid and swelling in a part of the eye called the macula, the central part of the retina, a light‐sensitive membrane at the back of the eye which is responsible for detailed vision and if so effected can make vision clouded and distorted) in the group that received only an NSAID </p> <p>The included studies in this comparison did not provide enough information to look into sharpness of vision, how long participants needed treatment, side effects of the medications, or cost. </p> <p><i>In comparing participants who received a combination of an NSAID plus a corticosteroid compared with those who received a corticosteroid alone:</i> </p> <p>• there was a higher instance of corneal edema in the group that received a combination of the two types of medications </p> <p>• there was a lower risk of developing cystoid macular edema one week after surgery in the group that received a combination of the two types of medications </p> <p>The included studies did not provide enough information to look into the amount of cells in the back of the eye, sharpness of vision, how long participants needed treatment, side effects of the medications or cost. </p> <p>This review compared many different types of drugs, dosing, and treatments. We tried to look at all types of anti‐inflammatory agents in this review. NSAIDs considered in this review were indomethacin, ketorolac, nepafenac, diclofenac, bromfenac, flurbiprofen, and pranoprofen. Corticosteroids included in this review were dexamethasone, prednisolone acetate, betamethasone, rimexolone, fluorometholone, and loteprednol. A future review with different outcomes may be more effective in determining whether NSAIDs or corticosteroids are better at treating swelling after cataract surgery. </p> <p><b>How up to date is this review?</b> <br/> Cochrane review authors searched for studies that had been published up to 16 December 2016. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010516-sec-0100" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010516-sec-0100"></div> <h3 class="title" id="CD010516-sec-0101">Implications for practice</h3> <section id="CD010516-sec-0101"> <p>The evidence for the treatment of postoperative inflammation after uncomplicated phacoemulsification is insufficient to inform practice. From the 48 trials included in this review, we could not ascertain the equivalence or superiority of non‐steroidal anti‐inflammatory drugs (NSAIDs) with or without corticosteroids versus corticosteroids for the treatment of postoperative inflammation; we were unable to make conclusions about our primary outcome. The amount of flare in the anterior chamber at one week postoperatively may be lower for those treated with an NSAID, but the evidence is weak. There may be some risk reduction of CME with NSAIDs alone (low‐certainty evidence) or in combination with corticosteroids (low‐certainty evidence) in the first month after phacoemulsification. </p> </section> <h3 class="title" id="CD010516-sec-0102">Implications for research</h3> <section id="CD010516-sec-0102"> <p>Large, adequately powered, well‐designed, independently‐funded RCTs to compare NSAIDs with and without corticosteroids versus corticosteroids alone for the treatment of inflammation following uncomplicated phacoemulsification are needed. These studies should ideally standardize the type of medication used, dosing, and treatment regimen. Data should be collected and presented using the Standardization of Uveitis Nomenclature (SUN) outcome measures so that dichotomous outcomes can be analyzed. Reporting these outcomes as percentages rather than means will allow clinicians to determine whether there will be a difference in risk of inflammation when prescribing an NSAID, a corticosteroid, or a combination. This is preferable to a mean change in an inflammation measure, because an individual patient may have measures higher or lower than the mean. With meta‐analyses based on dichotomous outcomes, ophthalmologists could make clinical decisions on which medication to use based on the risk of inflammation rather than the expected mean change. Future meta‐analyses and systematic reviews may make use of continuous data for BCVA in order to elucidate the relationship of macular edema and BCVA. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010516-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010516-sec-0022"></div> <div class="table" id="CD010516-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings for NSAIDs versus corticosteroids</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>NSAIDs compared with corticosteroids for controlling inflammation after uncomplicated cataract surgery</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people who received phacoemulsification </p> <p><b>Intervention:</b> NSAID </p> <p><b>Comparison:</b> corticosteroid </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corticosteroid</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NSAID</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Intraocular inflammation measured by anterior chamber cell and flare</b> </p> <p>1 week</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Cell values</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>174</p> <p>(3 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<sup>1</sup> <br/> <b>moderate</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The cell values presented were measured using a Kowa cell meter. 2 additional studies measured cells using a slit lamp, but we were unable to combine these data as the studies used different scales to report the number of cells. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean cell value ranged from 3.7 to 5.8.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean cell value was<b>0.24 cells lower</b> (1.65 lower to 1.16 higher). </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Flare values</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>365</p> <p>(5 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<sup>1,2</sup> <br/> <b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The flare values presented were measured using a Kowa cell meter. There was high statistical heterogeneity among the included studies (I<sup>2</sup> = 92%). </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean flare ranged from 15.65 to 48.3 photons/ms.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean flare was <b>13.74 photons/ms lower</b> (21.47 lower to 6 lower). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intraocular inflammation measured by proportion of participants with corneal edema</b> </p> <p>1 week</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>133 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>103 per 1000</b> </p> <p>(35 to 305)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.77</b> (0.26 to 2.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>3,4</sup> <br/> <b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proportion of participants with best‐corrected visual acuity of 20/40</b> </p> <p>1 week</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>None of the included studies reported on this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proportion of participants with cystoid macular edema</b> </p> <p>1 week</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>521 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>135 per 1000</b> </p> <p>(89 to 214)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.26</b> (0.17 to 0.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>291<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>1,5</sup> <br/> <b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None of the included studies reported the proportion of participants with cystoid macular edema at 1 week, our intended outcome of interest. <b>The data shown here are for 4 studies that reported on the presence of macular edema at 1 month.</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to cessation of treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>None of the included studies reported on this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>None of the included studies reported on this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Economic outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>None of the included studies reported on this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High‐certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate‐certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low‐certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low‐certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded the evidence due to risk of bias: the studies included in this meta‐analysis were poorly reported.<br/> <sup>2</sup>We downgraded the certainty of the evidence due to inconsistency: the I<sup>2</sup> for this estimate was 92%.<br/> <sup>3</sup>We downgraded the certainty of the evidence because the study was unmasked: participants and outcome assessor were not masked, and there was high risk of performance and detection bias.<br/> <sup>4</sup>We downgraded the certainty of the evidence due to imprecision.<br/> <sup>5</sup>We downgraded the certainty of the evidence due to indirectness: the time point at which the study data were reported was one month rather than one week, and two of the studies, which made up 30% of the weight, used a weak corticosteroid in their comparison. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010516-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings for NSAIDs plus corticosteroids versus corticosteroids alone</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>NSAIDs plus corticosteroids compared with corticosteroids alone for controlling inflammation after uncomplicated cataract surgery</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people who received phacoemulsification </p> <p><b>Intervention:</b> NSAID plus corticosteroid </p> <p><b>Comparison:</b> corticosteroid alone </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corticosteroid alone</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NSAID plus corticosteroid</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intraocular inflammation measured by anterior chamber cell and flare</b> </p> <p>1 week</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>None of the included studies reported on this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intraocular inflammation measured by proportion of participants with corneal edema</b> </p> <p>1 week</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>912 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>976 per 1000</b> </p> <p>(894 to 1000)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.07</b> (0.98 to 1.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>138<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>1</sup> <br/> <b>moderate</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proportion of participants with best‐corrected visual acuity of 20/40</b> </p> <p>1 week</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>None of the included studies reported on this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proportion of participants with cystoid macular edema</b> </p> <p>1 week</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>47 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>8 per 1000</b> <br/> (1 to 46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.17</b> (0.03 to 0.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>220<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>2,3</sup> <br/> <b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 additional studies (including 1213 participants) reported on the presence of cystoid macular edema at <b>1 month</b> postoperatively. The meta‐analysis showed that the group that received a combination of NSAID plus corticosteroid had a lower risk of macular edema at 1 month compared with the group that received a corticosteroid only, however there was uncertainty in the measurement (<b>RR 0.50, 95% CI 0.23 to 1.06</b>) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to cessation of treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>None of the included studies reported on this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 2 studies reported on adverse events. 1 reported that there were no adverse events related to NSAID use, but that 1 participant randomized to NSAIDs plus corticosteroid had heterogeneous retinal detachment as a complication of cataract surgery. Another study used the COMTOL questionnaire to ask participants about the frequency and severity of side effects; 3 of the top 5 most commonly reported side effects were markers of ocular discomfort: burning, redness, and blurred vision. The adverse events reported in this study were not separated by intervention group. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Economic outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>None of the included studies reported on this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>COMTOL:</b> Comparison of Ophthalmic Medications for Tolerability; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High‐certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate‐certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low‐certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low‐certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded the certainty of the evidence due to high risk of reporting bias: the study reported collecting data for certain time points, but results were not reported.<br/> <sup>2</sup>We downgraded the certainty of the evidence due to inconsistency based on the heterogeneity of types, doses, and regimens of NSAIDs and corticosteroids used.<br/> <sup>3</sup>We downgraded the certainty of the evidence due to imprecision: there was a small number of events for this outcome. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010516-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010516-sec-0023"></div> <section id="CD010516-sec-0024"> <h3 class="title" id="CD010516-sec-0024">Description of the condition</h3> <p>Cataract is a leading cause of blindness worldwide. It is the leading cause of visual impairment in the United States, affecting approximately 20.5 million Americans older than 40 years, and is expected to increase to 30.1 million by 2020. Cataract progresses with age, therefore the number of surgeries is expected to increase more than four‐fold from 8 million annually to 35 million as the population grows older (<a href="./references#CD010516-bbs2-0111" title="CongdonN , VingerlingJR , KleinBE , WestS , FriedmanDS , KempenJ , et al. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Archives of Ophthalmology2004;122(4):487‐94. ">Congdon 2004</a>). </p> <p>Presently, surgery is the only curative therapy. Cataract surgery is one of the most commonly performed surgical procedures worldwide and one of the most successful. Following cataract surgery, inflammation occurs in the eye. The severity of postoperative inflammation varies and in most cases is self limiting. Anti‐inflammatory agents may hasten resolution and decrease patient discomfort following surgery. In theory, any agent that blocks the action of inflammatory mediators can control postoperative inflammation. Non‐steroidal anti‐inflammatory drugs (NSAIDs) and corticosteroids are used to prevent and reduce inflammation following cataract surgery. NSAIDs and corticosteroids work by different mechanisms to decrease inflammation (<a href="./references#CD010516-bbs2-0122" title="HirneissC , NeubauerAS , KampikA , SchönfeldCL . Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double‐masked study. Graefe's Archives of Clinical and Experimental Ophthalmology2005;243(8):768‐73. ">Hirneiss 2005</a>). </p> </section> <section id="CD010516-sec-0025"> <h3 class="title" id="CD010516-sec-0025">Description of the intervention</h3> <p>Despite advances in cataract surgery, postoperative inflammation continues to cause patient discomfort, delay recovery for surgery and, in some cases, result in suboptimal vision. Inadequately controlled inflammation increases the risk of complications such as anterior or posterior synechiae (where the iris adheres to either the cornea or the lens capsule), corneal edema, progression of pre‐existing glaucoma, post‐operative pain or cystoid macular edema (CME) (<a href="./references#CD010516-bbs2-0110" title="ColinJ . The role of NSAIDs in the management of postoperative ophthalmic inflammation. Drugs2007;67(9):1291‐308. ">Colin 2007</a>; <a href="./references#CD010516-bbs2-0115" title="FlachAJ , LavelleCJ , OlanderKW , RetzlaffJA , SorensonLW . The effect of ketorolac tromethamine solution 0.5% in reducing postoperative inflammation after cataract extraction and intraocular lens implantation. Ophthalmology1988;95(9):1279‐84. ">Flach 1988</a>; <a href="./references#CD010516-bbs2-0128" title="McColginAZ , HeierJS . Control of intraocular inflammation associated with cataract surgery. Current Opinion in Ophthalmology2000;11(1):3‐6. ">McColgin 2000</a>). </p> </section> <section id="CD010516-sec-0026"> <h3 class="title" id="CD010516-sec-0026">How the intervention might work</h3> <p>Corticosteroids are well known to have anti‐inflammatory action. Despite their effectiveness, corticosteroids can cause ocular side effects such as inhibition of corneal wound healing, elevation of intraocular pressure (IOP), increased likelihood of infection, and complications in the presence of herpes virus infection (<a href="./references#CD010516-bbs2-0126" title="LaneSS , ModiSS , LehmannRP , HollandEJ . Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery. Journal of Cataract and Refractive Surgery2007;33(1):53‐8. ">Lane 2007</a>). Due to these potential significant side effects, cataract surgeons have been interested in alternatives to corticosteroids. NSAIDs are commercially available, in topical and systemic formulations, for ocular indications. Topically applied NSAIDs are commonly used in the management and prevention of non‐infectious ocular inflammation. They have been shown to be effective against chronic CME following cataract surgery (<a href="./references#CD010516-bbs2-0133" title="SivaprasadS , BunceC , Crosby‐NwaobiR . Non‐steroidal anti‐inflammatory agents for treating cystoid macular oedema following cataract surgery. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD004239.pub3] ">Sivaprasad 2012</a>). NSAIDs may provide an additional benefit to reduce inflammation when given in conjunction with corticosteroids. </p> <p>Corticosteroids inhibit the action of phospholipase‐A<sub>2</sub> and consequently inhibit the release of arachidonic acid (<a href="./references#CD010516-bbs2-0136" title="VaneJR , BottingRM . Mechanism of action of anti‐inflammatory drugs. Scandinavian Journal of Rheumatology, Supplement1996;25(Suppl 102):9‐21. ">Vane 1996</a>). Arachidonic acid is metabolized to leukotrienes and prostaglandins, both of which mediate the inflammatory response (<a href="./references#CD010516-bbs2-0129" title="NeedlemanP , TurkJ , JakschikBA , MorrisonAR , LefkowithJB . Arachidonic acid metabolism. Annual Reviews in Biochemistry1986;55(1):69‐102. ">Needleman 1986</a>). Corticosteroids also down‐regulate genes that encode cytokines, chemokines, adhesion molecules, inflammatory enzymes, receptors, and proteins (<a href="./references#CD010516-bbs2-0109" title="BarnesPJ . How corticosteroids control inflammation: Quintiles Prize Lecture 2005. British Journal of Pharmacology2006;148(3):245‐54. ">Barnes 2006</a>). </p> <p>NSAIDs inhibit the enzyme cyclo‐oxygenase and consequently inhibit prostaglandin production (<a href="./references#CD010516-bbs2-0137" title="VaneJR , BottingRM . Anti‐inflammatory drugs and their mechanism of action. Inflammation Research1998;47(2):S78‐S87. ">Vane 1998</a>). They are known for their anti‐inflammatory, antipyretic, and analgesic effects. Topical ocular NSAIDs first became available in the 1990s and are used for the inhibition of intraoperative miosis, management of postoperative inflammation, treatment of allergic conditions, and control of pain after excimer laser procedures (<a href="./references#CD010516-bbs2-0119" title="GuideraAC , LuchsJI , UdellIJ . Keratitis, ulceration, and perforation associated with topical non‐steroidal anti‐inflammatory drugs. Ophthalmology2001;108(5):936‐44. ">Guidera 2001</a>). Reports from several studies have indicated that NSAIDs decrease the incidence of postoperative CME apparent on fluorescein angiography (<a href="./references#CD010516-bbs2-0131" title="RossettiL , BujtarE , CastoldiD , TorrazzaC , OrzalesiN . Effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of cystoid macular edema after cataract surgery. Journal of Cataract and Refractive Surgery1996;22(Suppl 1):794‐9. ">Rossetti 1996</a>; <a href="./references#CD010516-bbs2-0135" title="SolomonLD . Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema. Journal of Cataract and Refractive Surgery1995;21(1):73‐81. ">Solomon 1995</a>), as well as improve postoperative visual acuity (<a href="./references#CD010516-bbs2-0114" title="FlachAJ , DolanBJ , IrvineAR . Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema. American Journal of Ophthalmology1987;103(4):479‐86. ">Flach 1987</a>; <a href="./references#CD010516-bbs2-0116" title="FlachAJ , JampolLM , WeinbergD , KraffMC , YannuzziLA , CampoRV , et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. American Journal of Ophthalmology1991;112(5):514‐9. ">Flach 1991</a>; <a href="./references#CD010516-bbs2-0133" title="SivaprasadS , BunceC , Crosby‐NwaobiR . Non‐steroidal anti‐inflammatory agents for treating cystoid macular oedema following cataract surgery. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD004239.pub3] ">Sivaprasad 2012</a>). </p> <p>Topical ocular NSAIDs can have side effects such as post‐cataract surgery atonic mydriasis, contact dermatitis, delayed wound healing (including slowed corneal re‐epithelialization), and corneal melting (<a href="./references#CD010516-bbs2-0117" title="FlachAJ . Topical nonsteroidal antiinflammatory drugs in ophthalmology. International Ophthalmology Clinics2002;42(1):1‐11. ">Flach 2002</a>; <a href="./references#CD010516-bbs2-0119" title="GuideraAC , LuchsJI , UdellIJ . Keratitis, ulceration, and perforation associated with topical non‐steroidal anti‐inflammatory drugs. Ophthalmology2001;108(5):936‐44. ">Guidera 2001</a>). Rare, systemic adverse reactions include asthma, gastrointestinal irritation and ulceration, inhibition of platelet function, and renal dysfunction (<a href="./references#CD010516-bbs2-0132" title="SharirM . Exacerbation of asthma by topical diclofenac. Archives of Ophthalmology1997;115(2):294‐5. ">Sharir 1997</a>). </p> </section> <section id="CD010516-sec-0027"> <h3 class="title" id="CD010516-sec-0027">Why it is important to do this review</h3> <p>Both topical NSAIDs and corticosteroids are used to control postoperative inflammation following cataract surgery. The most effective treatment or combination of treatments for controlling inflammation following cataract surgery has not been established. </p> <p>A comparison of the effectiveness and safety of NSAIDs and corticosteroids alone and their combined use will help elucidate the role of NSAIDs in controlling inflammation after routine cataract surgery (<a href="./references#CD010516-bbs2-0112" title="DeCroosFC , AfshariNA . Perioperative antibiotics and anti‐inflammatory agents in cataract surgery. Current Opinion in Ophthalmology2008;19(1):22‐6. ">DeCroos 2008</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010516-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010516-sec-0028"></div> <p>To evaluate the comparative effectiveness of topical NSAIDs (alone or in combination with topical corticosteroids) versus topical corticosteroids to control intraocular inflammation after uncomplicated phacoemulsification for cataract extraction. To assess postoperative best‐corrected visual acuity (BCVA), patient‐reported discomfort, symptoms, or complications (such as elevation of IOP), and cost‐effectiveness with the use of postoperative NSAIDs or corticosteroids. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010516-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010516-sec-0029"></div> <section id="CD010516-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010516-sec-0031"> <h4 class="title">Types of studies</h4> <p>We included randomized controlled trials (RCTs) in which the medications of interest were compared. We had planned to include quasi‐RCTs if there were few RCTs identified, however as we identified an abundance of RCTs, we chose to focus our review on those trials. We considered methods of treatment allocation such as alternation or based date of birth, Social Security number, and medical record number to be quasi‐random methods of allocation and thus did not included studies that used these methods. </p> </section> <section id="CD010516-sec-0032"> <h4 class="title">Types of participants</h4> <p>We included trials in which participants underwent phacoemulsification only for cataract extraction. We excluded trials that used other types of cataract surgery, such as manual small‐incision cataract surgery, extracapsular cataract extraction, and intracapsular cataract extraction. The focus of this review was the control of inflammation after uncomplicated cataract surgery, however we did not exclude studies in which participants may have experienced a complication after randomization. </p> </section> <section id="CD010516-sec-0033"> <h4 class="title">Types of interventions</h4> <p>We included trials in which topical NSAIDs were compared with topical corticosteroids and trials in which combination therapy (topical NSAIDs and corticosteroids) was compared with topical corticosteroids alone. We did not include dosing studies. We did not include studies that compared only one type of topical anti‐inflammatory agent with placebo, since administering inactive drops may be construed as being unethical following an inflammation‐inducing procedure such as cataract surgery. </p> </section> <section id="CD010516-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD010516-sec-0035"> <h5 class="title">Primary outcomes</h5> <p>The primary outcomes for this review were intraocular inflammation and BCVA, defined as: </p> <p> <ol id="CD010516-list-0001"> <li> <p>the proportion of participants with intraocular inflammation at one‐week after surgery;</p> </li> <li> <p>the proportion of participants with BCVA of 20/40 or better at one‐week after surgery.</p> </li> </ol> </p> <p>Intraocular inflammation is assessed clinically based on the presence of corneal edema, as well as anterior chamber cells and flare (<a href="./references#CD010516-bbs2-0122" title="HirneissC , NeubauerAS , KampikA , SchönfeldCL . Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double‐masked study. Graefe's Archives of Clinical and Experimental Ophthalmology2005;243(8):768‐73. ">Hirneiss 2005</a>; <a href="./references#CD010516-bbs2-0123" title="JabsDA , NussenblattRB , RosenbaumJT , Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. American Journal of Ophthalmology2005;140(3):509‐16. ">Jabs 2005</a>; <a href="./references#CD010516-bbs2-0134" title="SnyderRW , SiekertRW , SchwiegerlingJ , DonnenfeldE , ThompsonP . Acular as a single agent for use as an antimiotic and anti‐inflammatory in cataract surgery. Cataract and Refractive Surgery2000;26(8):1225‐7. ">Snyder 2000</a>). Corneal edema may be classified as 0 (none), 1 (moderate), 2 (marked), and 3 (severe). We sought data for anterior chamber cells (<a href="#CD010516-tbl-0003">Table 1</a>) and flare (<a href="#CD010516-tbl-0004">Table 2</a>) assessed by slit‐lamp examination as described by the Standardization of Uveitis Nomenclature (SUN) working group criteria (<a href="./references#CD010516-bbs2-0123" title="JabsDA , NussenblattRB , RosenbaumJT , Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. American Journal of Ophthalmology2005;140(3):509‐16. ">Jabs 2005</a>). For the purposes of this review, we considered corneal edema grades above 0 and anterior chamber cells and flare grades above 1 as indication of intraocular inflammation. </p> <div class="table" id="CD010516-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">The SUN Working Group Grading Scheme for Anterior Chamber Cells</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cells/Grade</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cells per field</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Less than 1</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.5+</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 to 5 cells</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1+</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 to 15 cells</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2+</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16 to 25 cells</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3+</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26 to 50 cells</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4+</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>More than 50 cells</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD010516-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">The SUN Working Group Grading Scheme for Anterior Chamber Flare</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Flare/Grade</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Description</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None to trace</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Faint</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate (iris and lens details clear)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Marked (iris and lens details hazy)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intense (fibrin or plastic aqueous)</p> </td> </tr> </tbody> </table> </div> <p>We also considered intraocular inflammation measured and defined in other ways in included studies. Although our protocol called for meta‐analysis on anterior chamber cell and flare as dichotomous outcomes (<a href="./references#CD010516-bbs2-0139" title="GonzalesJA , GritzDC , ChannaR , QuintoGG , KimA , ChuckRS . Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD010516] ">Gonzales 2013</a>), we performed meta‐analyses on continuous cell and flare data as this was how this information was reported in many of the included studies. </p> <p>The primary time point was one‐week after surgery, however we also included data reported at time points up to one month after surgery. </p> </section> <section id="CD010516-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010516-list-0002"> <li> <p>The proportion of participants with CME, as measured by ocular coherence tomography or fluorescein angiography, at one‐week after surgery. (Cystoid macular edema is frequently used as a surrogate for active intraocular inflammation.) We used definitions of CME as defined by the study authors, for example, any dye leakage or dye accumulation captured by fluorescein angiography. </p> </li> <li> <p>Time to cessation of treatment for inflammation.</p> </li> </ol> </p> <section id="CD010516-sec-0037"> <h6 class="title">Adverse events</h6> <p>We aimed to summarize the proportion of participants who reported self‐rated ocular discomfort at one day, one week, and one month after surgery. An example of a scale used to rate ocular discomfort is a 0‐to‐3‐point scale within one hour after self‐instillation of the topical agent, as described by <a href="./references#CD010516-bbs2-0113" title="DonnenfeldED , HollandEJ , StewartRH , GowJA , GrilloneLR , Bromfenac Ophthalmic Solution 0.09% (Xibrom) Study Group. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation. Ophthalmology2007;114(9):1653‐62. ">Donnenfeld 2007</a> and shown in <a href="#CD010516-tbl-0005">Table 3</a>. </p> <div class="table" id="CD010516-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Rating scale to determine the degree of ocular discomfort</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Grade</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Degree of ocular discomfort</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Description</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absent</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mild</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>You experience ocular discomfort, but it does not interfere at all with your completion of daily tasks. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>You experience ocular discomfort and it slows you down, but you are able to carry out work of a light or sedentary nature (e.g. light house work, office work). </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Severe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Your experience of ocular discomfort makes you completely unable to carry out any work activities. </p> </td> </tr> </tbody> </table> </div> <p>We investigated the proportion of participants with complications such as elevated IOP (greater than 21 mm Hg), corneal melting, ocular surface toxicity defined as punctate epithelial erosion or tear film instability, delayed wound healing (greater than two weeks), wound infection, or endophthalmitis. </p> </section> <section id="CD010516-sec-0038"> <h6 class="title">Economic outcomes</h6> <p>We planned to document economic outcomes reported from the included trials, namely whether topical NSAIDs alone or in combination with topical corticosteroids provide a significant benefit in primary or secondary outcome measures that would warrant their use as well as cost, however none of the included studies reported a cost comparison. </p> </section> </section> </section> </section> <section id="CD010516-sec-0039"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010516-sec-0040"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Eyes and Vision Information Specialist conducted systematic searches in the following databases for randomized controlled trials and controlled clinical trials. There were no language or publication year restrictions. The date of the search was 16 December 2016. </p> <p> <ul id="CD010516-list-0003"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 12) (which contains the Cochrane Eyes and Vision Trials Register) in the Cochrane Library (searched 16 December 2016) (<a href="./appendices#CD010516-sec-0106">Appendix 1</a>) </p> </li> <li> <p>MEDLINE Ovid (1946 to 16 December 2016) (<a href="./appendices#CD010516-sec-0107">Appendix 2</a>) </p> </li> <li> <p>Embase.com (1947 to 16 December 2016) (<a href="./appendices#CD010516-sec-0108">Appendix 3</a>) </p> </li> <li> <p>PubMed (1948 to 16 December 2016) (<a href="./appendices#CD010516-sec-0109">Appendix 4</a>) </p> </li> <li> <p>LILACS (Latin American and Caribbean Health Science Information database (1982 to 16 December 2016) (<a href="./appendices#CD010516-sec-0110">Appendix 5</a>) </p> </li> <li> <p><i>meta</i> Register of Controlled Trials (<i>m</i>RCT) (<a href="http://www.controlled-trials.com" target="_blank">www.controlled‐trials.com</a>; last searched 17 June 2013) (<a href="./appendices#CD010516-sec-0111">Appendix 6</a>) </p> </li> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>; searched 16 December 2016) (<a href="./appendices#CD010516-sec-0112">Appendix 7</a>) </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (<a href="http://www.who.int/ictrp" target="_blank">www.who.int/ictrp</a>; searched 16 December 2016) (<a href="./appendices#CD010516-sec-0113">Appendix 8</a>) </p> </li> </ul> </p> </section> <section id="CD010516-sec-0041"> <h4 class="title">Searching other resources</h4> <p>We searched reference lists of trials included in the review to identify any additional candidate studies. We searched the Web of Science Citation Index in December 2016 to find potentially eligible studies that had cited the included trials. We did not search conference proceedings for this review. </p> </section> </section> <section id="CD010516-sec-0042"> <h3 class="title" id="CD010516-sec-0042">Data collection and analysis</h3> <section id="CD010516-sec-0043"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently screened titles and abstracts retrieved from the searches. We classified each abstract as reporting a study eligible for inclusion, unsure, or definitely ineligible. We retrieved full‐text articles corresponding to abstracts classified as eligible for inclusion or unsure. Two review authors then independently screened each full‐text article to determine final eligibility for inclusion in the review. We classified each study as eligible for inclusion, exclusion, or awaiting assessment. We documented excluded studies and reported the reasons for exclusion. We contacted study authors of reports from studies classified as awaiting assessment for information that would allow us to either include or exclude the study from the review. We allowed study authors four weeks to respond. When we received no response after the allotted time period, we classified the study based on available information. Disagreements between the two review authors were resolved by discussion or by arbitration from a third review author if the two authors could not come to an agreement. We did not mask the names of authors, institutions, or journals when reviewing reports from studies during screening. </p> </section> <section id="CD010516-sec-0044"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently extracted data from the included trials. We resolved discrepancies and disagreements by discussion. We contacted trial authors to obtain unreported outcome data, allowing them four weeks for a response. Whenever we did not receive a response within four weeks, we reported this and extracted available data. One review author entered data into Review Manager 5 (<a href="./references#CD010516-bbs2-0130" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 5 2014</a>), and a second review author checked the data for inaccuracies. </p> </section> <section id="CD010516-sec-0045"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed the included trials for risk of bias. Domains assessed for each included trial are listed below and described in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010516-bbs2-0120" title="HigginsJP , AltmanDG , SterneJAC , editor(s) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). We assessed each trial for each 'Risk of bias' domain as being "low," "high," or "unclear" risk of bias and provide descriptions to support our assessments. Disagreements were resolved by discussion. </p> <p>We assessed risk of bias for the following domains.</p> <p> <ul id="CD010516-list-0004"> <li> <p>Selection bias</p> <ul id="CD010516-list-0005"> <li> <p>Sequence generation. We considered use of methods such as random number tables and computer‐based algorithms to confer "low" risk of bias. </p> </li> <li> <p>Allocation concealment before randomization. We considered methods such as sequentially numbered, opaque envelopes or central randomization to result in "low" risk of bias. </p> </li> </ul> </li> <li> <p>Performance bias</p> <ul id="CD010516-list-0006"> <li> <p>We considered masking of participants and personnel (including any treating physician and other trial staff) to provide "low" risk of bias. </p> </li> </ul> </li> <li> <p>Detection bias</p> <ul id="CD010516-list-0007"> <li> <p>Masking (blinding) of outcome assessors. We examined masking of outcome assessors for the primary and secondary outcomes. </p> </li> </ul> </li> <li> <p>Attrition bias</p> <ul id="CD010516-list-0008"> <li> <p>Incomplete outcome data. We examined reasons for incomplete data or losses to follow‐up for the primary and secondary outcomes. We also assessed methods used in the trial to account for incomplete data in analyses. </p> </li> </ul> </li> <li> <p>Reporting bias</p> <ul id="CD010516-list-0009"> <li> <p>Selective outcome reporting. Whenever the protocol or other reports of methods in the included trial were available, we compared the outcomes specified a prior with those reported for evidence of selective outcome reporting. </p> </li> </ul> </li> <li> <p>Other sources of bias</p> <ul id="CD010516-list-0010"> <li> <p>We extracted data on other sources of bias such as source of funding.</p> </li> </ul> </li> </ul> </p> </section> <section id="CD010516-sec-0046"> <h4 class="title">Measures of treatment effect</h4> <p>For outcome measures reported as dichotomous data (proportions of participants with intraocular inflammation, BCVA of 20/40 or better, CME, ocular discomfort, and complications), we calculated risk ratios (RR) with 95% confidence intervals (CI). For outcome measures reported as continuous data (time to cessation of treatment and cost analysis), we calculated mean differences (MD) with 95% CIs. </p> </section> <section id="CD010516-sec-0047"> <h4 class="title">Unit of analysis issues</h4> <p>We expected that most of the included trials would have assigned randomization based on participant, either one or both eyes to the same intervention. We considered the participant to be a cluster when both eyes of a single participant were randomized. We applied the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> for analyzing cluster‐randomized trials (Section 16.3) (<a href="./references#CD010516-bbs2-0121" title="HigginsJP , DeeksJJ , AltmanDG , editor(s) . Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). We sought statistical support from the Cochrane Eyes and Vision Group Editorial Base for analysis of data from trials with both eyes of participants randomized to the same intervention. If some participants in a trial had more than one eye included, for example one eye randomized to one treatment arm and one eye randomized to another treatment arm, we considered the non‐independence of eyes within the same person. </p> </section> <section id="CD010516-sec-0048"> <h4 class="title">Dealing with missing data</h4> <p>We attempted to contact the authors of reports from included trials for unclear or unreported information needed to assess risk of bias and to analyze outcomes. In the event of unsuccessful contact, we planned to conduct sensitivity analyses and discuss the implications. We planned to (a) assume all participants with missing data in the treatment group had the worse outcome, and (b) no participant with missing data in the other treatment group had the worse outcome. We used methods to handle missing data in the included trials described in the attrition bias section of the 'Risk of bias' tables in the <a href="./references#CD010516-sec-0121" title="">Characteristics of included studies</a> tables. </p> </section> <section id="CD010516-sec-0049"> <h4 class="title">Assessment of heterogeneity</h4> <p>We examined whether effect estimates among the included trials differed by characteristics of participants and methodology. We examined the forest plots of the primary outcomes and the characteristics of the studies for consistency across studies by considering the value of the I<sup>2</sup> statistic. We considered I<sup>2</sup> values greater than 50% to represent substantial statistical heterogeneity. </p> </section> <section id="CD010516-sec-0050"> <h4 class="title">Assessment of reporting biases</h4> <p>We assessed selective reporting of outcomes and analysis as described in the <a href="#CD010516-sec-0045">Assessment of risk of bias in included studies</a> section. We assessed potential publication bias by examining the symmetry of funnel plots. </p> </section> <section id="CD010516-sec-0051"> <h4 class="title">Data synthesis</h4> <p>We conducted meta‐analyses using random‐effects models, unless there were fewer than three trials that contributed outcome data for a meta‐analysis, in which case we used a fixed‐effect model. </p> </section> <section id="CD010516-sec-0052"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We had planned to conduct subgroup analyses to investigate heterogeneity of type, dose, and timing of interventions across trials. We examined consistency in effect estimates in two subgroup comparisons: studies that compared an NSAID with a corticosteroid and studies that compared a combination of an NSAID plus a corticosteroid with corticosteroid treatment alone. We were unable to conduct subgroup analyses using dose and timing of interventions because there were too many different dosing schedules and combinations of treatments to define meaningful subgroups. We had planned to conduct a subgroup analysis for participants who were currently on systemic immunosuppression at the time of cataract surgery or who had received periocular corticosteroid injection less than six weeks prior to cataract surgery compared with participants who were not on immunosuppression and had not received periocular corticosteroid injections, but required data were reported from too few included studies. </p> </section> <section id="CD010516-sec-0053"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to conduct sensitivity analyses by excluding trials that were judged to be at high risk of bias on domains of allocation and detection bias, but none of the studies included in the meta‐analyses was judged to have high risk of bias for these domains. We performed a sensitivity analysis in which we excluded a study that was industry funded. We also had planned to perform a sensitivity analysis excluding any unpublished studies, but all of the studies included in our meta‐analyses were published journal articles. Sensitivity analyses for incomplete outcome data were described in the <a href="#CD010516-sec-0048">Dealing with missing data</a> section. </p> <section id="CD010516-sec-0054"> <h5 class="title">'Summary of findings' table</h5> <p>We prepared a 'Summary of findings' table for each comparison to summarize the results of our analyses (<a href="./full#CD010516-tbl-0001">summary of findings Table for the main comparison</a>, <a href="./full#CD010516-tbl-0002">summary of findings Table 2</a>). We used the GRADE classification system to assess the certainty of the evidence for each outcome based on five factors: study limitations (risk of bias), inconsistency of effect, imprecision, indirectness, and publication bias (<a href="./references#CD010516-bbs2-0118" title="GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 10 January 2017. Hamilton (ON): GRADE Working Group, McMaster University, 2014. ">GRADEpro 2014</a>). The main outcomes presented in the 'Summary of findings' tables are: </p> <p> <ol id="CD010516-list-0011"> <li> <p>intraocular inflammation measured by anterior chamber cell and flare at one week;</p> </li> <li> <p>intraocular inflammation measured by proportion of participants with corneal edema at one week; </p> </li> <li> <p>proportion of participants with BCVA of 20/40 at one week;</p> </li> <li> <p>proportion of participants with CME at one week;</p> </li> <li> <p>time to cessation of treatment;</p> </li> <li> <p>adverse events; and</p> </li> <li> <p>economic outcomes.</p> </li> </ol> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010516-sec-0055" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010516-sec-0055"></div> <section id="CD010516-sec-0056"> <h3 class="title">Description of studies</h3> <section id="CD010516-sec-0057"> <h4 class="title">Results of the search</h4> <p>The initial electronic search performed in June 2013 identified 4886 potentially relevant unique references and 386 registry records. We revised the search strategy slightly and conducted updated searches in April and December 2016, identifying an additional 1409 references and 135 registry records. We reviewed 6816 total records (6295 unique references and 521 unique registry records) (<a href="#CD010516-fig-0001">Figure 1</a>). We assessed 126 full‐text reports and identified 48 studies that fulfilled our inclusion criteria. These 48 studies were published in 60 reports. We excluded 50 studies from 52 full‐text reports. We categorized eight studies as <a href="./references#CD010516-bbs1-0003" title="">Studies awaiting classification</a>, either because they appeared to fulfill the inclusion criteria but the registry record provided insufficient detail or lacked data, or because the study was published in a language other than English and we have yet to identify someone to assist with determining the eligibility. Two studies identified as ongoing are currently recruiting participants or have just completed data collection. Details of these studies are reported in the <a href="./references#CD010516-bbs1-0004" title="">Ongoing studies</a> section. We have reported details of the included studies in the <a href="./references#CD010516-sec-0121" title="">Characteristics of included studies</a> table. </p> <div class="figure" id="CD010516-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010516-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD010516-sec-0058"> <h4 class="title">Included studies</h4> <p>We included 48 studies in this review. Details and results from the studies were published in 60 reports and included over 5000 eyes. All included studies were parallel‐group RCTs. Some studies had participants with more than one eye included; in this studies both eyes may be randomized to the same intervention group or one eye randomized to one treatment arm and one eye randomized to another treatment arm. We observed that the analyses reported in these studies did not take into account the non‐independence of eyes and outcomes by using paired‐eye analysis methods. The appropriate use of paired‐eye analysis methods may have resulted in different findings in the individual studies, and therefore may have effected our findings; however, we are unable to assess the effect without the raw data from each included study with this problem. </p> <section id="CD010516-sec-0059"> <h5 class="title">Types of participants</h5> <p>We included studies that enrolled participants who received phacoemulsification for cataract. Some studies included a group of participants who received other types of cataract surgery, in which case we used only the data from the participants who underwent phacoemulsification. The studies were conducted in 17 different countries: three in Brazil (<a href="./references#CD010516-bbs2-0039" title="TiclyFG , LiraRP , ZanettiFR , MachadoMC , RodriguesGB , ArietaCE . Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial. Journal of Ocular Pharmacology and Therapeutics2014;30(6):495‐501. ">Ticly 2014</a>; <a href="./references#CD010516-bbs2-0041" title="TzelikisPF , VieiraM , HidaWT , MottaAF , NakanoCT , NakanoEM , et al. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo‐controlled randomised study. British Journal of Ophthalmology2015;99(5):654‐8. ">Tzelikis 2015</a>; <a href="./references#CD010516-bbs2-0047" title="ZanettiFR , FulcoEA , ChavesFR , daCosta PintoAP , ArietaCE , LiraRP . Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on maintenance of intraoperative mydriasis during cataract surgery: a randomized trial. Indian Journal of Ophthalmology2012;60(4):277‐81. ">Zanetti 2012</a>), two in Canada (<a href="./references#CD010516-bbs2-0002" title="AlmeidaDR , JohnsonD , HollandsH , SmallmanD , BaxterS , EngKT , et al. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. Journal of Cataract and Refractive Surgery2008;34(1):64‐9. ">Almeida 2008</a>; <a href="./references#CD010516-bbs2-0003" title="AlmeidaDR , KhanZ , XingL , BakarSN , RahimK , UrtonT , et al. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. Journal of Cataract and Refractive Surgery2012;38(9):1537‐43. ">Almeida 2012</a>), four in China (<a href="./references#CD010516-bbs2-0008" title="ChenJ , WangGQ . Clinical observation of bromfenac sodium 0.1% eye drops on cataract surgery. International Eye Science2015;15(12):2102‐4. ">Chen 2015</a>; <a href="./references#CD010516-bbs2-0023" title="LiMC , YangXR , LiuF , ShaoDP , LiYB . Effect of topical NSAIDs in preventing macular edema after phacoemulsification in diabetes. International Journal of Ophthalmology2011;11(9):1614‐6. ">Li 2011</a>; <a href="./references#CD010516-bbs2-0043" title="WangQW , YaoK , XuW , ChenPQ , ShentuXC , XieX , et al. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification. Ophthalmologica2013;229(4):187‐94. ">Wang 2013</a>; <a href="./references#CD010516-bbs2-0048" title="ZhangHY , ZhuSQ . Clinical study of pranoprofen eyedrops on prophylaxis of cystoids macular edema after cataract surgery. International Journal of Ophthalmology2008;8(7):1370‐2. ">Zhang 2008</a>), one in Cuba (<a href="./references#CD010516-bbs2-0033" title="RodríguezYR , PereraIIYM , HernándezIM , ÁvilaIIRI , Hernández SilvaJR , OchoaMJ . Diclofenac sodium eyedrops in cataract's surgery by phacoemulsification [Colirio de diclofenaco sódico en cirugía de catarata por facoemulsificación]. Revista Cubana de Oftalmología2011;24(1):46‐54. ">Ruiz Rodríguez 2011</a>), one in Egypt (<a href="./references#CD010516-bbs2-0014" title="ElsawyMF , BadawiN , KhairyHA . Prophylactic postoperative ketorolac improves outcomes in diabetic patients assigned for cataract surgery. Clinical Ophthalmology2013;7:1245‐9. ">Elsawy 2013</a>), one in France (<a href="./references#CD010516-bbs2-0001" title="AdamR , RodallecT , NordmannJP . Indometacine and macular thickness undergoing cataract surgery: a prospective randomized study. Investigative Ophthalmology &amp; Visual Science2005; Vol. 46:E‐Abstract 787. ">Adam 2005</a>), two in Germany (<a href="./references#CD010516-bbs2-0018" title="HessemerV , SchartnerH . Low influence of anti‐inflammatory therapy on intraocular inflammation following minimally invasive phacoemulsification [Geringer Einfluß antiinflammatorischer Therapie auf den intraokularen Reizzustand nach minimal invasiver Phakoemulsifikation]. Der Ophthalmologe1997;94(1):30‐2. HessemerV , SchmidtK , SchartnerH . Minimally inflammatory cataract surgery [Minimal inflammatorische Kataraktchirurgie (MIK)]. Klinische Montasblätter für Augenheilkunde1996;209(6):331‐9. ">Hessemer 1996</a>; <a href="./references#CD010516-bbs2-0035" title="SchmittTH . Anti‐inflammatory therapy after cataract surgery — a laser‐flare‐cell photometer controlled study [Zur antiinflammatorischen therapie nach kataraktchirurigie. Eine kontrollierte studie mittels Laser‐Flare‐Cell‐Photometrie]. Aktuelle Augenheilkunde1995;20(5):263‐8. ">Schmitt 1995</a>), two in Greece (<a href="./references#CD010516-bbs2-0007" title="ChatziralliIP , PapazisisL , SergentanisTN . Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial. Ophthalmologica2011;225(2):89‐94. ChatziralliIP , SergentanisTN , ParikakisEA , PapazisisLE , MitropoulosP , MoschosMM . The impact of non‐steroidal anti‐inflammatory agents after phacoemulsification on quality of life: a randomized study. Ophthalmology and Therapy2017;6(1):133‐40. ">Chatziralli 2011</a>; <a href="./references#CD010516-bbs2-0029" title="MoschosMM , ChatziralliIP , PantazisP , RouvasAA , SergentanisTN . Is topical diclofenac essential before and after uneventful phacoemulsification cataract surgery?. Journal of Ocular Pharmacology and Therapeutics2012;28(4):335‐9. ">Moschos 2012</a>), one in India (<a href="./references#CD010516-bbs2-0034" title="SahuS , RamJ , BansalR , PandavSS , GuptaA . Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification. Journal of Cataract and Refractive Surgery2015;41(10):2043‐8. ">Sahu 2015</a>), one in Iran (<a href="./references#CD010516-bbs2-0016" title="EntezariM , RamezaniA , NikkhahH , YaseriM . The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial. International Ophthalmology2017;37(1):13‐8. [DOI: 10.1007/s10792‐016‐0209‐4] ">Entezari 2016</a>), seven in Japan (<a href="./references#CD010516-bbs2-0004" title="AsanoS , MiyakeK , OtaI , SugitaG , KimuraW , SakkaY , et al. Reducing angiographic cystoid macular edema and blood‐aqueous barrier disruption after small‐incision phacoemulsification and foldable intraocular lens implantation. Multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasonone 0.1%. Journal of Cataract and Refractive Surgery2008;31(1):57‐63. ">Asano 2008</a>; <a href="./references#CD010516-bbs2-0015" title="EndoN , KatoS , HaruyamaK , ShojiM , KitanoS . Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes. Acta Ophthalmologica2010;88(8):896‐900. KitanoS , EndoN , ShojiM , HaruyamaK , KatoS . Effect of bromfenac sodium ophthalmic solution on preventing cystoids macular edema and inflammation after phacoemulsification and implantation of intraocular lens in diabetic patients. Investigative Ophthalmology &amp; Visual Science2008; Vol. 49:ARVO E‐Abstract 3470. ">Endo 2010</a>; <a href="./references#CD010516-bbs2-0021" title="KatoS , BokuC , OnishiT , KoikeM , KageyamaT , NishiharaH , et al. Comparison of postoperative inflammation with two types of intraocular lense and anti‐inflammatory agents. Folia Ophthalmologica Japonica1998;49:286‐9. ">Kato 1998</a>; <a href="./references#CD010516-bbs2-0026" title="MiyakeK , NishimuraK , HarinoS , OtaI , AsanoS , KondoN , et al. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation. Investigative Ophthalmology &amp; Visual Science2007;48(12):5647‐52. ">Miyake 2007</a>; <a href="./references#CD010516-bbs2-0027" title="MiyakeK , OtaI , MiyakeG , NumagaJ . Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. Journal of Cataract and Refractive Surgery2011;37(9):1581‐8. ">Miyake 2011</a>; <a href="./references#CD010516-bbs2-0028" title="MiyanagaM , MiyaiT , NejimaR , MaruyamaY , MiyataK , KatoS . Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. Acta Ophthalmologica2009;87(3):300‐5. ">Miyanaga 2009</a>; <a href="./references#CD010516-bbs2-0036" title="ShimazakiJ , FujishimaH , YagiY , TsubotaK . Effects of diclofenac eye drops on corneal epithelial structure and function after small‐incision cataract surgery. Ophthalmology1996;103(1):50‐7. ">Shimazaki 1996</a>), one in Mexico (<a href="./references#CD010516-bbs2-0006" title="Cervantes‐CosteG , Sánchez‐CastroY , Orozco‐CarrollM , Mendoza‐SchusterE , Velasco‐BaronaC . Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac. Clinical Ophthalmology2009;3(1):219‐26. ">Cervantes‐Coste 2009</a>), one in South Korea (<a href="./references#CD010516-bbs2-0020" title="JungJW , ChungBH , KimEK , SeoKY , KimTI . The effects of two non‐steroidal anti‐inflammatory drugs, bromfenac 0.1% and ketorolac 0.45%, on cataract surgery. Yonsei Medical Journal2015;56(6):1671‐7. ">Jung 2015</a>), two in Sweden (<a href="./references#CD010516-bbs2-0022" title="LaurellCG , ZetterströmC . Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery. British Journal of Ophthalmology2002;86(12):1380‐4. ">Laurell 2002</a>; <a href="./references#CD010516-bbs2-0046" title="ZaczekA , ArtzenD , LaurellCG , SteneviU , MontanP . Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery. Journal of Cataract and Refractive Surgery2014;40(9):1498‐505. ">Zaczek 2014</a>), one in Thailand (<a href="./references#CD010516-bbs2-0040" title="TrinavaratA , AtchaneeyasakulL , SurachatkumtonekulT , KosrirukvongsP . Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification. Journal of the Medical Association of Thailand2003;86(2):143‐50. ">Trinavarat 2003</a>), two in Turkey (<a href="./references#CD010516-bbs2-0009" title="DalD , SaraçO , TokluY , CakmakHB , GungorED . Efficacy of topical ketoroloc on macular thickness in patients undergoing cataract surgery. Ophthalmologica2014;232(Suppl 2):43. ">Dal 2014</a>; <a href="./references#CD010516-bbs2-0045" title="YavasGF , OztürkF , KüsbeciT . Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema. Journal of Cataract and Refractive Surgery2007;33(5):804‐7. ">Yavas 2007</a>), and seven in the United States (<a href="./references#CD010516-bbs2-0012" title="DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Acta Ophthalmologica2015;93(4):e314‐5. DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Asia‐Pacific Journal of Ophthalmology2014;3(4):220‐5. ">Duong 2014</a>; <a href="./references#CD010516-bbs2-0013" title="el‐HaraziSM , RuizRS , FeldmanRM , VillanuevaG , ChuangAZ . A randomized double‐masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post‐phacoemulsification flare and cells. Ophthalmic Surgery and Lasers1998;29(7):539‐44. ">el‐Harazi 1998</a>; <a href="./references#CD010516-bbs2-0019" title="HolzerMP , SolomonKD , SandovalHP , VromanDT . Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification. Journal of Cataract and Refractive Surgery2002;28(1):93‐9. ">Holzer 2002</a>; <a href="./references#CD010516-bbs2-0024" title="AschbrennerMW , MathysKC , CohenKL . Do biological parameters and phaco metrics affect OCT measured CMT with and without nepafenac 0.1% treatment?. Investigative Ophthalmology &amp; Visual Science2008;49(13):389. MathysKC , CohenKL . Effect of nepafenac on macular thickness following uncomplicated cataract surgery. Investigative Ophthalmology &amp; Visual Science2008; Vol. 49:ARVO E‐Abstract 5674. MathysKC , CohenKL . Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema. Eye2010;24(1):90‐6. ">Mathys 2010</a>; <a href="./references#CD010516-bbs2-0037" title="SinghR , AlpernL , JaffeGJ , LehmannRP , LimJ , ReiserHJ , et al. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clinical Ophthalmology2012;2012(6):1259‐69. ">Singh 2012</a>; <a href="./references#CD010516-bbs2-0038" title="SolomonKD , VromanDT , BarkerD , GehlkenJ . Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Journal of Cataract and Refractive Surgery2001;27(8):1232‐7. ">Solomon 2001</a>; <a href="./references#CD010516-bbs2-0044" title="WittpennJR , SilversteinS , HeierJ , KenyonKR , HunkelerJD , EarlM , et al. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low‐risk cataract surgery patients. American Journal of Ophthalmology2008;146(4):554‐60. ">Wittpenn 2008</a>). Investigators of nine studies did not report in which country the trial had been conducted (<a href="./references#CD010516-bbs2-0005" title="BucciFA , MattaAZ . An objective comparison of acular vs vexol to control inflammation following phacoemulsification. American Academy of Ophthalmology; 2001 Nov 11‐14; New Orleans (LA). 2001:117. ">Bucci 2001</a>; <a href="./references#CD010516-bbs2-0010" title="DemcoTA . Topical diclofenac versus prednisolone acetate in control of inflammation after phacoemulsification. American Academy of Ophthalmology1995:150. DemcoTA , SuttonH , DemcoCJ , RajPS . Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification‐lens implant surgery. European Journal of Ophthalmology1997;7(3):236‐40. ">Demco 1997</a>; <a href="./references#CD010516-bbs2-0011" title="DonnenfeldED , PerryHD , WittpennJR , SolomonR , NattisA , ChouT . Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic‐response curve. Journal of Cataract and Refractive Surgery2006;32(9):1474‐82. ">Donnenfeld 2006</a>; <a href="./references#CD010516-bbs2-0017" title="GuzeyM , KaradedeZ , DoganZ , SaticiA . Ketorolac‐tobramycin combination vs fluorometholone‐tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision. Ophthalmic Surgery and Lasers2000;31(6):451‐6. ">Guzey 2000</a>; <a href="./references#CD010516-bbs2-0025" title="McColginAZ , RaizmanMB . Efficacy of topical voltaren in reducing the incidence of postoperative cystoid macular edema. Investigative Ophthalmology &amp; Visual Science1999; Vol. 40:ARVO E‐Abstract 1529. ">McColgin 1999</a>; <a href="./references#CD010516-bbs2-0030" title="MuletME , AlioJL , AyalaMJ , De laHozF , BedaJL . Efficacy of 0.5% ketorolac (Acular™) as an anti‐inflammatory treatment after cataract surgery. Investigative Ophthalmology &amp; Visual Science2001;42:ARVO E‐Abstract 66. ">Mulet 2001</a>; <a href="./references#CD010516-bbs2-0031" title="OstrovCS , SirkinSR , DeutschWE , MasiRJ , ChandlerJW , LindquistTD . Ketorolac, prednisolone, and dexamethasone for postoperative inflammation. Clinical Therapeutics1997;19(2):259‐72. ">Ostrov 1997</a>; <a href="./references#CD010516-bbs2-0032" title="BrennanKM , BrownRM , RobertsCW . A comparison of topical non‐steroidal anti‐inflammatory drugs to steroids for control of post cataract inflammation. Journal of the American Society of Ophthalmic Registered Nurses1993;18(1):8‐11. BrownRM , RobertsCW . Preoperative and postoperative use of nonsteroidal antiinflammatory drugs in cataract surgery. Journal of the American Society of Ophthalmic Registered Nurses1996;21(1):13‐6. RobertsCW . A comparison of non‐steroidal anti‐inflammatory drug to steroids for postoperative inflammation. American Academy of Ophthalmology1992; Vol. 22. RobertsCW , BrennanKM . A comparison on topical diclofenac with prednisolone for postcataract inflammation. Archives of Ophthalmology1995;113(6):725‐7. ">Roberts 1995</a>; <a href="./references#CD010516-bbs2-0042" title="VoudouriA , ZafirakisP , Livir‐RallatosG , Livir‐RallatosC , CanakisC , MarkomichelakisN . Diclofenac versus prednisolone post phacoemulsification treatment: a randomized clinical trial. Investigative Ophthalmology &amp; Visual Science2002; Vol. 43:ARVO E‐Abstract 373. ">Voudouri 2002</a>). </p> </section> <section id="CD010516-sec-0060"> <h5 class="title">Types of interventions</h5> <p>Fifteen studies compared an NSAID to a corticosteroid (<a href="./references#CD010516-bbs2-0004" title="AsanoS , MiyakeK , OtaI , SugitaG , KimuraW , SakkaY , et al. Reducing angiographic cystoid macular edema and blood‐aqueous barrier disruption after small‐incision phacoemulsification and foldable intraocular lens implantation. Multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasonone 0.1%. Journal of Cataract and Refractive Surgery2008;31(1):57‐63. ">Asano 2008</a>; <a href="./references#CD010516-bbs2-0005" title="BucciFA , MattaAZ . An objective comparison of acular vs vexol to control inflammation following phacoemulsification. American Academy of Ophthalmology; 2001 Nov 11‐14; New Orleans (LA). 2001:117. ">Bucci 2001</a>; <a href="./references#CD010516-bbs2-0010" title="DemcoTA . Topical diclofenac versus prednisolone acetate in control of inflammation after phacoemulsification. American Academy of Ophthalmology1995:150. DemcoTA , SuttonH , DemcoCJ , RajPS . Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification‐lens implant surgery. European Journal of Ophthalmology1997;7(3):236‐40. ">Demco 1997</a>; <a href="./references#CD010516-bbs2-0012" title="DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Acta Ophthalmologica2015;93(4):e314‐5. DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Asia‐Pacific Journal of Ophthalmology2014;3(4):220‐5. ">Duong 2014</a>; <a href="./references#CD010516-bbs2-0015" title="EndoN , KatoS , HaruyamaK , ShojiM , KitanoS . Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes. Acta Ophthalmologica2010;88(8):896‐900. KitanoS , EndoN , ShojiM , HaruyamaK , KatoS . Effect of bromfenac sodium ophthalmic solution on preventing cystoids macular edema and inflammation after phacoemulsification and implantation of intraocular lens in diabetic patients. Investigative Ophthalmology &amp; Visual Science2008; Vol. 49:ARVO E‐Abstract 3470. ">Endo 2010</a>; <a href="./references#CD010516-bbs2-0017" title="GuzeyM , KaradedeZ , DoganZ , SaticiA . Ketorolac‐tobramycin combination vs fluorometholone‐tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision. Ophthalmic Surgery and Lasers2000;31(6):451‐6. ">Guzey 2000</a>; <a href="./references#CD010516-bbs2-0019" title="HolzerMP , SolomonKD , SandovalHP , VromanDT . Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification. Journal of Cataract and Refractive Surgery2002;28(1):93‐9. ">Holzer 2002</a>; <a href="./references#CD010516-bbs2-0021" title="KatoS , BokuC , OnishiT , KoikeM , KageyamaT , NishiharaH , et al. Comparison of postoperative inflammation with two types of intraocular lense and anti‐inflammatory agents. Folia Ophthalmologica Japonica1998;49:286‐9. ">Kato 1998</a>; <a href="./references#CD010516-bbs2-0022" title="LaurellCG , ZetterströmC . Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery. British Journal of Ophthalmology2002;86(12):1380‐4. ">Laurell 2002</a>; <a href="./references#CD010516-bbs2-0026" title="MiyakeK , NishimuraK , HarinoS , OtaI , AsanoS , KondoN , et al. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation. Investigative Ophthalmology &amp; Visual Science2007;48(12):5647‐52. ">Miyake 2007</a>; <a href="./references#CD010516-bbs2-0027" title="MiyakeK , OtaI , MiyakeG , NumagaJ . Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. Journal of Cataract and Refractive Surgery2011;37(9):1581‐8. ">Miyake 2011</a>; <a href="./references#CD010516-bbs2-0032" title="BrennanKM , BrownRM , RobertsCW . A comparison of topical non‐steroidal anti‐inflammatory drugs to steroids for control of post cataract inflammation. Journal of the American Society of Ophthalmic Registered Nurses1993;18(1):8‐11. BrownRM , RobertsCW . Preoperative and postoperative use of nonsteroidal antiinflammatory drugs in cataract surgery. Journal of the American Society of Ophthalmic Registered Nurses1996;21(1):13‐6. RobertsCW . A comparison of non‐steroidal anti‐inflammatory drug to steroids for postoperative inflammation. American Academy of Ophthalmology1992; Vol. 22. RobertsCW , BrennanKM . A comparison on topical diclofenac with prednisolone for postcataract inflammation. Archives of Ophthalmology1995;113(6):725‐7. ">Roberts 1995</a>; <a href="./references#CD010516-bbs2-0038" title="SolomonKD , VromanDT , BarkerD , GehlkenJ . Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Journal of Cataract and Refractive Surgery2001;27(8):1232‐7. ">Solomon 2001</a>; <a href="./references#CD010516-bbs2-0042" title="VoudouriA , ZafirakisP , Livir‐RallatosG , Livir‐RallatosC , CanakisC , MarkomichelakisN . Diclofenac versus prednisolone post phacoemulsification treatment: a randomized clinical trial. Investigative Ophthalmology &amp; Visual Science2002; Vol. 43:ARVO E‐Abstract 373. ">Voudouri 2002</a>; <a href="./references#CD010516-bbs2-0043" title="WangQW , YaoK , XuW , ChenPQ , ShentuXC , XieX , et al. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification. Ophthalmologica2013;229(4):187‐94. ">Wang 2013</a>). Nineteen studies compared a combination of an NSAID plus a corticosteroid with a corticosteroid only (<a href="./references#CD010516-bbs2-0001" title="AdamR , RodallecT , NordmannJP . Indometacine and macular thickness undergoing cataract surgery: a prospective randomized study. Investigative Ophthalmology &amp; Visual Science2005; Vol. 46:E‐Abstract 787. ">Adam 2005</a>; <a href="./references#CD010516-bbs2-0002" title="AlmeidaDR , JohnsonD , HollandsH , SmallmanD , BaxterS , EngKT , et al. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. Journal of Cataract and Refractive Surgery2008;34(1):64‐9. ">Almeida 2008</a>; <a href="./references#CD010516-bbs2-0006" title="Cervantes‐CosteG , Sánchez‐CastroY , Orozco‐CarrollM , Mendoza‐SchusterE , Velasco‐BaronaC . Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac. Clinical Ophthalmology2009;3(1):219‐26. ">Cervantes‐Coste 2009</a>; <a href="./references#CD010516-bbs2-0007" title="ChatziralliIP , PapazisisL , SergentanisTN . Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial. Ophthalmologica2011;225(2):89‐94. ChatziralliIP , SergentanisTN , ParikakisEA , PapazisisLE , MitropoulosP , MoschosMM . The impact of non‐steroidal anti‐inflammatory agents after phacoemulsification on quality of life: a randomized study. Ophthalmology and Therapy2017;6(1):133‐40. ">Chatziralli 2011</a>; <a href="./references#CD010516-bbs2-0008" title="ChenJ , WangGQ . Clinical observation of bromfenac sodium 0.1% eye drops on cataract surgery. International Eye Science2015;15(12):2102‐4. ">Chen 2015</a>; <a href="./references#CD010516-bbs2-0009" title="DalD , SaraçO , TokluY , CakmakHB , GungorED . Efficacy of topical ketoroloc on macular thickness in patients undergoing cataract surgery. Ophthalmologica2014;232(Suppl 2):43. ">Dal 2014</a>; <a href="./references#CD010516-bbs2-0014" title="ElsawyMF , BadawiN , KhairyHA . Prophylactic postoperative ketorolac improves outcomes in diabetic patients assigned for cataract surgery. Clinical Ophthalmology2013;7:1245‐9. ">Elsawy 2013</a>; <a href="./references#CD010516-bbs2-0016" title="EntezariM , RamezaniA , NikkhahH , YaseriM . The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial. International Ophthalmology2017;37(1):13‐8. [DOI: 10.1007/s10792‐016‐0209‐4] ">Entezari 2016</a>; <a href="./references#CD010516-bbs2-0023" title="LiMC , YangXR , LiuF , ShaoDP , LiYB . Effect of topical NSAIDs in preventing macular edema after phacoemulsification in diabetes. International Journal of Ophthalmology2011;11(9):1614‐6. ">Li 2011</a>; <a href="./references#CD010516-bbs2-0024" title="AschbrennerMW , MathysKC , CohenKL . Do biological parameters and phaco metrics affect OCT measured CMT with and without nepafenac 0.1% treatment?. Investigative Ophthalmology &amp; Visual Science2008;49(13):389. MathysKC , CohenKL . Effect of nepafenac on macular thickness following uncomplicated cataract surgery. Investigative Ophthalmology &amp; Visual Science2008; Vol. 49:ARVO E‐Abstract 5674. MathysKC , CohenKL . Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema. Eye2010;24(1):90‐6. ">Mathys 2010</a>; <a href="./references#CD010516-bbs2-0025" title="McColginAZ , RaizmanMB . Efficacy of topical voltaren in reducing the incidence of postoperative cystoid macular edema. Investigative Ophthalmology &amp; Visual Science1999; Vol. 40:ARVO E‐Abstract 1529. ">McColgin 1999</a>; <a href="./references#CD010516-bbs2-0029" title="MoschosMM , ChatziralliIP , PantazisP , RouvasAA , SergentanisTN . Is topical diclofenac essential before and after uneventful phacoemulsification cataract surgery?. Journal of Ocular Pharmacology and Therapeutics2012;28(4):335‐9. ">Moschos 2012</a>; <a href="./references#CD010516-bbs2-0033" title="RodríguezYR , PereraIIYM , HernándezIM , ÁvilaIIRI , Hernández SilvaJR , OchoaMJ . Diclofenac sodium eyedrops in cataract's surgery by phacoemulsification [Colirio de diclofenaco sódico en cirugía de catarata por facoemulsificación]. Revista Cubana de Oftalmología2011;24(1):46‐54. ">Ruiz Rodríguez 2011</a>; <a href="./references#CD010516-bbs2-0036" title="ShimazakiJ , FujishimaH , YagiY , TsubotaK . Effects of diclofenac eye drops on corneal epithelial structure and function after small‐incision cataract surgery. Ophthalmology1996;103(1):50‐7. ">Shimazaki 1996</a>; <a href="./references#CD010516-bbs2-0037" title="SinghR , AlpernL , JaffeGJ , LehmannRP , LimJ , ReiserHJ , et al. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clinical Ophthalmology2012;2012(6):1259‐69. ">Singh 2012</a>; <a href="./references#CD010516-bbs2-0039" title="TiclyFG , LiraRP , ZanettiFR , MachadoMC , RodriguesGB , ArietaCE . Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial. Journal of Ocular Pharmacology and Therapeutics2014;30(6):495‐501. ">Ticly 2014</a>; <a href="./references#CD010516-bbs2-0044" title="WittpennJR , SilversteinS , HeierJ , KenyonKR , HunkelerJD , EarlM , et al. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low‐risk cataract surgery patients. American Journal of Ophthalmology2008;146(4):554‐60. ">Wittpenn 2008</a>; <a href="./references#CD010516-bbs2-0046" title="ZaczekA , ArtzenD , LaurellCG , SteneviU , MontanP . Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery. Journal of Cataract and Refractive Surgery2014;40(9):1498‐505. ">Zaczek 2014</a>; <a href="./references#CD010516-bbs2-0048" title="ZhangHY , ZhuSQ . Clinical study of pranoprofen eyedrops on prophylaxis of cystoids macular edema after cataract surgery. International Journal of Ophthalmology2008;8(7):1370‐2. ">Zhang 2008</a>). Fourteen other studies had three or more arms and had such combinations as an NSAID alone versus a corticosteroid alone versus a combination (<a href="./references#CD010516-bbs2-0018" title="HessemerV , SchartnerH . Low influence of anti‐inflammatory therapy on intraocular inflammation following minimally invasive phacoemulsification [Geringer Einfluß antiinflammatorischer Therapie auf den intraokularen Reizzustand nach minimal invasiver Phakoemulsifikation]. Der Ophthalmologe1997;94(1):30‐2. HessemerV , SchmidtK , SchartnerH . Minimally inflammatory cataract surgery [Minimal inflammatorische Kataraktchirurgie (MIK)]. Klinische Montasblätter für Augenheilkunde1996;209(6):331‐9. ">Hessemer 1996</a>; <a href="./references#CD010516-bbs2-0028" title="MiyanagaM , MiyaiT , NejimaR , MaruyamaY , MiyataK , KatoS . Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. Acta Ophthalmologica2009;87(3):300‐5. ">Miyanaga 2009</a>; <a href="./references#CD010516-bbs2-0035" title="SchmittTH . Anti‐inflammatory therapy after cataract surgery — a laser‐flare‐cell photometer controlled study [Zur antiinflammatorischen therapie nach kataraktchirurigie. Eine kontrollierte studie mittels Laser‐Flare‐Cell‐Photometrie]. Aktuelle Augenheilkunde1995;20(5):263‐8. ">Schmitt 1995</a>); multiple NSAIDs compared with each other and versus a corticosteroid (<a href="./references#CD010516-bbs2-0013" title="el‐HaraziSM , RuizRS , FeldmanRM , VillanuevaG , ChuangAZ . A randomized double‐masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post‐phacoemulsification flare and cells. Ophthalmic Surgery and Lasers1998;29(7):539‐44. ">el‐Harazi 1998</a>; <a href="./references#CD010516-bbs2-0030" title="MuletME , AlioJL , AyalaMJ , De laHozF , BedaJL . Efficacy of 0.5% ketorolac (Acular™) as an anti‐inflammatory treatment after cataract surgery. Investigative Ophthalmology &amp; Visual Science2001;42:ARVO E‐Abstract 66. ">Mulet 2001</a>; <a href="./references#CD010516-bbs2-0047" title="ZanettiFR , FulcoEA , ChavesFR , daCosta PintoAP , ArietaCE , LiraRP . Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on maintenance of intraoperative mydriasis during cataract surgery: a randomized trial. Indian Journal of Ophthalmology2012;60(4):277‐81. ">Zanetti 2012</a>); an NSAID versus a corticosteroid versus a different corticosteroid (<a href="./references#CD010516-bbs2-0031" title="OstrovCS , SirkinSR , DeutschWE , MasiRJ , ChandlerJW , LindquistTD . Ketorolac, prednisolone, and dexamethasone for postoperative inflammation. Clinical Therapeutics1997;19(2):259‐72. ">Ostrov 1997</a>; <a href="./references#CD010516-bbs2-0040" title="TrinavaratA , AtchaneeyasakulL , SurachatkumtonekulT , KosrirukvongsP . Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification. Journal of the Medical Association of Thailand2003;86(2):143‐50. ">Trinavarat 2003</a>); and multiple combinations of an NSAID plus a corticosteroid against each other with a corticosteroid‐only arm in addition (<a href="./references#CD010516-bbs2-0003" title="AlmeidaDR , KhanZ , XingL , BakarSN , RahimK , UrtonT , et al. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. Journal of Cataract and Refractive Surgery2012;38(9):1537‐43. ">Almeida 2012</a>; <a href="./references#CD010516-bbs2-0011" title="DonnenfeldED , PerryHD , WittpennJR , SolomonR , NattisA , ChouT . Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic‐response curve. Journal of Cataract and Refractive Surgery2006;32(9):1474‐82. ">Donnenfeld 2006</a>; <a href="./references#CD010516-bbs2-0020" title="JungJW , ChungBH , KimEK , SeoKY , KimTI . The effects of two non‐steroidal anti‐inflammatory drugs, bromfenac 0.1% and ketorolac 0.45%, on cataract surgery. Yonsei Medical Journal2015;56(6):1671‐7. ">Jung 2015</a>; <a href="./references#CD010516-bbs2-0034" title="SahuS , RamJ , BansalR , PandavSS , GuptaA . Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification. Journal of Cataract and Refractive Surgery2015;41(10):2043‐8. ">Sahu 2015</a>; <a href="./references#CD010516-bbs2-0041" title="TzelikisPF , VieiraM , HidaWT , MottaAF , NakanoCT , NakanoEM , et al. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo‐controlled randomised study. British Journal of Ophthalmology2015;99(5):654‐8. ">Tzelikis 2015</a>; <a href="./references#CD010516-bbs2-0045" title="YavasGF , OztürkF , KüsbeciT . Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema. Journal of Cataract and Refractive Surgery2007;33(5):804‐7. ">Yavas 2007</a>). NSAIDs given in the studies were indomethacin, ketorolac, nepafenac, diclofenac, bromfenac, flurbiprofen, and pranoprofen. Corticosteroids given in the trials were dexamethasone, prednisolone acetate, betamethasone, rimexolone, fluorometholone, and loteprednol etabonate. </p> </section> <section id="CD010516-sec-0061"> <h5 class="title">Types of outcomes</h5> <p>The most common primary outcomes reported were flare and cell measurements, visual acuity, IOP measurements, presence of macular edema, and macular thickness and macular volume measurements. The majority of the studies that reported on ocular inflammation using cell and flare measurements in the anterior chamber provided data in a continuous format (mean number of cells, mean photons per milliseconds of flare, or sum of cells and flare), rather than the dichotomous format we expected for this review. The disparity between the format of the expected data and the reported data is shown in <a href="#CD010516-tbl-0006">Table 4</a>. There were few studies that reported other outcome data in a dichotomous format, stating the "proportion of participants" with a certain outcome, but there were a much larger number of studies that provided outcome data in continuous format. Besides inflammation measured by anterior chamber cells and flare, this situation was also seen with BCVA outcomes (visual acuity reported as a mean for each group rather than a proportion having better than a certain measure) and CME outcomes (mean or change in OCT measures rather than the proportion with CME). Some of the studies collected data on the outcomes we intended to include, but these data were reported only in figures from which we were unable to extract the numbers needed for a meta‐analysis; these studies are noted in the table. For the first primary outcome of this review, the proportion of participants with intraocular inflammation measured by presence of macular edema, only 4/48 (8%) of the included studies reported data (<a href="./references#CD010516-bbs2-0007" title="ChatziralliIP , PapazisisL , SergentanisTN . Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial. Ophthalmologica2011;225(2):89‐94. ChatziralliIP , SergentanisTN , ParikakisEA , PapazisisLE , MitropoulosP , MoschosMM . The impact of non‐steroidal anti‐inflammatory agents after phacoemulsification on quality of life: a randomized study. Ophthalmology and Therapy2017;6(1):133‐40. ">Chatziralli 2011</a>; <a href="./references#CD010516-bbs2-0037" title="SinghR , AlpernL , JaffeGJ , LehmannRP , LimJ , ReiserHJ , et al. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clinical Ophthalmology2012;2012(6):1259‐69. ">Singh 2012</a>; <a href="./references#CD010516-bbs2-0040" title="TrinavaratA , AtchaneeyasakulL , SurachatkumtonekulT , KosrirukvongsP . Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification. Journal of the Medical Association of Thailand2003;86(2):143‐50. ">Trinavarat 2003</a> and <a href="./references#CD010516-bbs2-0041" title="TzelikisPF , VieiraM , HidaWT , MottaAF , NakanoCT , NakanoEM , et al. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo‐controlled randomised study. British Journal of Ophthalmology2015;99(5):654‐8. ">Tzelikis 2015</a>). Of the four studies, three reported the data in a format that we could not use for meta‐analysis (data was presented either in a figure only, at time points that were not of interest in this review, or used a different definition of macular edema). The other measure of intraocular inflammation that we had planned as our primary outcome was the proportion of participants with anterior chamber cells and flare above grade 1 using the SUN scale, and only 3/48 (6%) studies reported the data in this dichotomous format. We were unable to use these data in any meta‐analysis because in one study, the time point at which these outcomes were measured did not fit our planned time point (<a href="./references#CD010516-bbs2-0033" title="RodríguezYR , PereraIIYM , HernándezIM , ÁvilaIIRI , Hernández SilvaJR , OchoaMJ . Diclofenac sodium eyedrops in cataract's surgery by phacoemulsification [Colirio de diclofenaco sódico en cirugía de catarata por facoemulsificación]. Revista Cubana de Oftalmología2011;24(1):46‐54. ">Ruiz Rodríguez 2011</a>), and in the two other studies the authors used their own grading scales instead of using the SUN scale (<a href="./references#CD010516-bbs2-0031" title="OstrovCS , SirkinSR , DeutschWE , MasiRJ , ChandlerJW , LindquistTD . Ketorolac, prednisolone, and dexamethasone for postoperative inflammation. Clinical Therapeutics1997;19(2):259‐72. ">Ostrov 1997</a>); therefore, we were unable to perform a meta‐analysis for this outcome. For the comparison of NSAIDs versus corticosteroids, 12 studies reported measures of inflammation of either the mean number of cells, the mean flare, both separately, or a sum of cells and flare. We were able to include 6 of these in meta‐analyses (<a href="./references#CD010516-bbs2-0004" title="AsanoS , MiyakeK , OtaI , SugitaG , KimuraW , SakkaY , et al. Reducing angiographic cystoid macular edema and blood‐aqueous barrier disruption after small‐incision phacoemulsification and foldable intraocular lens implantation. Multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasonone 0.1%. Journal of Cataract and Refractive Surgery2008;31(1):57‐63. ">Asano 2008</a>; <a href="./references#CD010516-bbs2-0005" title="BucciFA , MattaAZ . An objective comparison of acular vs vexol to control inflammation following phacoemulsification. American Academy of Ophthalmology; 2001 Nov 11‐14; New Orleans (LA). 2001:117. ">Bucci 2001</a>; <a href="./references#CD010516-bbs2-0019" title="HolzerMP , SolomonKD , SandovalHP , VromanDT . Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification. Journal of Cataract and Refractive Surgery2002;28(1):93‐9. ">Holzer 2002</a>; <a href="./references#CD010516-bbs2-0026" title="MiyakeK , NishimuraK , HarinoS , OtaI , AsanoS , KondoN , et al. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation. Investigative Ophthalmology &amp; Visual Science2007;48(12):5647‐52. ">Miyake 2007</a>; <a href="./references#CD010516-bbs2-0027" title="MiyakeK , OtaI , MiyakeG , NumagaJ . Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. Journal of Cataract and Refractive Surgery2011;37(9):1581‐8. ">Miyake 2011</a> and <a href="./references#CD010516-bbs2-0032" title="BrennanKM , BrownRM , RobertsCW . A comparison of topical non‐steroidal anti‐inflammatory drugs to steroids for control of post cataract inflammation. Journal of the American Society of Ophthalmic Registered Nurses1993;18(1):8‐11. BrownRM , RobertsCW . Preoperative and postoperative use of nonsteroidal antiinflammatory drugs in cataract surgery. Journal of the American Society of Ophthalmic Registered Nurses1996;21(1):13‐6. RobertsCW . A comparison of non‐steroidal anti‐inflammatory drug to steroids for postoperative inflammation. American Academy of Ophthalmology1992; Vol. 22. RobertsCW , BrennanKM . A comparison on topical diclofenac with prednisolone for postcataract inflammation. Archives of Ophthalmology1995;113(6):725‐7. ">Roberts 1995</a>). Reasons that data from some studies were not usable in meta‐analysis included the studies using their own scale rather than the SUN scale, studies missing data or not reporting all data needed to perform a meta‐analysis, studies reporting data at time points that were not of interest for this review, or studies providing data in the figure only. The second part of our primary outcome was the proportion of participants with BCVA of 20/40 or better at one‐week after surgery, but none of the included studies included BCVA in a dichotomous format. More than half of the included studies provided visual acuity outcomes as continuous measures, such as mean BCVA at a time point or mean BCVA at a time point. </p> <div class="table" id="CD010516-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Outcomes in included studies: Expected outcomes compared with reported outcomes</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Primary Outcomes</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Secondary outcomes</b> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expected outcome: Proportion of participants with corneal edema &gt;grade 0</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expected outcome: Proportion of participants with anterior chamber cells and flare &gt;grade 1</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported outcome: Cells and flare as a continuous measure</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expected outcome: Proportion of participants with BCVA of 20/40 or better</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported outcome: Visual acuity as a continuous measure</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expected outcome: Proportion of participants with CME</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported outcome: OCT outcomes or FFA outcomes measured continuously (macular thickness, total macular volume, macular cube volume, fluorescein leakage,etc)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expected outcome: Time to cessation of treatment for inflammation</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expected outcome: Adverse events</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expected outcome: Economic outcomes (cost)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Studies comparing an NSAID to a corticosteroid</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0004" title="AsanoS , MiyakeK , OtaI , SugitaG , KimuraW , SakkaY , et al. Reducing angiographic cystoid macular edema and blood‐aqueous barrier disruption after small‐incision phacoemulsification and foldable intraocular lens implantation. Multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasonone 0.1%. Journal of Cataract and Refractive Surgery2008;31(1):57‐63. ">Asano 2008</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0005" title="BucciFA , MattaAZ . An objective comparison of acular vs vexol to control inflammation following phacoemulsification. American Academy of Ophthalmology; 2001 Nov 11‐14; New Orleans (LA). 2001:117. ">Bucci 2001</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0010" title="DemcoTA . Topical diclofenac versus prednisolone acetate in control of inflammation after phacoemulsification. American Academy of Ophthalmology1995:150. DemcoTA , SuttonH , DemcoCJ , RajPS . Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification‐lens implant surgery. European Journal of Ophthalmology1997;7(3):236‐40. ">Demco 1997</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0012" title="DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Acta Ophthalmologica2015;93(4):e314‐5. DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Asia‐Pacific Journal of Ophthalmology2014;3(4):220‐5. ">Duong 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0015" title="EndoN , KatoS , HaruyamaK , ShojiM , KitanoS . Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes. Acta Ophthalmologica2010;88(8):896‐900. KitanoS , EndoN , ShojiM , HaruyamaK , KatoS . Effect of bromfenac sodium ophthalmic solution on preventing cystoids macular edema and inflammation after phacoemulsification and implantation of intraocular lens in diabetic patients. Investigative Ophthalmology &amp; Visual Science2008; Vol. 49:ARVO E‐Abstract 3470. ">Endo 2010</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data in figure only</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0017" title="GuzeyM , KaradedeZ , DoganZ , SaticiA . Ketorolac‐tobramycin combination vs fluorometholone‐tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision. Ophthalmic Surgery and Lasers2000;31(6):451‐6. ">Guzey 2000</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0019" title="HolzerMP , SolomonKD , SandovalHP , VromanDT . Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification. Journal of Cataract and Refractive Surgery2002;28(1):93‐9. ">Holzer 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0021" title="KatoS , BokuC , OnishiT , KoikeM , KageyamaT , NishiharaH , et al. Comparison of postoperative inflammation with two types of intraocular lense and anti‐inflammatory agents. Folia Ophthalmologica Japonica1998;49:286‐9. ">Kato 1998</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Partial</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0022" title="LaurellCG , ZetterströmC . Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery. British Journal of Ophthalmology2002;86(12):1380‐4. ">Laurell 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0026" title="MiyakeK , NishimuraK , HarinoS , OtaI , AsanoS , KondoN , et al. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation. Investigative Ophthalmology &amp; Visual Science2007;48(12):5647‐52. ">Miyake 2007</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0027" title="MiyakeK , OtaI , MiyakeG , NumagaJ . Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. Journal of Cataract and Refractive Surgery2011;37(9):1581‐8. ">Miyake 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0032" title="BrennanKM , BrownRM , RobertsCW . A comparison of topical non‐steroidal anti‐inflammatory drugs to steroids for control of post cataract inflammation. Journal of the American Society of Ophthalmic Registered Nurses1993;18(1):8‐11. BrownRM , RobertsCW . Preoperative and postoperative use of nonsteroidal antiinflammatory drugs in cataract surgery. Journal of the American Society of Ophthalmic Registered Nurses1996;21(1):13‐6. RobertsCW . A comparison of non‐steroidal anti‐inflammatory drug to steroids for postoperative inflammation. American Academy of Ophthalmology1992; Vol. 22. RobertsCW , BrennanKM . A comparison on topical diclofenac with prednisolone for postcataract inflammation. Archives of Ophthalmology1995;113(6):725‐7. ">Roberts 1995</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0038" title="SolomonKD , VromanDT , BarkerD , GehlkenJ . Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Journal of Cataract and Refractive Surgery2001;27(8):1232‐7. ">Solomon 2001</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0042" title="VoudouriA , ZafirakisP , Livir‐RallatosG , Livir‐RallatosC , CanakisC , MarkomichelakisN . Diclofenac versus prednisolone post phacoemulsification treatment: a randomized clinical trial. Investigative Ophthalmology &amp; Visual Science2002; Vol. 43:ARVO E‐Abstract 373. ">Voudouri 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0043" title="WangQW , YaoK , XuW , ChenPQ , ShentuXC , XieX , et al. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification. Ophthalmologica2013;229(4):187‐94. ">Wang 2013</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Studies comparing an NSAID plus a corticosteroid to a corticosteroid alone</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0001" title="AdamR , RodallecT , NordmannJP . Indometacine and macular thickness undergoing cataract surgery: a prospective randomized study. Investigative Ophthalmology &amp; Visual Science2005; Vol. 46:E‐Abstract 787. ">Adam 2005</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0002" title="AlmeidaDR , JohnsonD , HollandsH , SmallmanD , BaxterS , EngKT , et al. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. Journal of Cataract and Refractive Surgery2008;34(1):64‐9. ">Almeida 2008</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0006" title="Cervantes‐CosteG , Sánchez‐CastroY , Orozco‐CarrollM , Mendoza‐SchusterE , Velasco‐BaronaC . Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac. Clinical Ophthalmology2009;3(1):219‐26. ">Cervantes‐Coste 2009</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0007" title="ChatziralliIP , PapazisisL , SergentanisTN . Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial. Ophthalmologica2011;225(2):89‐94. ChatziralliIP , SergentanisTN , ParikakisEA , PapazisisLE , MitropoulosP , MoschosMM . The impact of non‐steroidal anti‐inflammatory agents after phacoemulsification on quality of life: a randomized study. Ophthalmology and Therapy2017;6(1):133‐40. ">Chatziralli 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data in figure only</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0008" title="ChenJ , WangGQ . Clinical observation of bromfenac sodium 0.1% eye drops on cataract surgery. International Eye Science2015;15(12):2102‐4. ">Chen 2015</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0009" title="DalD , SaraçO , TokluY , CakmakHB , GungorED . Efficacy of topical ketoroloc on macular thickness in patients undergoing cataract surgery. Ophthalmologica2014;232(Suppl 2):43. ">Dal 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0014" title="ElsawyMF , BadawiN , KhairyHA . Prophylactic postoperative ketorolac improves outcomes in diabetic patients assigned for cataract surgery. Clinical Ophthalmology2013;7:1245‐9. ">Elsawy 2013</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0016" title="EntezariM , RamezaniA , NikkhahH , YaseriM . The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial. International Ophthalmology2017;37(1):13‐8. [DOI: 10.1007/s10792‐016‐0209‐4] ">Entezari 2016</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0023" title="LiMC , YangXR , LiuF , ShaoDP , LiYB . Effect of topical NSAIDs in preventing macular edema after phacoemulsification in diabetes. International Journal of Ophthalmology2011;11(9):1614‐6. ">Li 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0024" title="AschbrennerMW , MathysKC , CohenKL . Do biological parameters and phaco metrics affect OCT measured CMT with and without nepafenac 0.1% treatment?. Investigative Ophthalmology &amp; Visual Science2008;49(13):389. MathysKC , CohenKL . Effect of nepafenac on macular thickness following uncomplicated cataract surgery. Investigative Ophthalmology &amp; Visual Science2008; Vol. 49:ARVO E‐Abstract 5674. MathysKC , CohenKL . Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema. Eye2010;24(1):90‐6. ">Mathys 2010</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0025" title="McColginAZ , RaizmanMB . Efficacy of topical voltaren in reducing the incidence of postoperative cystoid macular edema. Investigative Ophthalmology &amp; Visual Science1999; Vol. 40:ARVO E‐Abstract 1529. ">McColgin 1999</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0029" title="MoschosMM , ChatziralliIP , PantazisP , RouvasAA , SergentanisTN . Is topical diclofenac essential before and after uneventful phacoemulsification cataract surgery?. Journal of Ocular Pharmacology and Therapeutics2012;28(4):335‐9. ">Moschos 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0033" title="RodríguezYR , PereraIIYM , HernándezIM , ÁvilaIIRI , Hernández SilvaJR , OchoaMJ . Diclofenac sodium eyedrops in cataract's surgery by phacoemulsification [Colirio de diclofenaco sódico en cirugía de catarata por facoemulsificación]. Revista Cubana de Oftalmología2011;24(1):46‐54. ">Ruiz Rodríguez 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Partial</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0036" title="ShimazakiJ , FujishimaH , YagiY , TsubotaK . Effects of diclofenac eye drops on corneal epithelial structure and function after small‐incision cataract surgery. Ophthalmology1996;103(1):50‐7. ">Shimazaki 1996</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data in figure only</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0037" title="SinghR , AlpernL , JaffeGJ , LehmannRP , LimJ , ReiserHJ , et al. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clinical Ophthalmology2012;2012(6):1259‐69. ">Singh 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Partial</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0039" title="TiclyFG , LiraRP , ZanettiFR , MachadoMC , RodriguesGB , ArietaCE . Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial. Journal of Ocular Pharmacology and Therapeutics2014;30(6):495‐501. ">Ticly 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0044" title="WittpennJR , SilversteinS , HeierJ , KenyonKR , HunkelerJD , EarlM , et al. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low‐risk cataract surgery patients. American Journal of Ophthalmology2008;146(4):554‐60. ">Wittpenn 2008</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0046" title="ZaczekA , ArtzenD , LaurellCG , SteneviU , MontanP . Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery. Journal of Cataract and Refractive Surgery2014;40(9):1498‐505. ">Zaczek 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data in figure only</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0048" title="ZhangHY , ZhuSQ . Clinical study of pranoprofen eyedrops on prophylaxis of cystoids macular edema after cataract surgery. International Journal of Ophthalmology2008;8(7):1370‐2. ">Zhang 2008</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Studies with other combinations of NSAIDs and corticosteroids</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0003" title="AlmeidaDR , KhanZ , XingL , BakarSN , RahimK , UrtonT , et al. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. Journal of Cataract and Refractive Surgery2012;38(9):1537‐43. ">Almeida 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0011" title="DonnenfeldED , PerryHD , WittpennJR , SolomonR , NattisA , ChouT . Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic‐response curve. Journal of Cataract and Refractive Surgery2006;32(9):1474‐82. ">Donnenfeld 2006</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0013" title="el‐HaraziSM , RuizRS , FeldmanRM , VillanuevaG , ChuangAZ . A randomized double‐masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post‐phacoemulsification flare and cells. Ophthalmic Surgery and Lasers1998;29(7):539‐44. ">el‐Harazi 1998</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0018" title="HessemerV , SchartnerH . Low influence of anti‐inflammatory therapy on intraocular inflammation following minimally invasive phacoemulsification [Geringer Einfluß antiinflammatorischer Therapie auf den intraokularen Reizzustand nach minimal invasiver Phakoemulsifikation]. Der Ophthalmologe1997;94(1):30‐2. HessemerV , SchmidtK , SchartnerH . Minimally inflammatory cataract surgery [Minimal inflammatorische Kataraktchirurgie (MIK)]. Klinische Montasblätter für Augenheilkunde1996;209(6):331‐9. ">Hessemer 1996</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data in figure only</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0020" title="JungJW , ChungBH , KimEK , SeoKY , KimTI . The effects of two non‐steroidal anti‐inflammatory drugs, bromfenac 0.1% and ketorolac 0.45%, on cataract surgery. Yonsei Medical Journal2015;56(6):1671‐7. ">Jung 2015</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0028" title="MiyanagaM , MiyaiT , NejimaR , MaruyamaY , MiyataK , KatoS . Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. Acta Ophthalmologica2009;87(3):300‐5. ">Miyanaga 2009</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0030" title="MuletME , AlioJL , AyalaMJ , De laHozF , BedaJL . Efficacy of 0.5% ketorolac (Acular™) as an anti‐inflammatory treatment after cataract surgery. Investigative Ophthalmology &amp; Visual Science2001;42:ARVO E‐Abstract 66. ">Mulet 2001</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0031" title="OstrovCS , SirkinSR , DeutschWE , MasiRJ , ChandlerJW , LindquistTD . Ketorolac, prednisolone, and dexamethasone for postoperative inflammation. Clinical Therapeutics1997;19(2):259‐72. ">Ostrov 1997</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0034" title="SahuS , RamJ , BansalR , PandavSS , GuptaA . Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification. Journal of Cataract and Refractive Surgery2015;41(10):2043‐8. ">Sahu 2015</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0035" title="SchmittTH . Anti‐inflammatory therapy after cataract surgery — a laser‐flare‐cell photometer controlled study [Zur antiinflammatorischen therapie nach kataraktchirurigie. Eine kontrollierte studie mittels Laser‐Flare‐Cell‐Photometrie]. Aktuelle Augenheilkunde1995;20(5):263‐8. ">Schmitt 1995</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data in figure only</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0040" title="TrinavaratA , AtchaneeyasakulL , SurachatkumtonekulT , KosrirukvongsP . Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification. Journal of the Medical Association of Thailand2003;86(2):143‐50. ">Trinavarat 2003</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0041" title="TzelikisPF , VieiraM , HidaWT , MottaAF , NakanoCT , NakanoEM , et al. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo‐controlled randomised study. British Journal of Ophthalmology2015;99(5):654‐8. ">Tzelikis 2015</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0045" title="YavasGF , OztürkF , KüsbeciT . Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema. Journal of Cataract and Refractive Surgery2007;33(5):804‐7. ">Yavas 2007</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0047" title="ZanettiFR , FulcoEA , ChavesFR , daCosta PintoAP , ArietaCE , LiraRP . Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on maintenance of intraoperative mydriasis during cataract surgery: a randomized trial. Indian Journal of Ophthalmology2012;60(4):277‐81. ">Zanetti 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> <div class="table-footnote"> <p>Partial refers to studies missing data or not reporting all data needed to perform a meta‐analysis (such as reporting means without standard deviations) and studies reporting data at time points that were not of interest for this review. </p> </div> </div> </section> </section> <section id="CD010516-sec-0062"> <h4 class="title">Excluded studies</h4> <p>We excluded 50 studies from the review after assessing the full‐text reports. The reasons for exclusion are detailed in the <a href="./references#CD010516-sec-0122" title="">Characteristics of excluded studies</a> tables. We excluded nine studies because participants received a type of cataract surgery other than phacoemulsification (such as extracapsular cataract extraction or intracapsular cataract extraction) (<a href="./references#CD010516-bbs2-0049" title="AbelsonMB , SmithLM , OrmerodLD . Prospective, randomized trial of oral piroxicam in the prophylaxis of postoperative cystoid macular edema. Journal of Ocular Pharmacology1989;5(2):147‐53. ">Abelson 1989</a>; <a href="./references#CD010516-bbs2-0061" title="HessemerV , SchmittK . Local treatment with steroids and/or non‐steroid antiphlogistic agents in cataract surgery? A lasertyndallometric answer [Lokaltherapie mit Steroiden und/oder nichtsteroidalen Antiphlogistika in der Kataraktchirurgie? Eine lasertyndallometrische Antword]. Klinische Monatsblatter Fur Augenheilkunde1994;204:186. ">Hessemer 1994</a>; <a href="./references#CD010516-bbs2-0065" title="KnopfMM . A double‐blind study of fluorometholone. American Journal of Ophthalmology1970;70:739‐40. ">Knopf 1970</a>; <a href="./references#CD010516-bbs2-0082" title="Othenin‐GirardP , TrittenJJ , PittetN , HerbortCP . Dexamethasone versus diclofenac sodium eyedrops to treat inflammation after cataract surgery. Journal of Cataract and Refractive Surgery1994;20(1):9‐12. ">Othenin‐Girard 1994</a>; <a href="./references#CD010516-bbs2-0089" title="SmerdonDL , HungSO , AkingbehinT . Double‐blind controlled trial to compare anti‐inflammatory effects of tolmetin 2%, prednisolone 0.5%, and placebo in post‐cataract extraction eyes. British Journal of Ophthalmology1986;70(10):761‐3. ">Smerdon 1986</a>; <a href="./references#CD010516-bbs2-0090" title="SourdilleP , ZanlonghiX , BronV , AllaireC , TrinquandC . Comparison of prednisolone and topical indomethacin in post‐operative inflammation. European Journal of Implant and Refractive Surgery1993;5(3):1959‐63. ">Sourdille 1993</a>; <a href="./references#CD010516-bbs2-0091" title="SuharwardyJ , LingC , BellJA , MuntonCG . A comparative trial between diclofenac‐gentamicin and bethamethasone‐neomycin drops in patients undergoing cataract extraction. Eye1994;8(4):550‐4. ">Suharwardy 1994</a>; <a href="./references#CD010516-bbs2-0092" title="SzymańskiA , Gierek‐LapińskaA , KoziakM . Influence of steroidal and nonsteroidal anti‐inflammatory drugs on post‐operative blood‐aqueous barrier in pseudophakia. Klinika Oczna1993;96(4‐5):145‐7. ">Szymanski 1994</a>; <a href="./references#CD010516-bbs2-0094" title="TuncM , SaatciOA , ErginMH , ErginS . Cystoid macular edema early after uncomplicated cataract surgery: the efficacy of diclofenac in prophylaxis. Annals of Ophthalmology ‐ Glaucoma1999;31(1):27‐32. ">Tunc 1999</a>). In six other studies, the type of cataract surgery was unclearly reported (<a href="./references#CD010516-bbs2-0058" title="EUCTR2015‐003296‐30‐FI . Efficacy of steroid and nonsteroidal anti‐inflammatory eye drops in management of post‐operative inflammation and prevention of pseudophakic cystic macular edema after uncomplicated cataract surgery. apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015‐003296‐30‐FI (accessed 5 October 2016). ">EUCTR2015‐003296‐30‐FI</a>; <a href="./references#CD010516-bbs2-0060" title="FerreiraPC , Bauer KoerichLC , LimaGS , RamalhoF , FigueiredoAM . Influence of prednisolone acetate 1% and ketorolac 0.5% eyedrops in endothelial cell loss after cataract surgery. American Academy of Ophthalmology; 2006 Nov 11‐14; Las Vegas (NV). 2006. ">Ferreira 2006</a>; <a href="./references#CD010516-bbs2-0066" title="KraffMC , SandersDF , McGuiganL , RaananMG . Inhibition of blood‐aqueous humor barrier breakdown with diclofenac. Archives of Ophthalmology1990;7(1):380‐3. ">Kraff 1990</a>; <a href="./references#CD010516-bbs2-0070" title="McDonaldMB , SchanzlinD . Diclofenac Sodium (DS) versus Prednisolone Acetate (PA) in the treatment of inflammation following cataract extraction. American Academy of Ophthalmology1998:147. ">McDonald 1998</a>; <a href="./references#CD010516-bbs2-0093" title="TauberS , GesslerJ , ScottW , PetersonC , HamletP . The effect of topical ketorolac 0.4% on cystoid macular edema following routine cataract surgery. Investigative Ophthalmology &amp; Visual Science2006; Vol. 47:ARVO E‐Abstract 683. ">Tauber 2006</a>; <a href="./references#CD010516-bbs2-0098" title="YungCW , HuiSL , WangJ , GaoH , PerachaMO , PrattLM , et al. The effect of topical ketorolac tromethamine 0.5% on macular thickness in diabetic patients after cataract surgery. American Academy of Ophthalmology; 2007 Nov 10‐13; New Orleans (LA). 2007. ">Yung 2007</a>). Four studies included a combination of participants who received various types of cataract surgery and did not report outcomes separately for phacoemulsification (<a href="./references#CD010516-bbs2-0051" title="BarequetIS , Wygnanski‐JaffeT , SachsD . Effect on posterior capsule opacification of topical diclofenac sodium vs dexamethasone phosphate after cataract surgery. Annals of Ophthalmology2002;34(2):142‐7. ">Barequet 2002</a>; <a href="./references#CD010516-bbs2-0059" title="FarooqQ , AliSI . Comparison of anti‐inflammatory activity of ofloxacin + dexamethasone eye drops and flurbiprofen eye drops in post operative cases. Pakistan Journal of Ophthalmology2003;19(4):122‐9. ">Farooq 2003</a>; <a href="./references#CD010516-bbs2-0072" title="MissottenL , RichardC , TrinquandC . Topical 0.1% indomethacin solution versus topical 0.1% dexamethasone solution in the prevention of inflammation after cataract surgery. Ophthalmologica2001;215(1):43‐50. ">Missotten 2001</a>; <a href="./references#CD010516-bbs2-0085" title="RajuAS , RajuNS , RajendranB , PajuB . Prospective randomized controlled trial between diclofenac sodium and prednisolone acetate eye drops in cataract surgery. American Academy of Ophthalmology; 2005 Oct 15‐18; Chicago (IL). 2005. ">Raju 2005</a>). We excluded eight studies because comparisons differed from those specified for this review, for example an NSAID plus a corticosteroid versus a placebo or an NSAID plus a corticosteroid versus an NSAID alone (<a href="./references#CD010516-bbs2-0057" title="EUCTR2009‐017031‐18‐NL . Treatment of cystoid macular edema following cataract surgery. A randomized, double‐masked, placebo‐controlled, clinical trial — treatment of post‐cataract CME. apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009‐017031‐18‐NL (accessed 5 October 2016). ">EUCTR2009‐017031‐18‐NL</a>; <a href="./references#CD010516-bbs2-0064" title="ISRCTN02628492 . Prevention of pseudophakic cystoid macula oedema with pre‐ and post‐operative ketorolac. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN02628492 (accessed 5 October 2016). ">ISRCTN02628492</a>; <a href="./references#CD010516-bbs2-0068" title="LuoY , FengJ , LuM , ChengXK . Clinical assessment of diclofenac sodium eye drops in toric intraocular lens implantation. International Eye Science2013;13(5):880‐2. ">Luo 2013</a>; <a href="./references#CD010516-bbs2-0076" title="NCT00407017 . Therapeutic variables in cataract surgery. clinicaltrials.gov/ct2/show/NCT00407017 (accessed 5 October 2016). ">NCT00407017</a>; <a href="./references#CD010516-bbs2-0078" title="NCT00698724 . Comparing optical coherence tomography (OCT) and visual acuity outcomes in subjects undergoing cataract surgery, who receive xibrom ophthalmic solution and standard presurgical care vs. xibrom ophthalmic solution plus prednisolone acetate 1% and standard presurgical care. clinicaltrials.gov/ct2/show/NCT00698724 (accessed 5 October 2016). ">NCT00698724</a>; <a href="./references#CD010516-bbs2-0080" title="NCT01193504 . Randomized, masked comparison of bromfenac and besifloxacin BID with either prednisolone BID or loteprednol 0.5% BID for prevention of retinal thickening and CME following phacoemulsification. clinicaltrials.gov/ct2/show/NCT01193504 (accessed 5 October 2016). ">NCT01193504</a>; <a href="./references#CD010516-bbs2-0081" title="NishinoM , EquchiH , IwataA , ShiotaH , TanakaM , TanakaT . Are topical steroids essential after an uneventful cataract surgery?. Journal of Medical Investigation2009;56(1‐2):11‐5. ">Nishino 2009</a>; <a href="./references#CD010516-bbs2-0086" title="RamakrishnanS , BaskaranP , TalwarB , VenkateshR . Prospective, randomized study comparing the effect of 0.1% nepafenac and 0.4% ketorolac tromethamine on macular thickness in cataract surgery patients with low risk for cystoid macular edema. Asia‐Pacific Journal of Ophthalmology2015;4(4):216‐20. ">Ramakrishnan 2015</a>); in one study the comparison was unclear (<a href="./references#CD010516-bbs2-0077" title="NCT00433225 . Efficacy of topical ketorolac versus placebo for improving visual outcomes following multifocal IOL implantation. clinicaltrials.gov/ct2/show/NCT00433225 (accessed 5 October 2016). ">NCT00433225</a>). Six other studies did not include an either NSAID arm or a corticosteroid arm (<a href="./references#CD010516-bbs2-0053" title="BurdeRM , WaltmanSR . Topical corticosteroids after cataract surgery. Annals of Ophthalmology1972;4(4):290‐3. ">Burde 1972</a>; <a href="./references#CD010516-bbs2-0055" title="ChangA , ArnoldJ , DaviesP , HeriotW , AdewaleA , JarossN . Efficacy and safety of nepafenac 0.3% ophthalmic suspension administered once‐daily in patients with diabetic retinopathy following cataract surgery. Clinical and Experimental Ophthalmology2016;44(Suppl 1):57‐8. ">Chang 2016</a>; <a href="./references#CD010516-bbs2-0056" title="CorbettMC , HingoraniM , BoultonJE , ShillingJS . Subconjunctival betamethasone is of benefit after cataract surgery. Eye1993;7(6):744‐8. ">Corbett 1993</a>; <a href="./references#CD010516-bbs2-0063" title="HosseiniK , WaltersT , DaVanzoR , LindstromRL . A randomized double‐masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects. Clinical Ophthalmology2016;10:2311‐7. ">Hosseini 2016</a>; <a href="./references#CD010516-bbs2-0071" title="MeconiS , ScorolliL , ScalinciSZ , MassimiM , MeduriR . A comparison of topical diclofenac with indomethacin for post‐phacoemulsification CME (cystoid macular edema) [Comparazione dell'utilizzo del diclofenac e dell'indometacina nell'emc post‐facoemulsificazione]. Annali di Ottolmaologia e Clinica Oculistica1998;124(11‐12):357‐65. ">Meconi 1998</a>; <a href="./references#CD010516-bbs2-0084" title="PollackA , StaurenghiG , SagerD , MukeshB , ReiserH , SinghRP . Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy. British Journal of Ophthalmology2017;101:423‐7. ">Pollack 2017</a>). Seven studies either were not randomized or we could not tell whether they were randomized (<a href="./references#CD010516-bbs2-0062" title="HossainMM , MohiuddinAA , HossainMA , AzizMA . Diclofenac sodium and prednisolone acetate ophthalmic solution in controlling inflammation after cataract surgery. Mymensingh Medical Journal2010;19(3):343‐7. ">Hossain 2010</a>; <a href="./references#CD010516-bbs2-0067" title="LiouSW , YenRJ . The effect of 0.1% indomethacin eyedrops on cataract surgery. Journal of Ocular Pharmacology1991;7(1):77‐81. ">Liou 1991</a>; <a href="./references#CD010516-bbs2-0073" title="MiyakeK , MasudaK , ShiratoS , OshikaT , EquchiK , HoshiH , et al. Preventive effects of diclofenac ophthalmic solution on post‐cataract‐surgical cystoid macular edema. Nippon Ganka Gakkai Zasshi1998;102(8):522‐30. ">Miyake 1998</a>; <a href="./references#CD010516-bbs2-0074" title="MiyakeK , MasudaK , ShiratoS , OshikaT , EguchaK , HoshiH , et al. Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: a multicentered prospective trial. Japanese Journal of Ophthalmology2000;44(1):58‐67. ">Miyake 2000</a>; <a href="./references#CD010516-bbs2-0083" title="OzkurtY , OralY . Comparison of postoperative anti‐inflammatory effects of ketorolac 0.5% and prednisolone 1% after phacoemulsification and intraocular lens implantation. SOE 2003: XIV Congress of the European Society of Ophthalmology2003:305‐9. ">Ozkurt 2003</a>; <a href="./references#CD010516-bbs2-0095" title="Turan‐VuralE , HaliliE , SerinD . Assessing the effect of ketorolac and acetazolamide on macular thickness by optical coherence tomography following cataract. International Ophthalmology2013;34(3):525‐31. ">Turan‐Vural 2013</a>; <a href="./references#CD010516-bbs2-0096" title="WaseemM , HumayunS . Comparison of anti‐inflammatory activity of dexamethasone and diclofenac sodium eye drops in phacoemulsification. Journal of the College of Physicians and Surgeons Pakistan2009;19(9):570‐4. ">Waseem 2009</a>). Two were letters to the editor (<a href="./references#CD010516-bbs2-0052" title="BarequetIS . Posterior capsule opacification: The effect of postoperative topical therapy with Voltaren vs. Maxidex after cataract surgery. American Academy of Ophthalmology1999, issue AAO abstract 244. BarequetIS , Wygnanski‐JaffeT , SachsD . Effect of diclofenac versus dexamethasone on posterior capsule opacification. Journal of Cataract and Refractive Surgery2004;30(11):2253‐4. ">Barequet 2004</a>; <a href="./references#CD010516-bbs2-0087" title="RochaG . A randomized, masked comparison of topical ketorolac 0.4% plus steroid alone in low‐risk cataract surgery patients. Evidence‐Based Ophthalmology2009;10(2):92‐3. ">Rocha 2009</a>), one had no comparison group (<a href="./references#CD010516-bbs2-0054" title="CareniniBB , BrancatoR , DeMolfettaV , FrezzottiR , BalestrazziE , CardiaL , et al. Indomethacin ophthalmic suspension in the prevention of cystoid macular oedema in cataract extraction patients [L'Indometacina, sospensione oftalmica, nella prevenzione dell'edema maculare cistoide in pazienti sottoposti ad estrazione di cataratta]. Annali di Ottalmologia e Clinica Oculistica1993;119(9):681‐7. ">Carenini 1993</a>), one modeled existing trial data (<a href="./references#CD010516-bbs2-0075" title="MullinsA , MeijerP , AireyR , GundaP , BanhaziJ . Cost‐effectiveness of nepafenac 3 mg/ml for the reduction in risk of post‐operative macular oedema associated with cataract surgery: from UK NHS perspective. Value in Health2016;19(7):A569‐70. ">Mullins 2016</a>), two studies reported on a mix of surgeries for various eye conditions (<a href="./references#CD010516-bbs2-0069" title="MaheshwariR , AtherM , BhandariV . A study on comparative efficacy of topical non‐steroidal anti inflammatory drug, flurbiprofen and corticosteroids in post operative ocular inflammation. Afro‐Asian Journal of Ophthalmology1995;14(1):12‐4. ">Maheshwari 1995</a>; <a href="./references#CD010516-bbs2-0097" title="YasudaK , MotohashiR , KotakeO , NakagawaH , NomaH , ShimuraM . Comparative effects of topical diclofenac and betamethasone on inflammation after vitrectomy and cataract surgery in various vitreoretinal diseases. Journal of Ocular Pharmacology and Therapeutics2016;32(10):677‐84. ">Yasuda 2016</a>), one was a dosage study (<a href="./references#CD010516-bbs2-0079" title="NCT00758199 . Determination of optimum duration of treatment with bromfenac (xibrom) eyedrops following cataract surgery. clinicaltrials.gov/ct2/show/NCT00758199 (accessed 5 October 2016). ">NCT00758199</a>), and one used oral rather than topical corticosteroids (<a href="./references#CD010516-bbs2-0088" title="SabistonDW , RobinsonIG . An evaluation of the anti‐inflammatory effect of flurbiprofen after cataract extraction. British Journal of Ophthalmology1987;71(6):418‐21. ">Sabiston 1987</a>). We excluded one other study because the report was not intended to assess vision outcomes (<a href="./references#CD010516-bbs2-0050" title="BaharI , RosenblatI , ErenbergM , EldarI , GatonD , AvisarR , et al. Effect of dexamethasone eyedrops on blood glucose profile. Current Eye Research2007;32(9):739‐42. ">Bahar 2007</a>). </p> </section> </section> <section id="CD010516-sec-0063"> <h3 class="title">Risk of bias in included studies</h3> <p>Only one of the included studies had low risk of bias in all categories (<a href="./references#CD010516-bbs2-0047" title="ZanettiFR , FulcoEA , ChavesFR , daCosta PintoAP , ArietaCE , LiraRP . Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on maintenance of intraoperative mydriasis during cataract surgery: a randomized trial. Indian Journal of Ophthalmology2012;60(4):277‐81. ">Zanetti 2012</a>). We judged seven studies to be at unclear risk of bias across all domains; four of these studies had been reported only in abstracts and provided limited detail on study characteristics (<a href="./references#CD010516-bbs2-0005" title="BucciFA , MattaAZ . An objective comparison of acular vs vexol to control inflammation following phacoemulsification. American Academy of Ophthalmology; 2001 Nov 11‐14; New Orleans (LA). 2001:117. ">Bucci 2001</a>; <a href="./references#CD010516-bbs2-0009" title="DalD , SaraçO , TokluY , CakmakHB , GungorED . Efficacy of topical ketoroloc on macular thickness in patients undergoing cataract surgery. Ophthalmologica2014;232(Suppl 2):43. ">Dal 2014</a>; <a href="./references#CD010516-bbs2-0017" title="GuzeyM , KaradedeZ , DoganZ , SaticiA . Ketorolac‐tobramycin combination vs fluorometholone‐tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision. Ophthalmic Surgery and Lasers2000;31(6):451‐6. ">Guzey 2000</a>; <a href="./references#CD010516-bbs2-0021" title="KatoS , BokuC , OnishiT , KoikeM , KageyamaT , NishiharaH , et al. Comparison of postoperative inflammation with two types of intraocular lense and anti‐inflammatory agents. Folia Ophthalmologica Japonica1998;49:286‐9. ">Kato 1998</a>; <a href="./references#CD010516-bbs2-0028" title="MiyanagaM , MiyaiT , NejimaR , MaruyamaY , MiyataK , KatoS . Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. Acta Ophthalmologica2009;87(3):300‐5. ">Miyanaga 2009</a>; <a href="./references#CD010516-bbs2-0030" title="MuletME , AlioJL , AyalaMJ , De laHozF , BedaJL . Efficacy of 0.5% ketorolac (Acular™) as an anti‐inflammatory treatment after cataract surgery. Investigative Ophthalmology &amp; Visual Science2001;42:ARVO E‐Abstract 66. ">Mulet 2001</a>; <a href="./references#CD010516-bbs2-0042" title="VoudouriA , ZafirakisP , Livir‐RallatosG , Livir‐RallatosC , CanakisC , MarkomichelakisN . Diclofenac versus prednisolone post phacoemulsification treatment: a randomized clinical trial. Investigative Ophthalmology &amp; Visual Science2002; Vol. 43:ARVO E‐Abstract 373. ">Voudouri 2002</a>). The majority of the studies (26 of 48) were judged to be at unclear risk of bias in five or more domains. <a href="#CD010516-fig-0002">Figure 2</a> and <a href="#CD010516-fig-0003">Figure 3</a> summarize the 'Risk of bias' judgements across studies and for each individual study, respectively. </p> <div class="figure" id="CD010516-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010516-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010516-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010516-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010516-sec-0064"> <h4 class="title">Allocation</h4> <p>Though all included studies were reported to be randomized, reports from 36 studies did not describe either how the randomization was performed or how allocation was concealed before randomization. We judged these studies to be at unclear risk for selection bias (<a href="./references#CD010516-bbs2-0001" title="AdamR , RodallecT , NordmannJP . Indometacine and macular thickness undergoing cataract surgery: a prospective randomized study. Investigative Ophthalmology &amp; Visual Science2005; Vol. 46:E‐Abstract 787. ">Adam 2005</a>; <a href="./references#CD010516-bbs2-0002" title="AlmeidaDR , JohnsonD , HollandsH , SmallmanD , BaxterS , EngKT , et al. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. Journal of Cataract and Refractive Surgery2008;34(1):64‐9. ">Almeida 2008</a>; <a href="./references#CD010516-bbs2-0003" title="AlmeidaDR , KhanZ , XingL , BakarSN , RahimK , UrtonT , et al. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. Journal of Cataract and Refractive Surgery2012;38(9):1537‐43. ">Almeida 2012</a>; <a href="./references#CD010516-bbs2-0005" title="BucciFA , MattaAZ . An objective comparison of acular vs vexol to control inflammation following phacoemulsification. American Academy of Ophthalmology; 2001 Nov 11‐14; New Orleans (LA). 2001:117. ">Bucci 2001</a>; <a href="./references#CD010516-bbs2-0006" title="Cervantes‐CosteG , Sánchez‐CastroY , Orozco‐CarrollM , Mendoza‐SchusterE , Velasco‐BaronaC . Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac. Clinical Ophthalmology2009;3(1):219‐26. ">Cervantes‐Coste 2009</a>; <a href="./references#CD010516-bbs2-0007" title="ChatziralliIP , PapazisisL , SergentanisTN . Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial. Ophthalmologica2011;225(2):89‐94. ChatziralliIP , SergentanisTN , ParikakisEA , PapazisisLE , MitropoulosP , MoschosMM . The impact of non‐steroidal anti‐inflammatory agents after phacoemulsification on quality of life: a randomized study. Ophthalmology and Therapy2017;6(1):133‐40. ">Chatziralli 2011</a>; <a href="./references#CD010516-bbs2-0008" title="ChenJ , WangGQ . Clinical observation of bromfenac sodium 0.1% eye drops on cataract surgery. International Eye Science2015;15(12):2102‐4. ">Chen 2015</a>; <a href="./references#CD010516-bbs2-0009" title="DalD , SaraçO , TokluY , CakmakHB , GungorED . Efficacy of topical ketoroloc on macular thickness in patients undergoing cataract surgery. Ophthalmologica2014;232(Suppl 2):43. ">Dal 2014</a>; <a href="./references#CD010516-bbs2-0010" title="DemcoTA . Topical diclofenac versus prednisolone acetate in control of inflammation after phacoemulsification. American Academy of Ophthalmology1995:150. DemcoTA , SuttonH , DemcoCJ , RajPS . Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification‐lens implant surgery. European Journal of Ophthalmology1997;7(3):236‐40. ">Demco 1997</a>; <a href="./references#CD010516-bbs2-0013" title="el‐HaraziSM , RuizRS , FeldmanRM , VillanuevaG , ChuangAZ . A randomized double‐masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post‐phacoemulsification flare and cells. Ophthalmic Surgery and Lasers1998;29(7):539‐44. ">el‐Harazi 1998</a>; <a href="./references#CD010516-bbs2-0015" title="EndoN , KatoS , HaruyamaK , ShojiM , KitanoS . Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes. Acta Ophthalmologica2010;88(8):896‐900. KitanoS , EndoN , ShojiM , HaruyamaK , KatoS . Effect of bromfenac sodium ophthalmic solution on preventing cystoids macular edema and inflammation after phacoemulsification and implantation of intraocular lens in diabetic patients. Investigative Ophthalmology &amp; Visual Science2008; Vol. 49:ARVO E‐Abstract 3470. ">Endo 2010</a>; <a href="./references#CD010516-bbs2-0016" title="EntezariM , RamezaniA , NikkhahH , YaseriM . The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial. International Ophthalmology2017;37(1):13‐8. [DOI: 10.1007/s10792‐016‐0209‐4] ">Entezari 2016</a>; <a href="./references#CD010516-bbs2-0017" title="GuzeyM , KaradedeZ , DoganZ , SaticiA . Ketorolac‐tobramycin combination vs fluorometholone‐tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision. Ophthalmic Surgery and Lasers2000;31(6):451‐6. ">Guzey 2000</a>; <a href="./references#CD010516-bbs2-0018" title="HessemerV , SchartnerH . Low influence of anti‐inflammatory therapy on intraocular inflammation following minimally invasive phacoemulsification [Geringer Einfluß antiinflammatorischer Therapie auf den intraokularen Reizzustand nach minimal invasiver Phakoemulsifikation]. Der Ophthalmologe1997;94(1):30‐2. HessemerV , SchmidtK , SchartnerH . Minimally inflammatory cataract surgery [Minimal inflammatorische Kataraktchirurgie (MIK)]. Klinische Montasblätter für Augenheilkunde1996;209(6):331‐9. ">Hessemer 1996</a>; <a href="./references#CD010516-bbs2-0019" title="HolzerMP , SolomonKD , SandovalHP , VromanDT . Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification. Journal of Cataract and Refractive Surgery2002;28(1):93‐9. ">Holzer 2002</a>; <a href="./references#CD010516-bbs2-0020" title="JungJW , ChungBH , KimEK , SeoKY , KimTI . The effects of two non‐steroidal anti‐inflammatory drugs, bromfenac 0.1% and ketorolac 0.45%, on cataract surgery. Yonsei Medical Journal2015;56(6):1671‐7. ">Jung 2015</a>; <a href="./references#CD010516-bbs2-0021" title="KatoS , BokuC , OnishiT , KoikeM , KageyamaT , NishiharaH , et al. Comparison of postoperative inflammation with two types of intraocular lense and anti‐inflammatory agents. Folia Ophthalmologica Japonica1998;49:286‐9. ">Kato 1998</a>; <a href="./references#CD010516-bbs2-0023" title="LiMC , YangXR , LiuF , ShaoDP , LiYB . Effect of topical NSAIDs in preventing macular edema after phacoemulsification in diabetes. International Journal of Ophthalmology2011;11(9):1614‐6. ">Li 2011</a>; <a href="./references#CD010516-bbs2-0025" title="McColginAZ , RaizmanMB . Efficacy of topical voltaren in reducing the incidence of postoperative cystoid macular edema. Investigative Ophthalmology &amp; Visual Science1999; Vol. 40:ARVO E‐Abstract 1529. ">McColgin 1999</a>; <a href="./references#CD010516-bbs2-0026" title="MiyakeK , NishimuraK , HarinoS , OtaI , AsanoS , KondoN , et al. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation. Investigative Ophthalmology &amp; Visual Science2007;48(12):5647‐52. ">Miyake 2007</a>; <a href="./references#CD010516-bbs2-0027" title="MiyakeK , OtaI , MiyakeG , NumagaJ . Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. Journal of Cataract and Refractive Surgery2011;37(9):1581‐8. ">Miyake 2011</a>; <a href="./references#CD010516-bbs2-0028" title="MiyanagaM , MiyaiT , NejimaR , MaruyamaY , MiyataK , KatoS . Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. Acta Ophthalmologica2009;87(3):300‐5. ">Miyanaga 2009</a>; <a href="./references#CD010516-bbs2-0030" title="MuletME , AlioJL , AyalaMJ , De laHozF , BedaJL . Efficacy of 0.5% ketorolac (Acular™) as an anti‐inflammatory treatment after cataract surgery. Investigative Ophthalmology &amp; Visual Science2001;42:ARVO E‐Abstract 66. ">Mulet 2001</a>; <a href="./references#CD010516-bbs2-0031" title="OstrovCS , SirkinSR , DeutschWE , MasiRJ , ChandlerJW , LindquistTD . Ketorolac, prednisolone, and dexamethasone for postoperative inflammation. Clinical Therapeutics1997;19(2):259‐72. ">Ostrov 1997</a>; <a href="./references#CD010516-bbs2-0032" title="BrennanKM , BrownRM , RobertsCW . A comparison of topical non‐steroidal anti‐inflammatory drugs to steroids for control of post cataract inflammation. Journal of the American Society of Ophthalmic Registered Nurses1993;18(1):8‐11. BrownRM , RobertsCW . Preoperative and postoperative use of nonsteroidal antiinflammatory drugs in cataract surgery. Journal of the American Society of Ophthalmic Registered Nurses1996;21(1):13‐6. RobertsCW . A comparison of non‐steroidal anti‐inflammatory drug to steroids for postoperative inflammation. American Academy of Ophthalmology1992; Vol. 22. RobertsCW , BrennanKM . A comparison on topical diclofenac with prednisolone for postcataract inflammation. Archives of Ophthalmology1995;113(6):725‐7. ">Roberts 1995</a>; <a href="./references#CD010516-bbs2-0033" title="RodríguezYR , PereraIIYM , HernándezIM , ÁvilaIIRI , Hernández SilvaJR , OchoaMJ . Diclofenac sodium eyedrops in cataract's surgery by phacoemulsification [Colirio de diclofenaco sódico en cirugía de catarata por facoemulsificación]. Revista Cubana de Oftalmología2011;24(1):46‐54. ">Ruiz Rodríguez 2011</a>; <a href="./references#CD010516-bbs2-0035" title="SchmittTH . Anti‐inflammatory therapy after cataract surgery — a laser‐flare‐cell photometer controlled study [Zur antiinflammatorischen therapie nach kataraktchirurigie. Eine kontrollierte studie mittels Laser‐Flare‐Cell‐Photometrie]. Aktuelle Augenheilkunde1995;20(5):263‐8. ">Schmitt 1995</a>; <a href="./references#CD010516-bbs2-0036" title="ShimazakiJ , FujishimaH , YagiY , TsubotaK . Effects of diclofenac eye drops on corneal epithelial structure and function after small‐incision cataract surgery. Ophthalmology1996;103(1):50‐7. ">Shimazaki 1996</a>; <a href="./references#CD010516-bbs2-0037" title="SinghR , AlpernL , JaffeGJ , LehmannRP , LimJ , ReiserHJ , et al. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clinical Ophthalmology2012;2012(6):1259‐69. ">Singh 2012</a>; <a href="./references#CD010516-bbs2-0038" title="SolomonKD , VromanDT , BarkerD , GehlkenJ . Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Journal of Cataract and Refractive Surgery2001;27(8):1232‐7. ">Solomon 2001</a>; <a href="./references#CD010516-bbs2-0040" title="TrinavaratA , AtchaneeyasakulL , SurachatkumtonekulT , KosrirukvongsP . Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification. Journal of the Medical Association of Thailand2003;86(2):143‐50. ">Trinavarat 2003</a>; <a href="./references#CD010516-bbs2-0042" title="VoudouriA , ZafirakisP , Livir‐RallatosG , Livir‐RallatosC , CanakisC , MarkomichelakisN . Diclofenac versus prednisolone post phacoemulsification treatment: a randomized clinical trial. Investigative Ophthalmology &amp; Visual Science2002; Vol. 43:ARVO E‐Abstract 373. ">Voudouri 2002</a>; <a href="./references#CD010516-bbs2-0043" title="WangQW , YaoK , XuW , ChenPQ , ShentuXC , XieX , et al. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification. Ophthalmologica2013;229(4):187‐94. ">Wang 2013</a>; <a href="./references#CD010516-bbs2-0045" title="YavasGF , OztürkF , KüsbeciT . Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema. Journal of Cataract and Refractive Surgery2007;33(5):804‐7. ">Yavas 2007</a>; <a href="./references#CD010516-bbs2-0046" title="ZaczekA , ArtzenD , LaurellCG , SteneviU , MontanP . Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery. Journal of Cataract and Refractive Surgery2014;40(9):1498‐505. ">Zaczek 2014</a>; <a href="./references#CD010516-bbs2-0048" title="ZhangHY , ZhuSQ . Clinical study of pranoprofen eyedrops on prophylaxis of cystoids macular edema after cataract surgery. International Journal of Ophthalmology2008;8(7):1370‐2. ">Zhang 2008</a>). Reports from six studies described on how the randomization sequence was generated but did not report allocation concealment (<a href="./references#CD010516-bbs2-0011" title="DonnenfeldED , PerryHD , WittpennJR , SolomonR , NattisA , ChouT . Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic‐response curve. Journal of Cataract and Refractive Surgery2006;32(9):1474‐82. ">Donnenfeld 2006</a>; <a href="./references#CD010516-bbs2-0014" title="ElsawyMF , BadawiN , KhairyHA . Prophylactic postoperative ketorolac improves outcomes in diabetic patients assigned for cataract surgery. Clinical Ophthalmology2013;7:1245‐9. ">Elsawy 2013</a>; <a href="./references#CD010516-bbs2-0024" title="AschbrennerMW , MathysKC , CohenKL . Do biological parameters and phaco metrics affect OCT measured CMT with and without nepafenac 0.1% treatment?. Investigative Ophthalmology &amp; Visual Science2008;49(13):389. MathysKC , CohenKL . Effect of nepafenac on macular thickness following uncomplicated cataract surgery. Investigative Ophthalmology &amp; Visual Science2008; Vol. 49:ARVO E‐Abstract 5674. MathysKC , CohenKL . Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema. Eye2010;24(1):90‐6. ">Mathys 2010</a>; <a href="./references#CD010516-bbs2-0029" title="MoschosMM , ChatziralliIP , PantazisP , RouvasAA , SergentanisTN . Is topical diclofenac essential before and after uneventful phacoemulsification cataract surgery?. Journal of Ocular Pharmacology and Therapeutics2012;28(4):335‐9. ">Moschos 2012</a>; <a href="./references#CD010516-bbs2-0034" title="SahuS , RamJ , BansalR , PandavSS , GuptaA . Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification. Journal of Cataract and Refractive Surgery2015;41(10):2043‐8. ">Sahu 2015</a>; <a href="./references#CD010516-bbs2-0041" title="TzelikisPF , VieiraM , HidaWT , MottaAF , NakanoCT , NakanoEM , et al. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo‐controlled randomised study. British Journal of Ophthalmology2015;99(5):654‐8. ">Tzelikis 2015</a>). Investigators from only four studies reported both how the randomization sequence was generated and how allocation was concealed (<a href="./references#CD010516-bbs2-0022" title="LaurellCG , ZetterströmC . Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery. British Journal of Ophthalmology2002;86(12):1380‐4. ">Laurell 2002</a>; <a href="./references#CD010516-bbs2-0039" title="TiclyFG , LiraRP , ZanettiFR , MachadoMC , RodriguesGB , ArietaCE . Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial. Journal of Ocular Pharmacology and Therapeutics2014;30(6):495‐501. ">Ticly 2014</a>; <a href="./references#CD010516-bbs2-0044" title="WittpennJR , SilversteinS , HeierJ , KenyonKR , HunkelerJD , EarlM , et al. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low‐risk cataract surgery patients. American Journal of Ophthalmology2008;146(4):554‐60. ">Wittpenn 2008</a>; <a href="./references#CD010516-bbs2-0047" title="ZanettiFR , FulcoEA , ChavesFR , daCosta PintoAP , ArietaCE , LiraRP . Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on maintenance of intraoperative mydriasis during cataract surgery: a randomized trial. Indian Journal of Ophthalmology2012;60(4):277‐81. ">Zanetti 2012</a>). One study described allocation concealment but not sequence generation (<a href="./references#CD010516-bbs2-0004" title="AsanoS , MiyakeK , OtaI , SugitaG , KimuraW , SakkaY , et al. Reducing angiographic cystoid macular edema and blood‐aqueous barrier disruption after small‐incision phacoemulsification and foldable intraocular lens implantation. Multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasonone 0.1%. Journal of Cataract and Refractive Surgery2008;31(1):57‐63. ">Asano 2008</a>). We judged one study to have a high risk of selection bias: <a href="./references#CD010516-bbs2-0012" title="DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Acta Ophthalmologica2015;93(4):e314‐5. DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Asia‐Pacific Journal of Ophthalmology2014;3(4):220‐5. ">Duong 2014</a> reported randomizing participants to an intervention group based on which week of the month they were going to receive surgery. Since it was planned in advance which groups the participants would be assigned to, allocation was not concealed, creating a high risk of selection bias in this study. </p> <section id="CD010516-sec-0065"> <h5 class="title">Masking (performance bias and detection bias)</h5> <p>Many of the included studies did not report masking of participants and personnel or masking of outcome assessors and were therefore judged to have an unclear risk of both performance and detection bias (<a href="./references#CD010516-bbs2-0004" title="AsanoS , MiyakeK , OtaI , SugitaG , KimuraW , SakkaY , et al. Reducing angiographic cystoid macular edema and blood‐aqueous barrier disruption after small‐incision phacoemulsification and foldable intraocular lens implantation. Multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasonone 0.1%. Journal of Cataract and Refractive Surgery2008;31(1):57‐63. ">Asano 2008</a>; <a href="./references#CD010516-bbs2-0005" title="BucciFA , MattaAZ . An objective comparison of acular vs vexol to control inflammation following phacoemulsification. American Academy of Ophthalmology; 2001 Nov 11‐14; New Orleans (LA). 2001:117. ">Bucci 2001</a>; <a href="./references#CD010516-bbs2-0006" title="Cervantes‐CosteG , Sánchez‐CastroY , Orozco‐CarrollM , Mendoza‐SchusterE , Velasco‐BaronaC . Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac. Clinical Ophthalmology2009;3(1):219‐26. ">Cervantes‐Coste 2009</a>; <a href="./references#CD010516-bbs2-0008" title="ChenJ , WangGQ . Clinical observation of bromfenac sodium 0.1% eye drops on cataract surgery. International Eye Science2015;15(12):2102‐4. ">Chen 2015</a>; <a href="./references#CD010516-bbs2-0009" title="DalD , SaraçO , TokluY , CakmakHB , GungorED . Efficacy of topical ketoroloc on macular thickness in patients undergoing cataract surgery. Ophthalmologica2014;232(Suppl 2):43. ">Dal 2014</a>; <a href="./references#CD010516-bbs2-0011" title="DonnenfeldED , PerryHD , WittpennJR , SolomonR , NattisA , ChouT . Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic‐response curve. Journal of Cataract and Refractive Surgery2006;32(9):1474‐82. ">Donnenfeld 2006</a>; <a href="./references#CD010516-bbs2-0014" title="ElsawyMF , BadawiN , KhairyHA . Prophylactic postoperative ketorolac improves outcomes in diabetic patients assigned for cataract surgery. Clinical Ophthalmology2013;7:1245‐9. ">Elsawy 2013</a>; <a href="./references#CD010516-bbs2-0017" title="GuzeyM , KaradedeZ , DoganZ , SaticiA . Ketorolac‐tobramycin combination vs fluorometholone‐tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision. Ophthalmic Surgery and Lasers2000;31(6):451‐6. ">Guzey 2000</a>; <a href="./references#CD010516-bbs2-0021" title="KatoS , BokuC , OnishiT , KoikeM , KageyamaT , NishiharaH , et al. Comparison of postoperative inflammation with two types of intraocular lense and anti‐inflammatory agents. Folia Ophthalmologica Japonica1998;49:286‐9. ">Kato 1998</a>; <a href="./references#CD010516-bbs2-0023" title="LiMC , YangXR , LiuF , ShaoDP , LiYB . Effect of topical NSAIDs in preventing macular edema after phacoemulsification in diabetes. International Journal of Ophthalmology2011;11(9):1614‐6. ">Li 2011</a>; <a href="./references#CD010516-bbs2-0028" title="MiyanagaM , MiyaiT , NejimaR , MaruyamaY , MiyataK , KatoS . Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. Acta Ophthalmologica2009;87(3):300‐5. ">Miyanaga 2009</a>; <a href="./references#CD010516-bbs2-0029" title="MoschosMM , ChatziralliIP , PantazisP , RouvasAA , SergentanisTN . Is topical diclofenac essential before and after uneventful phacoemulsification cataract surgery?. Journal of Ocular Pharmacology and Therapeutics2012;28(4):335‐9. ">Moschos 2012</a>; <a href="./references#CD010516-bbs2-0030" title="MuletME , AlioJL , AyalaMJ , De laHozF , BedaJL . Efficacy of 0.5% ketorolac (Acular™) as an anti‐inflammatory treatment after cataract surgery. Investigative Ophthalmology &amp; Visual Science2001;42:ARVO E‐Abstract 66. ">Mulet 2001</a>; <a href="./references#CD010516-bbs2-0031" title="OstrovCS , SirkinSR , DeutschWE , MasiRJ , ChandlerJW , LindquistTD . Ketorolac, prednisolone, and dexamethasone for postoperative inflammation. Clinical Therapeutics1997;19(2):259‐72. ">Ostrov 1997</a>; <a href="./references#CD010516-bbs2-0033" title="RodríguezYR , PereraIIYM , HernándezIM , ÁvilaIIRI , Hernández SilvaJR , OchoaMJ . Diclofenac sodium eyedrops in cataract's surgery by phacoemulsification [Colirio de diclofenaco sódico en cirugía de catarata por facoemulsificación]. Revista Cubana de Oftalmología2011;24(1):46‐54. ">Ruiz Rodríguez 2011</a>; <a href="./references#CD010516-bbs2-0035" title="SchmittTH . Anti‐inflammatory therapy after cataract surgery — a laser‐flare‐cell photometer controlled study [Zur antiinflammatorischen therapie nach kataraktchirurigie. Eine kontrollierte studie mittels Laser‐Flare‐Cell‐Photometrie]. Aktuelle Augenheilkunde1995;20(5):263‐8. ">Schmitt 1995</a>; <a href="./references#CD010516-bbs2-0042" title="VoudouriA , ZafirakisP , Livir‐RallatosG , Livir‐RallatosC , CanakisC , MarkomichelakisN . Diclofenac versus prednisolone post phacoemulsification treatment: a randomized clinical trial. Investigative Ophthalmology &amp; Visual Science2002; Vol. 43:ARVO E‐Abstract 373. ">Voudouri 2002</a>; <a href="./references#CD010516-bbs2-0048" title="ZhangHY , ZhuSQ . Clinical study of pranoprofen eyedrops on prophylaxis of cystoids macular edema after cataract surgery. International Journal of Ophthalmology2008;8(7):1370‐2. ">Zhang 2008</a>). We judged four studies to have a high risk of both performance bias and detection bias because they were reported to be non‐masked, open‐label trials (<a href="./references#CD010516-bbs2-0002" title="AlmeidaDR , JohnsonD , HollandsH , SmallmanD , BaxterS , EngKT , et al. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. Journal of Cataract and Refractive Surgery2008;34(1):64‐9. ">Almeida 2008</a>; <a href="./references#CD010516-bbs2-0015" title="EndoN , KatoS , HaruyamaK , ShojiM , KitanoS . Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes. Acta Ophthalmologica2010;88(8):896‐900. KitanoS , EndoN , ShojiM , HaruyamaK , KatoS . Effect of bromfenac sodium ophthalmic solution on preventing cystoids macular edema and inflammation after phacoemulsification and implantation of intraocular lens in diabetic patients. Investigative Ophthalmology &amp; Visual Science2008; Vol. 49:ARVO E‐Abstract 3470. ">Endo 2010</a>; <a href="./references#CD010516-bbs2-0034" title="SahuS , RamJ , BansalR , PandavSS , GuptaA . Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification. Journal of Cataract and Refractive Surgery2015;41(10):2043‐8. ">Sahu 2015</a>; <a href="./references#CD010516-bbs2-0036" title="ShimazakiJ , FujishimaH , YagiY , TsubotaK . Effects of diclofenac eye drops on corneal epithelial structure and function after small‐incision cataract surgery. Ophthalmology1996;103(1):50‐7. ">Shimazaki 1996</a>). We judged four studies to have a low risk of both performance bias and detection bias because they reported masking for participants, personnel, and outcome assessors (<a href="./references#CD010516-bbs2-0010" title="DemcoTA . Topical diclofenac versus prednisolone acetate in control of inflammation after phacoemulsification. American Academy of Ophthalmology1995:150. DemcoTA , SuttonH , DemcoCJ , RajPS . Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification‐lens implant surgery. European Journal of Ophthalmology1997;7(3):236‐40. ">Demco 1997</a>; <a href="./references#CD010516-bbs2-0019" title="HolzerMP , SolomonKD , SandovalHP , VromanDT . Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification. Journal of Cataract and Refractive Surgery2002;28(1):93‐9. ">Holzer 2002</a>; <a href="./references#CD010516-bbs2-0039" title="TiclyFG , LiraRP , ZanettiFR , MachadoMC , RodriguesGB , ArietaCE . Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial. Journal of Ocular Pharmacology and Therapeutics2014;30(6):495‐501. ">Ticly 2014</a>; <a href="./references#CD010516-bbs2-0047" title="ZanettiFR , FulcoEA , ChavesFR , daCosta PintoAP , ArietaCE , LiraRP . Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on maintenance of intraoperative mydriasis during cataract surgery: a randomized trial. Indian Journal of Ophthalmology2012;60(4):277‐81. ">Zanetti 2012</a>). Some of the included studies reported that participants and surgeons were masked, but did not report on masking for outcome assessors; we judged these studies to have a low risk of performance bias but an unclear risk of detection bias (<a href="./references#CD010516-bbs2-0003" title="AlmeidaDR , KhanZ , XingL , BakarSN , RahimK , UrtonT , et al. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. Journal of Cataract and Refractive Surgery2012;38(9):1537‐43. ">Almeida 2012</a>; <a href="./references#CD010516-bbs2-0007" title="ChatziralliIP , PapazisisL , SergentanisTN . Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial. Ophthalmologica2011;225(2):89‐94. ChatziralliIP , SergentanisTN , ParikakisEA , PapazisisLE , MitropoulosP , MoschosMM . The impact of non‐steroidal anti‐inflammatory agents after phacoemulsification on quality of life: a randomized study. Ophthalmology and Therapy2017;6(1):133‐40. ">Chatziralli 2011</a>; <a href="./references#CD010516-bbs2-0013" title="el‐HaraziSM , RuizRS , FeldmanRM , VillanuevaG , ChuangAZ . A randomized double‐masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post‐phacoemulsification flare and cells. Ophthalmic Surgery and Lasers1998;29(7):539‐44. ">el‐Harazi 1998</a>; <a href="./references#CD010516-bbs2-0018" title="HessemerV , SchartnerH . Low influence of anti‐inflammatory therapy on intraocular inflammation following minimally invasive phacoemulsification [Geringer Einfluß antiinflammatorischer Therapie auf den intraokularen Reizzustand nach minimal invasiver Phakoemulsifikation]. Der Ophthalmologe1997;94(1):30‐2. HessemerV , SchmidtK , SchartnerH . Minimally inflammatory cataract surgery [Minimal inflammatorische Kataraktchirurgie (MIK)]. Klinische Montasblätter für Augenheilkunde1996;209(6):331‐9. ">Hessemer 1996</a>; <a href="./references#CD010516-bbs2-0022" title="LaurellCG , ZetterströmC . Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery. British Journal of Ophthalmology2002;86(12):1380‐4. ">Laurell 2002</a>; <a href="./references#CD010516-bbs2-0038" title="SolomonKD , VromanDT , BarkerD , GehlkenJ . Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Journal of Cataract and Refractive Surgery2001;27(8):1232‐7. ">Solomon 2001</a>; <a href="./references#CD010516-bbs2-0044" title="WittpennJR , SilversteinS , HeierJ , KenyonKR , HunkelerJD , EarlM , et al. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low‐risk cataract surgery patients. American Journal of Ophthalmology2008;146(4):554‐60. ">Wittpenn 2008</a>; <a href="./references#CD010516-bbs2-0046" title="ZaczekA , ArtzenD , LaurellCG , SteneviU , MontanP . Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery. Journal of Cataract and Refractive Surgery2014;40(9):1498‐505. ">Zaczek 2014</a>). Conversely, we judged other studies to have an unclear risk of performance bias because they did not report whether participants and physicians were masked, but a low risk of detection bias because they reported that outcome assessors were masked (<a href="./references#CD010516-bbs2-0001" title="AdamR , RodallecT , NordmannJP . Indometacine and macular thickness undergoing cataract surgery: a prospective randomized study. Investigative Ophthalmology &amp; Visual Science2005; Vol. 46:E‐Abstract 787. ">Adam 2005</a>; <a href="./references#CD010516-bbs2-0016" title="EntezariM , RamezaniA , NikkhahH , YaseriM . The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial. International Ophthalmology2017;37(1):13‐8. [DOI: 10.1007/s10792‐016‐0209‐4] ">Entezari 2016</a>; <a href="./references#CD010516-bbs2-0020" title="JungJW , ChungBH , KimEK , SeoKY , KimTI . The effects of two non‐steroidal anti‐inflammatory drugs, bromfenac 0.1% and ketorolac 0.45%, on cataract surgery. Yonsei Medical Journal2015;56(6):1671‐7. ">Jung 2015</a>; <a href="./references#CD010516-bbs2-0024" title="AschbrennerMW , MathysKC , CohenKL . Do biological parameters and phaco metrics affect OCT measured CMT with and without nepafenac 0.1% treatment?. Investigative Ophthalmology &amp; Visual Science2008;49(13):389. MathysKC , CohenKL . Effect of nepafenac on macular thickness following uncomplicated cataract surgery. Investigative Ophthalmology &amp; Visual Science2008; Vol. 49:ARVO E‐Abstract 5674. MathysKC , CohenKL . Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema. Eye2010;24(1):90‐6. ">Mathys 2010</a>; <a href="./references#CD010516-bbs2-0026" title="MiyakeK , NishimuraK , HarinoS , OtaI , AsanoS , KondoN , et al. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation. Investigative Ophthalmology &amp; Visual Science2007;48(12):5647‐52. ">Miyake 2007</a>; <a href="./references#CD010516-bbs2-0027" title="MiyakeK , OtaI , MiyakeG , NumagaJ . Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. Journal of Cataract and Refractive Surgery2011;37(9):1581‐8. ">Miyake 2011</a>; <a href="./references#CD010516-bbs2-0032" title="BrennanKM , BrownRM , RobertsCW . A comparison of topical non‐steroidal anti‐inflammatory drugs to steroids for control of post cataract inflammation. Journal of the American Society of Ophthalmic Registered Nurses1993;18(1):8‐11. BrownRM , RobertsCW . Preoperative and postoperative use of nonsteroidal antiinflammatory drugs in cataract surgery. Journal of the American Society of Ophthalmic Registered Nurses1996;21(1):13‐6. RobertsCW . A comparison of non‐steroidal anti‐inflammatory drug to steroids for postoperative inflammation. American Academy of Ophthalmology1992; Vol. 22. RobertsCW , BrennanKM . A comparison on topical diclofenac with prednisolone for postcataract inflammation. Archives of Ophthalmology1995;113(6):725‐7. ">Roberts 1995</a>; <a href="./references#CD010516-bbs2-0037" title="SinghR , AlpernL , JaffeGJ , LehmannRP , LimJ , ReiserHJ , et al. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clinical Ophthalmology2012;2012(6):1259‐69. ">Singh 2012</a>; <a href="./references#CD010516-bbs2-0040" title="TrinavaratA , AtchaneeyasakulL , SurachatkumtonekulT , KosrirukvongsP . Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification. Journal of the Medical Association of Thailand2003;86(2):143‐50. ">Trinavarat 2003</a>; <a href="./references#CD010516-bbs2-0041" title="TzelikisPF , VieiraM , HidaWT , MottaAF , NakanoCT , NakanoEM , et al. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo‐controlled randomised study. British Journal of Ophthalmology2015;99(5):654‐8. ">Tzelikis 2015</a>; <a href="./references#CD010516-bbs2-0045" title="YavasGF , OztürkF , KüsbeciT . Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema. Journal of Cataract and Refractive Surgery2007;33(5):804‐7. ">Yavas 2007</a>). We judged one study that reported that participants were not masked, although the surgeons and evaluating ophthalmologist were, to be at high risk for performance bias and low risk for detection bias (<a href="./references#CD010516-bbs2-0012" title="DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Acta Ophthalmologica2015;93(4):e314‐5. DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Asia‐Pacific Journal of Ophthalmology2014;3(4):220‐5. ">Duong 2014</a>). We judged two studies that were self reported "single‐masked" studies to be at high risk of performance bias and unclear risk of detection bias due to participants having knowledge of their assigned study medication, but unclear reporting on whether the physicians, surgeons, or outcome assessors were masked (<a href="./references#CD010516-bbs2-0025" title="McColginAZ , RaizmanMB . Efficacy of topical voltaren in reducing the incidence of postoperative cystoid macular edema. Investigative Ophthalmology &amp; Visual Science1999; Vol. 40:ARVO E‐Abstract 1529. ">McColgin 1999</a>; <a href="./references#CD010516-bbs2-0043" title="WangQW , YaoK , XuW , ChenPQ , ShentuXC , XieX , et al. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification. Ophthalmologica2013;229(4):187‐94. ">Wang 2013</a>). </p> </section> </section> <section id="CD010516-sec-0066"> <h4 class="title">Incomplete outcome data</h4> <p>Eleven studies were judged to have a high risk of attrition bias because some or all participants who did not complete the study were not included in the data analysis (<a href="./references#CD010516-bbs2-0002" title="AlmeidaDR , JohnsonD , HollandsH , SmallmanD , BaxterS , EngKT , et al. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. Journal of Cataract and Refractive Surgery2008;34(1):64‐9. ">Almeida 2008</a>; <a href="./references#CD010516-bbs2-0004" title="AsanoS , MiyakeK , OtaI , SugitaG , KimuraW , SakkaY , et al. Reducing angiographic cystoid macular edema and blood‐aqueous barrier disruption after small‐incision phacoemulsification and foldable intraocular lens implantation. Multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasonone 0.1%. Journal of Cataract and Refractive Surgery2008;31(1):57‐63. ">Asano 2008</a>; <a href="./references#CD010516-bbs2-0007" title="ChatziralliIP , PapazisisL , SergentanisTN . Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial. Ophthalmologica2011;225(2):89‐94. ChatziralliIP , SergentanisTN , ParikakisEA , PapazisisLE , MitropoulosP , MoschosMM . The impact of non‐steroidal anti‐inflammatory agents after phacoemulsification on quality of life: a randomized study. Ophthalmology and Therapy2017;6(1):133‐40. ">Chatziralli 2011</a>; <a href="./references#CD010516-bbs2-0012" title="DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Acta Ophthalmologica2015;93(4):e314‐5. DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Asia‐Pacific Journal of Ophthalmology2014;3(4):220‐5. ">Duong 2014</a>; <a href="./references#CD010516-bbs2-0015" title="EndoN , KatoS , HaruyamaK , ShojiM , KitanoS . Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes. Acta Ophthalmologica2010;88(8):896‐900. KitanoS , EndoN , ShojiM , HaruyamaK , KatoS . Effect of bromfenac sodium ophthalmic solution on preventing cystoids macular edema and inflammation after phacoemulsification and implantation of intraocular lens in diabetic patients. Investigative Ophthalmology &amp; Visual Science2008; Vol. 49:ARVO E‐Abstract 3470. ">Endo 2010</a>; <a href="./references#CD010516-bbs2-0022" title="LaurellCG , ZetterströmC . Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery. British Journal of Ophthalmology2002;86(12):1380‐4. ">Laurell 2002</a>; <a href="./references#CD010516-bbs2-0027" title="MiyakeK , OtaI , MiyakeG , NumagaJ . Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. Journal of Cataract and Refractive Surgery2011;37(9):1581‐8. ">Miyake 2011</a>; <a href="./references#CD010516-bbs2-0038" title="SolomonKD , VromanDT , BarkerD , GehlkenJ . Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Journal of Cataract and Refractive Surgery2001;27(8):1232‐7. ">Solomon 2001</a>; <a href="./references#CD010516-bbs2-0039" title="TiclyFG , LiraRP , ZanettiFR , MachadoMC , RodriguesGB , ArietaCE . Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial. Journal of Ocular Pharmacology and Therapeutics2014;30(6):495‐501. ">Ticly 2014</a>; <a href="./references#CD010516-bbs2-0040" title="TrinavaratA , AtchaneeyasakulL , SurachatkumtonekulT , KosrirukvongsP . Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification. Journal of the Medical Association of Thailand2003;86(2):143‐50. ">Trinavarat 2003</a>; <a href="./references#CD010516-bbs2-0046" title="ZaczekA , ArtzenD , LaurellCG , SteneviU , MontanP . Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery. Journal of Cataract and Refractive Surgery2014;40(9):1498‐505. ">Zaczek 2014</a>). We evaluated 11 studies as having a low risk of attrition bias (<a href="./references#CD010516-bbs2-0003" title="AlmeidaDR , KhanZ , XingL , BakarSN , RahimK , UrtonT , et al. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. Journal of Cataract and Refractive Surgery2012;38(9):1537‐43. ">Almeida 2012</a>; <a href="./references#CD010516-bbs2-0006" title="Cervantes‐CosteG , Sánchez‐CastroY , Orozco‐CarrollM , Mendoza‐SchusterE , Velasco‐BaronaC . Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac. Clinical Ophthalmology2009;3(1):219‐26. ">Cervantes‐Coste 2009</a>; <a href="./references#CD010516-bbs2-0008" title="ChenJ , WangGQ . Clinical observation of bromfenac sodium 0.1% eye drops on cataract surgery. International Eye Science2015;15(12):2102‐4. ">Chen 2015</a>; <a href="./references#CD010516-bbs2-0010" title="DemcoTA . Topical diclofenac versus prednisolone acetate in control of inflammation after phacoemulsification. American Academy of Ophthalmology1995:150. DemcoTA , SuttonH , DemcoCJ , RajPS . Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification‐lens implant surgery. European Journal of Ophthalmology1997;7(3):236‐40. ">Demco 1997</a>; <a href="./references#CD010516-bbs2-0013" title="el‐HaraziSM , RuizRS , FeldmanRM , VillanuevaG , ChuangAZ . A randomized double‐masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post‐phacoemulsification flare and cells. Ophthalmic Surgery and Lasers1998;29(7):539‐44. ">el‐Harazi 1998</a>; <a href="./references#CD010516-bbs2-0014" title="ElsawyMF , BadawiN , KhairyHA . Prophylactic postoperative ketorolac improves outcomes in diabetic patients assigned for cataract surgery. Clinical Ophthalmology2013;7:1245‐9. ">Elsawy 2013</a>; <a href="./references#CD010516-bbs2-0031" title="OstrovCS , SirkinSR , DeutschWE , MasiRJ , ChandlerJW , LindquistTD . Ketorolac, prednisolone, and dexamethasone for postoperative inflammation. Clinical Therapeutics1997;19(2):259‐72. ">Ostrov 1997</a>; <a href="./references#CD010516-bbs2-0032" title="BrennanKM , BrownRM , RobertsCW . A comparison of topical non‐steroidal anti‐inflammatory drugs to steroids for control of post cataract inflammation. Journal of the American Society of Ophthalmic Registered Nurses1993;18(1):8‐11. BrownRM , RobertsCW . Preoperative and postoperative use of nonsteroidal antiinflammatory drugs in cataract surgery. Journal of the American Society of Ophthalmic Registered Nurses1996;21(1):13‐6. RobertsCW . A comparison of non‐steroidal anti‐inflammatory drug to steroids for postoperative inflammation. American Academy of Ophthalmology1992; Vol. 22. RobertsCW , BrennanKM . A comparison on topical diclofenac with prednisolone for postcataract inflammation. Archives of Ophthalmology1995;113(6):725‐7. ">Roberts 1995</a>; <a href="./references#CD010516-bbs2-0036" title="ShimazakiJ , FujishimaH , YagiY , TsubotaK . Effects of diclofenac eye drops on corneal epithelial structure and function after small‐incision cataract surgery. Ophthalmology1996;103(1):50‐7. ">Shimazaki 1996</a>; <a href="./references#CD010516-bbs2-0047" title="ZanettiFR , FulcoEA , ChavesFR , daCosta PintoAP , ArietaCE , LiraRP . Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on maintenance of intraoperative mydriasis during cataract surgery: a randomized trial. Indian Journal of Ophthalmology2012;60(4):277‐81. ">Zanetti 2012</a>; <a href="./references#CD010516-bbs2-0048" title="ZhangHY , ZhuSQ . Clinical study of pranoprofen eyedrops on prophylaxis of cystoids macular edema after cataract surgery. International Journal of Ophthalmology2008;8(7):1370‐2. ">Zhang 2008</a>). These studies reported that all participants completed all of the follow‐up visits (no missing data) or that missing data were handled appropriately by using an intention‐to‐treat analysis. The other 26 studies did not report on the degree of missing data or how this information was handled and were judged to have an unclear risk of attrition bias (<a href="./references#CD010516-bbs2-0001" title="AdamR , RodallecT , NordmannJP . Indometacine and macular thickness undergoing cataract surgery: a prospective randomized study. Investigative Ophthalmology &amp; Visual Science2005; Vol. 46:E‐Abstract 787. ">Adam 2005</a>; <a href="./references#CD010516-bbs2-0005" title="BucciFA , MattaAZ . An objective comparison of acular vs vexol to control inflammation following phacoemulsification. American Academy of Ophthalmology; 2001 Nov 11‐14; New Orleans (LA). 2001:117. ">Bucci 2001</a>; <a href="./references#CD010516-bbs2-0009" title="DalD , SaraçO , TokluY , CakmakHB , GungorED . Efficacy of topical ketoroloc on macular thickness in patients undergoing cataract surgery. Ophthalmologica2014;232(Suppl 2):43. ">Dal 2014</a>; <a href="./references#CD010516-bbs2-0011" title="DonnenfeldED , PerryHD , WittpennJR , SolomonR , NattisA , ChouT . Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic‐response curve. Journal of Cataract and Refractive Surgery2006;32(9):1474‐82. ">Donnenfeld 2006</a>; <a href="./references#CD010516-bbs2-0016" title="EntezariM , RamezaniA , NikkhahH , YaseriM . The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial. International Ophthalmology2017;37(1):13‐8. [DOI: 10.1007/s10792‐016‐0209‐4] ">Entezari 2016</a>; <a href="./references#CD010516-bbs2-0017" title="GuzeyM , KaradedeZ , DoganZ , SaticiA . Ketorolac‐tobramycin combination vs fluorometholone‐tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision. Ophthalmic Surgery and Lasers2000;31(6):451‐6. ">Guzey 2000</a>; <a href="./references#CD010516-bbs2-0018" title="HessemerV , SchartnerH . Low influence of anti‐inflammatory therapy on intraocular inflammation following minimally invasive phacoemulsification [Geringer Einfluß antiinflammatorischer Therapie auf den intraokularen Reizzustand nach minimal invasiver Phakoemulsifikation]. Der Ophthalmologe1997;94(1):30‐2. HessemerV , SchmidtK , SchartnerH . Minimally inflammatory cataract surgery [Minimal inflammatorische Kataraktchirurgie (MIK)]. Klinische Montasblätter für Augenheilkunde1996;209(6):331‐9. ">Hessemer 1996</a>; <a href="./references#CD010516-bbs2-0019" title="HolzerMP , SolomonKD , SandovalHP , VromanDT . Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification. Journal of Cataract and Refractive Surgery2002;28(1):93‐9. ">Holzer 2002</a>; <a href="./references#CD010516-bbs2-0020" title="JungJW , ChungBH , KimEK , SeoKY , KimTI . The effects of two non‐steroidal anti‐inflammatory drugs, bromfenac 0.1% and ketorolac 0.45%, on cataract surgery. Yonsei Medical Journal2015;56(6):1671‐7. ">Jung 2015</a>; <a href="./references#CD010516-bbs2-0021" title="KatoS , BokuC , OnishiT , KoikeM , KageyamaT , NishiharaH , et al. Comparison of postoperative inflammation with two types of intraocular lense and anti‐inflammatory agents. Folia Ophthalmologica Japonica1998;49:286‐9. ">Kato 1998</a>; <a href="./references#CD010516-bbs2-0023" title="LiMC , YangXR , LiuF , ShaoDP , LiYB . Effect of topical NSAIDs in preventing macular edema after phacoemulsification in diabetes. International Journal of Ophthalmology2011;11(9):1614‐6. ">Li 2011</a>; <a href="./references#CD010516-bbs2-0024" title="AschbrennerMW , MathysKC , CohenKL . Do biological parameters and phaco metrics affect OCT measured CMT with and without nepafenac 0.1% treatment?. Investigative Ophthalmology &amp; Visual Science2008;49(13):389. MathysKC , CohenKL . Effect of nepafenac on macular thickness following uncomplicated cataract surgery. Investigative Ophthalmology &amp; Visual Science2008; Vol. 49:ARVO E‐Abstract 5674. MathysKC , CohenKL . Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema. Eye2010;24(1):90‐6. ">Mathys 2010</a>; <a href="./references#CD010516-bbs2-0025" title="McColginAZ , RaizmanMB . Efficacy of topical voltaren in reducing the incidence of postoperative cystoid macular edema. Investigative Ophthalmology &amp; Visual Science1999; Vol. 40:ARVO E‐Abstract 1529. ">McColgin 1999</a>; <a href="./references#CD010516-bbs2-0026" title="MiyakeK , NishimuraK , HarinoS , OtaI , AsanoS , KondoN , et al. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation. Investigative Ophthalmology &amp; Visual Science2007;48(12):5647‐52. ">Miyake 2007</a>; <a href="./references#CD010516-bbs2-0028" title="MiyanagaM , MiyaiT , NejimaR , MaruyamaY , MiyataK , KatoS . Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. Acta Ophthalmologica2009;87(3):300‐5. ">Miyanaga 2009</a>; <a href="./references#CD010516-bbs2-0029" title="MoschosMM , ChatziralliIP , PantazisP , RouvasAA , SergentanisTN . Is topical diclofenac essential before and after uneventful phacoemulsification cataract surgery?. Journal of Ocular Pharmacology and Therapeutics2012;28(4):335‐9. ">Moschos 2012</a>; <a href="./references#CD010516-bbs2-0030" title="MuletME , AlioJL , AyalaMJ , De laHozF , BedaJL . Efficacy of 0.5% ketorolac (Acular™) as an anti‐inflammatory treatment after cataract surgery. Investigative Ophthalmology &amp; Visual Science2001;42:ARVO E‐Abstract 66. ">Mulet 2001</a>; <a href="./references#CD010516-bbs2-0033" title="RodríguezYR , PereraIIYM , HernándezIM , ÁvilaIIRI , Hernández SilvaJR , OchoaMJ . Diclofenac sodium eyedrops in cataract's surgery by phacoemulsification [Colirio de diclofenaco sódico en cirugía de catarata por facoemulsificación]. Revista Cubana de Oftalmología2011;24(1):46‐54. ">Ruiz Rodríguez 2011</a>; <a href="./references#CD010516-bbs2-0034" title="SahuS , RamJ , BansalR , PandavSS , GuptaA . Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification. Journal of Cataract and Refractive Surgery2015;41(10):2043‐8. ">Sahu 2015</a>; <a href="./references#CD010516-bbs2-0035" title="SchmittTH . Anti‐inflammatory therapy after cataract surgery — a laser‐flare‐cell photometer controlled study [Zur antiinflammatorischen therapie nach kataraktchirurigie. Eine kontrollierte studie mittels Laser‐Flare‐Cell‐Photometrie]. Aktuelle Augenheilkunde1995;20(5):263‐8. ">Schmitt 1995</a>; <a href="./references#CD010516-bbs2-0037" title="SinghR , AlpernL , JaffeGJ , LehmannRP , LimJ , ReiserHJ , et al. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clinical Ophthalmology2012;2012(6):1259‐69. ">Singh 2012</a>; <a href="./references#CD010516-bbs2-0041" title="TzelikisPF , VieiraM , HidaWT , MottaAF , NakanoCT , NakanoEM , et al. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo‐controlled randomised study. British Journal of Ophthalmology2015;99(5):654‐8. ">Tzelikis 2015</a>; <a href="./references#CD010516-bbs2-0042" title="VoudouriA , ZafirakisP , Livir‐RallatosG , Livir‐RallatosC , CanakisC , MarkomichelakisN . Diclofenac versus prednisolone post phacoemulsification treatment: a randomized clinical trial. Investigative Ophthalmology &amp; Visual Science2002; Vol. 43:ARVO E‐Abstract 373. ">Voudouri 2002</a>; <a href="./references#CD010516-bbs2-0043" title="WangQW , YaoK , XuW , ChenPQ , ShentuXC , XieX , et al. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification. Ophthalmologica2013;229(4):187‐94. ">Wang 2013</a>; <a href="./references#CD010516-bbs2-0044" title="WittpennJR , SilversteinS , HeierJ , KenyonKR , HunkelerJD , EarlM , et al. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low‐risk cataract surgery patients. American Journal of Ophthalmology2008;146(4):554‐60. ">Wittpenn 2008</a>; <a href="./references#CD010516-bbs2-0045" title="YavasGF , OztürkF , KüsbeciT . Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema. Journal of Cataract and Refractive Surgery2007;33(5):804‐7. ">Yavas 2007</a>). </p> </section> <section id="CD010516-sec-0067"> <h4 class="title">Selective reporting</h4> <p>For the majority of included studies we could not judge whether there was selective outcome reporting because a protocol was either not cited or not available (<a href="./references#CD010516-bbs2-0001" title="AdamR , RodallecT , NordmannJP . Indometacine and macular thickness undergoing cataract surgery: a prospective randomized study. Investigative Ophthalmology &amp; Visual Science2005; Vol. 46:E‐Abstract 787. ">Adam 2005</a>; <a href="./references#CD010516-bbs2-0004" title="AsanoS , MiyakeK , OtaI , SugitaG , KimuraW , SakkaY , et al. Reducing angiographic cystoid macular edema and blood‐aqueous barrier disruption after small‐incision phacoemulsification and foldable intraocular lens implantation. Multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasonone 0.1%. Journal of Cataract and Refractive Surgery2008;31(1):57‐63. ">Asano 2008</a>; <a href="./references#CD010516-bbs2-0005" title="BucciFA , MattaAZ . An objective comparison of acular vs vexol to control inflammation following phacoemulsification. American Academy of Ophthalmology; 2001 Nov 11‐14; New Orleans (LA). 2001:117. ">Bucci 2001</a>; <a href="./references#CD010516-bbs2-0006" title="Cervantes‐CosteG , Sánchez‐CastroY , Orozco‐CarrollM , Mendoza‐SchusterE , Velasco‐BaronaC . Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac. Clinical Ophthalmology2009;3(1):219‐26. ">Cervantes‐Coste 2009</a>; <a href="./references#CD010516-bbs2-0008" title="ChenJ , WangGQ . Clinical observation of bromfenac sodium 0.1% eye drops on cataract surgery. International Eye Science2015;15(12):2102‐4. ">Chen 2015</a>; <a href="./references#CD010516-bbs2-0009" title="DalD , SaraçO , TokluY , CakmakHB , GungorED . Efficacy of topical ketoroloc on macular thickness in patients undergoing cataract surgery. Ophthalmologica2014;232(Suppl 2):43. ">Dal 2014</a>; <a href="./references#CD010516-bbs2-0010" title="DemcoTA . Topical diclofenac versus prednisolone acetate in control of inflammation after phacoemulsification. American Academy of Ophthalmology1995:150. DemcoTA , SuttonH , DemcoCJ , RajPS . Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification‐lens implant surgery. European Journal of Ophthalmology1997;7(3):236‐40. ">Demco 1997</a>; <a href="./references#CD010516-bbs2-0011" title="DonnenfeldED , PerryHD , WittpennJR , SolomonR , NattisA , ChouT . Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic‐response curve. Journal of Cataract and Refractive Surgery2006;32(9):1474‐82. ">Donnenfeld 2006</a>; <a href="./references#CD010516-bbs2-0012" title="DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Acta Ophthalmologica2015;93(4):e314‐5. DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Asia‐Pacific Journal of Ophthalmology2014;3(4):220‐5. ">Duong 2014</a>; <a href="./references#CD010516-bbs2-0013" title="el‐HaraziSM , RuizRS , FeldmanRM , VillanuevaG , ChuangAZ . A randomized double‐masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post‐phacoemulsification flare and cells. Ophthalmic Surgery and Lasers1998;29(7):539‐44. ">el‐Harazi 1998</a>; <a href="./references#CD010516-bbs2-0014" title="ElsawyMF , BadawiN , KhairyHA . Prophylactic postoperative ketorolac improves outcomes in diabetic patients assigned for cataract surgery. Clinical Ophthalmology2013;7:1245‐9. ">Elsawy 2013</a>; <a href="./references#CD010516-bbs2-0015" title="EndoN , KatoS , HaruyamaK , ShojiM , KitanoS . Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes. Acta Ophthalmologica2010;88(8):896‐900. KitanoS , EndoN , ShojiM , HaruyamaK , KatoS . Effect of bromfenac sodium ophthalmic solution on preventing cystoids macular edema and inflammation after phacoemulsification and implantation of intraocular lens in diabetic patients. Investigative Ophthalmology &amp; Visual Science2008; Vol. 49:ARVO E‐Abstract 3470. ">Endo 2010</a>; <a href="./references#CD010516-bbs2-0017" title="GuzeyM , KaradedeZ , DoganZ , SaticiA . Ketorolac‐tobramycin combination vs fluorometholone‐tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision. Ophthalmic Surgery and Lasers2000;31(6):451‐6. ">Guzey 2000</a>; <a href="./references#CD010516-bbs2-0018" title="HessemerV , SchartnerH . Low influence of anti‐inflammatory therapy on intraocular inflammation following minimally invasive phacoemulsification [Geringer Einfluß antiinflammatorischer Therapie auf den intraokularen Reizzustand nach minimal invasiver Phakoemulsifikation]. Der Ophthalmologe1997;94(1):30‐2. HessemerV , SchmidtK , SchartnerH . Minimally inflammatory cataract surgery [Minimal inflammatorische Kataraktchirurgie (MIK)]. Klinische Montasblätter für Augenheilkunde1996;209(6):331‐9. ">Hessemer 1996</a>; <a href="./references#CD010516-bbs2-0019" title="HolzerMP , SolomonKD , SandovalHP , VromanDT . Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification. Journal of Cataract and Refractive Surgery2002;28(1):93‐9. ">Holzer 2002</a>; <a href="./references#CD010516-bbs2-0020" title="JungJW , ChungBH , KimEK , SeoKY , KimTI . The effects of two non‐steroidal anti‐inflammatory drugs, bromfenac 0.1% and ketorolac 0.45%, on cataract surgery. Yonsei Medical Journal2015;56(6):1671‐7. ">Jung 2015</a>; <a href="./references#CD010516-bbs2-0021" title="KatoS , BokuC , OnishiT , KoikeM , KageyamaT , NishiharaH , et al. Comparison of postoperative inflammation with two types of intraocular lense and anti‐inflammatory agents. Folia Ophthalmologica Japonica1998;49:286‐9. ">Kato 1998</a>; <a href="./references#CD010516-bbs2-0025" title="McColginAZ , RaizmanMB . Efficacy of topical voltaren in reducing the incidence of postoperative cystoid macular edema. Investigative Ophthalmology &amp; Visual Science1999; Vol. 40:ARVO E‐Abstract 1529. ">McColgin 1999</a>; <a href="./references#CD010516-bbs2-0026" title="MiyakeK , NishimuraK , HarinoS , OtaI , AsanoS , KondoN , et al. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation. Investigative Ophthalmology &amp; Visual Science2007;48(12):5647‐52. ">Miyake 2007</a>; <a href="./references#CD010516-bbs2-0027" title="MiyakeK , OtaI , MiyakeG , NumagaJ . Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. Journal of Cataract and Refractive Surgery2011;37(9):1581‐8. ">Miyake 2011</a>; <a href="./references#CD010516-bbs2-0028" title="MiyanagaM , MiyaiT , NejimaR , MaruyamaY , MiyataK , KatoS . Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. Acta Ophthalmologica2009;87(3):300‐5. ">Miyanaga 2009</a>; <a href="./references#CD010516-bbs2-0029" title="MoschosMM , ChatziralliIP , PantazisP , RouvasAA , SergentanisTN . Is topical diclofenac essential before and after uneventful phacoemulsification cataract surgery?. Journal of Ocular Pharmacology and Therapeutics2012;28(4):335‐9. ">Moschos 2012</a>; <a href="./references#CD010516-bbs2-0030" title="MuletME , AlioJL , AyalaMJ , De laHozF , BedaJL . Efficacy of 0.5% ketorolac (Acular™) as an anti‐inflammatory treatment after cataract surgery. Investigative Ophthalmology &amp; Visual Science2001;42:ARVO E‐Abstract 66. ">Mulet 2001</a>; <a href="./references#CD010516-bbs2-0031" title="OstrovCS , SirkinSR , DeutschWE , MasiRJ , ChandlerJW , LindquistTD . Ketorolac, prednisolone, and dexamethasone for postoperative inflammation. Clinical Therapeutics1997;19(2):259‐72. ">Ostrov 1997</a>; <a href="./references#CD010516-bbs2-0032" title="BrennanKM , BrownRM , RobertsCW . A comparison of topical non‐steroidal anti‐inflammatory drugs to steroids for control of post cataract inflammation. Journal of the American Society of Ophthalmic Registered Nurses1993;18(1):8‐11. BrownRM , RobertsCW . Preoperative and postoperative use of nonsteroidal antiinflammatory drugs in cataract surgery. Journal of the American Society of Ophthalmic Registered Nurses1996;21(1):13‐6. RobertsCW . A comparison of non‐steroidal anti‐inflammatory drug to steroids for postoperative inflammation. American Academy of Ophthalmology1992; Vol. 22. RobertsCW , BrennanKM . A comparison on topical diclofenac with prednisolone for postcataract inflammation. Archives of Ophthalmology1995;113(6):725‐7. ">Roberts 1995</a>; <a href="./references#CD010516-bbs2-0034" title="SahuS , RamJ , BansalR , PandavSS , GuptaA . Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification. Journal of Cataract and Refractive Surgery2015;41(10):2043‐8. ">Sahu 2015</a>; <a href="./references#CD010516-bbs2-0035" title="SchmittTH . Anti‐inflammatory therapy after cataract surgery — a laser‐flare‐cell photometer controlled study [Zur antiinflammatorischen therapie nach kataraktchirurigie. Eine kontrollierte studie mittels Laser‐Flare‐Cell‐Photometrie]. Aktuelle Augenheilkunde1995;20(5):263‐8. ">Schmitt 1995</a>; <a href="./references#CD010516-bbs2-0036" title="ShimazakiJ , FujishimaH , YagiY , TsubotaK . Effects of diclofenac eye drops on corneal epithelial structure and function after small‐incision cataract surgery. Ophthalmology1996;103(1):50‐7. ">Shimazaki 1996</a>; <a href="./references#CD010516-bbs2-0038" title="SolomonKD , VromanDT , BarkerD , GehlkenJ . Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Journal of Cataract and Refractive Surgery2001;27(8):1232‐7. ">Solomon 2001</a>; <a href="./references#CD010516-bbs2-0040" title="TrinavaratA , AtchaneeyasakulL , SurachatkumtonekulT , KosrirukvongsP . Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification. Journal of the Medical Association of Thailand2003;86(2):143‐50. ">Trinavarat 2003</a>; <a href="./references#CD010516-bbs2-0042" title="VoudouriA , ZafirakisP , Livir‐RallatosG , Livir‐RallatosC , CanakisC , MarkomichelakisN . Diclofenac versus prednisolone post phacoemulsification treatment: a randomized clinical trial. Investigative Ophthalmology &amp; Visual Science2002; Vol. 43:ARVO E‐Abstract 373. ">Voudouri 2002</a>; <a href="./references#CD010516-bbs2-0043" title="WangQW , YaoK , XuW , ChenPQ , ShentuXC , XieX , et al. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification. Ophthalmologica2013;229(4):187‐94. ">Wang 2013</a>; <a href="./references#CD010516-bbs2-0044" title="WittpennJR , SilversteinS , HeierJ , KenyonKR , HunkelerJD , EarlM , et al. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low‐risk cataract surgery patients. American Journal of Ophthalmology2008;146(4):554‐60. ">Wittpenn 2008</a>; <a href="./references#CD010516-bbs2-0045" title="YavasGF , OztürkF , KüsbeciT . Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema. Journal of Cataract and Refractive Surgery2007;33(5):804‐7. ">Yavas 2007</a>; <a href="./references#CD010516-bbs2-0046" title="ZaczekA , ArtzenD , LaurellCG , SteneviU , MontanP . Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery. Journal of Cataract and Refractive Surgery2014;40(9):1498‐505. ">Zaczek 2014</a>; <a href="./references#CD010516-bbs2-0048" title="ZhangHY , ZhuSQ . Clinical study of pranoprofen eyedrops on prophylaxis of cystoids macular edema after cataract surgery. International Journal of Ophthalmology2008;8(7):1370‐2. ">Zhang 2008</a>). We judged three studies to have a high risk of reporting bias: in <a href="./references#CD010516-bbs2-0022" title="LaurellCG , ZetterströmC . Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery. British Journal of Ophthalmology2002;86(12):1380‐4. ">Laurell 2002</a> and <a href="./references#CD010516-bbs2-0033" title="RodríguezYR , PereraIIYM , HernándezIM , ÁvilaIIRI , Hernández SilvaJR , OchoaMJ . Diclofenac sodium eyedrops in cataract's surgery by phacoemulsification [Colirio de diclofenaco sódico en cirugía de catarata por facoemulsificación]. Revista Cubana de Oftalmología2011;24(1):46‐54. ">Ruiz Rodríguez 2011</a> some outcomes were not reported at all follow‐up time points. In <a href="./references#CD010516-bbs2-0007" title="ChatziralliIP , PapazisisL , SergentanisTN . Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial. Ophthalmologica2011;225(2):89‐94. ChatziralliIP , SergentanisTN , ParikakisEA , PapazisisLE , MitropoulosP , MoschosMM . The impact of non‐steroidal anti‐inflammatory agents after phacoemulsification on quality of life: a randomized study. Ophthalmology and Therapy2017;6(1):133‐40. ">Chatziralli 2011</a> some participants continued treatment longer than others, but the results for the continued treatment were not reported. In nine studies, the reported outcomes matched the outcomes described in the trial registry, protocol, or methods section of the study reports (<a href="./references#CD010516-bbs2-0002" title="AlmeidaDR , JohnsonD , HollandsH , SmallmanD , BaxterS , EngKT , et al. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. Journal of Cataract and Refractive Surgery2008;34(1):64‐9. ">Almeida 2008</a>; <a href="./references#CD010516-bbs2-0003" title="AlmeidaDR , KhanZ , XingL , BakarSN , RahimK , UrtonT , et al. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. Journal of Cataract and Refractive Surgery2012;38(9):1537‐43. ">Almeida 2012</a>; <a href="./references#CD010516-bbs2-0016" title="EntezariM , RamezaniA , NikkhahH , YaseriM . The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial. International Ophthalmology2017;37(1):13‐8. [DOI: 10.1007/s10792‐016‐0209‐4] ">Entezari 2016</a>; <a href="./references#CD010516-bbs2-0023" title="LiMC , YangXR , LiuF , ShaoDP , LiYB . Effect of topical NSAIDs in preventing macular edema after phacoemulsification in diabetes. International Journal of Ophthalmology2011;11(9):1614‐6. ">Li 2011</a>; <a href="./references#CD010516-bbs2-0024" title="AschbrennerMW , MathysKC , CohenKL . Do biological parameters and phaco metrics affect OCT measured CMT with and without nepafenac 0.1% treatment?. Investigative Ophthalmology &amp; Visual Science2008;49(13):389. MathysKC , CohenKL . Effect of nepafenac on macular thickness following uncomplicated cataract surgery. Investigative Ophthalmology &amp; Visual Science2008; Vol. 49:ARVO E‐Abstract 5674. MathysKC , CohenKL . Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema. Eye2010;24(1):90‐6. ">Mathys 2010</a>; <a href="./references#CD010516-bbs2-0037" title="SinghR , AlpernL , JaffeGJ , LehmannRP , LimJ , ReiserHJ , et al. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clinical Ophthalmology2012;2012(6):1259‐69. ">Singh 2012</a>; <a href="./references#CD010516-bbs2-0039" title="TiclyFG , LiraRP , ZanettiFR , MachadoMC , RodriguesGB , ArietaCE . Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial. Journal of Ocular Pharmacology and Therapeutics2014;30(6):495‐501. ">Ticly 2014</a>; <a href="./references#CD010516-bbs2-0041" title="TzelikisPF , VieiraM , HidaWT , MottaAF , NakanoCT , NakanoEM , et al. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo‐controlled randomised study. British Journal of Ophthalmology2015;99(5):654‐8. ">Tzelikis 2015</a>; <a href="./references#CD010516-bbs2-0047" title="ZanettiFR , FulcoEA , ChavesFR , daCosta PintoAP , ArietaCE , LiraRP . Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on maintenance of intraoperative mydriasis during cataract surgery: a randomized trial. Indian Journal of Ophthalmology2012;60(4):277‐81. ">Zanetti 2012</a>). </p> </section> <section id="CD010516-sec-0068"> <h4 class="title">Other potential sources of bias</h4> <p>For 13 studies we did not identify any other potential sources of bias (<a href="./references#CD010516-bbs2-0002" title="AlmeidaDR , JohnsonD , HollandsH , SmallmanD , BaxterS , EngKT , et al. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. Journal of Cataract and Refractive Surgery2008;34(1):64‐9. ">Almeida 2008</a>; <a href="./references#CD010516-bbs2-0003" title="AlmeidaDR , KhanZ , XingL , BakarSN , RahimK , UrtonT , et al. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. Journal of Cataract and Refractive Surgery2012;38(9):1537‐43. ">Almeida 2012</a>; <a href="./references#CD010516-bbs2-0011" title="DonnenfeldED , PerryHD , WittpennJR , SolomonR , NattisA , ChouT . Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic‐response curve. Journal of Cataract and Refractive Surgery2006;32(9):1474‐82. ">Donnenfeld 2006</a>; <a href="./references#CD010516-bbs2-0015" title="EndoN , KatoS , HaruyamaK , ShojiM , KitanoS . Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes. Acta Ophthalmologica2010;88(8):896‐900. KitanoS , EndoN , ShojiM , HaruyamaK , KatoS . Effect of bromfenac sodium ophthalmic solution on preventing cystoids macular edema and inflammation after phacoemulsification and implantation of intraocular lens in diabetic patients. Investigative Ophthalmology &amp; Visual Science2008; Vol. 49:ARVO E‐Abstract 3470. ">Endo 2010</a>; <a href="./references#CD010516-bbs2-0020" title="JungJW , ChungBH , KimEK , SeoKY , KimTI . The effects of two non‐steroidal anti‐inflammatory drugs, bromfenac 0.1% and ketorolac 0.45%, on cataract surgery. Yonsei Medical Journal2015;56(6):1671‐7. ">Jung 2015</a>; <a href="./references#CD010516-bbs2-0023" title="LiMC , YangXR , LiuF , ShaoDP , LiYB . Effect of topical NSAIDs in preventing macular edema after phacoemulsification in diabetes. International Journal of Ophthalmology2011;11(9):1614‐6. ">Li 2011</a>; <a href="./references#CD010516-bbs2-0024" title="AschbrennerMW , MathysKC , CohenKL . Do biological parameters and phaco metrics affect OCT measured CMT with and without nepafenac 0.1% treatment?. Investigative Ophthalmology &amp; Visual Science2008;49(13):389. MathysKC , CohenKL . Effect of nepafenac on macular thickness following uncomplicated cataract surgery. Investigative Ophthalmology &amp; Visual Science2008; Vol. 49:ARVO E‐Abstract 5674. MathysKC , CohenKL . Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema. Eye2010;24(1):90‐6. ">Mathys 2010</a>; <a href="./references#CD010516-bbs2-0031" title="OstrovCS , SirkinSR , DeutschWE , MasiRJ , ChandlerJW , LindquistTD . Ketorolac, prednisolone, and dexamethasone for postoperative inflammation. Clinical Therapeutics1997;19(2):259‐72. ">Ostrov 1997</a>; <a href="./references#CD010516-bbs2-0035" title="SchmittTH . Anti‐inflammatory therapy after cataract surgery — a laser‐flare‐cell photometer controlled study [Zur antiinflammatorischen therapie nach kataraktchirurigie. Eine kontrollierte studie mittels Laser‐Flare‐Cell‐Photometrie]. Aktuelle Augenheilkunde1995;20(5):263‐8. ">Schmitt 1995</a>; <a href="./references#CD010516-bbs2-0041" title="TzelikisPF , VieiraM , HidaWT , MottaAF , NakanoCT , NakanoEM , et al. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo‐controlled randomised study. British Journal of Ophthalmology2015;99(5):654‐8. ">Tzelikis 2015</a>; <a href="./references#CD010516-bbs2-0043" title="WangQW , YaoK , XuW , ChenPQ , ShentuXC , XieX , et al. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification. Ophthalmologica2013;229(4):187‐94. ">Wang 2013</a>; <a href="./references#CD010516-bbs2-0045" title="YavasGF , OztürkF , KüsbeciT . Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema. Journal of Cataract and Refractive Surgery2007;33(5):804‐7. ">Yavas 2007</a>; <a href="./references#CD010516-bbs2-0047" title="ZanettiFR , FulcoEA , ChavesFR , daCosta PintoAP , ArietaCE , LiraRP . Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on maintenance of intraoperative mydriasis during cataract surgery: a randomized trial. Indian Journal of Ophthalmology2012;60(4):277‐81. ">Zanetti 2012</a>; <a href="./references#CD010516-bbs2-0048" title="ZhangHY , ZhuSQ . Clinical study of pranoprofen eyedrops on prophylaxis of cystoids macular edema after cataract surgery. International Journal of Ophthalmology2008;8(7):1370‐2. ">Zhang 2008</a>). We judged 22 studies to have an unclear risk of bias due to funding sources or declarations of interest or both not being reported (<a href="./references#CD010516-bbs2-0001" title="AdamR , RodallecT , NordmannJP . Indometacine and macular thickness undergoing cataract surgery: a prospective randomized study. Investigative Ophthalmology &amp; Visual Science2005; Vol. 46:E‐Abstract 787. ">Adam 2005</a>; <a href="./references#CD010516-bbs2-0004" title="AsanoS , MiyakeK , OtaI , SugitaG , KimuraW , SakkaY , et al. Reducing angiographic cystoid macular edema and blood‐aqueous barrier disruption after small‐incision phacoemulsification and foldable intraocular lens implantation. Multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasonone 0.1%. Journal of Cataract and Refractive Surgery2008;31(1):57‐63. ">Asano 2008</a>; <a href="./references#CD010516-bbs2-0005" title="BucciFA , MattaAZ . An objective comparison of acular vs vexol to control inflammation following phacoemulsification. American Academy of Ophthalmology; 2001 Nov 11‐14; New Orleans (LA). 2001:117. ">Bucci 2001</a>; <a href="./references#CD010516-bbs2-0006" title="Cervantes‐CosteG , Sánchez‐CastroY , Orozco‐CarrollM , Mendoza‐SchusterE , Velasco‐BaronaC . Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac. Clinical Ophthalmology2009;3(1):219‐26. ">Cervantes‐Coste 2009</a>; <a href="./references#CD010516-bbs2-0007" title="ChatziralliIP , PapazisisL , SergentanisTN . Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial. Ophthalmologica2011;225(2):89‐94. ChatziralliIP , SergentanisTN , ParikakisEA , PapazisisLE , MitropoulosP , MoschosMM . The impact of non‐steroidal anti‐inflammatory agents after phacoemulsification on quality of life: a randomized study. Ophthalmology and Therapy2017;6(1):133‐40. ">Chatziralli 2011</a>; <a href="./references#CD010516-bbs2-0008" title="ChenJ , WangGQ . Clinical observation of bromfenac sodium 0.1% eye drops on cataract surgery. International Eye Science2015;15(12):2102‐4. ">Chen 2015</a>; <a href="./references#CD010516-bbs2-0009" title="DalD , SaraçO , TokluY , CakmakHB , GungorED . Efficacy of topical ketoroloc on macular thickness in patients undergoing cataract surgery. Ophthalmologica2014;232(Suppl 2):43. ">Dal 2014</a>; <a href="./references#CD010516-bbs2-0014" title="ElsawyMF , BadawiN , KhairyHA . Prophylactic postoperative ketorolac improves outcomes in diabetic patients assigned for cataract surgery. Clinical Ophthalmology2013;7:1245‐9. ">Elsawy 2013</a>; <a href="./references#CD010516-bbs2-0017" title="GuzeyM , KaradedeZ , DoganZ , SaticiA . Ketorolac‐tobramycin combination vs fluorometholone‐tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision. Ophthalmic Surgery and Lasers2000;31(6):451‐6. ">Guzey 2000</a>; <a href="./references#CD010516-bbs2-0021" title="KatoS , BokuC , OnishiT , KoikeM , KageyamaT , NishiharaH , et al. Comparison of postoperative inflammation with two types of intraocular lense and anti‐inflammatory agents. Folia Ophthalmologica Japonica1998;49:286‐9. ">Kato 1998</a>; <a href="./references#CD010516-bbs2-0022" title="LaurellCG , ZetterströmC . Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery. British Journal of Ophthalmology2002;86(12):1380‐4. ">Laurell 2002</a>; <a href="./references#CD010516-bbs2-0025" title="McColginAZ , RaizmanMB . Efficacy of topical voltaren in reducing the incidence of postoperative cystoid macular edema. Investigative Ophthalmology &amp; Visual Science1999; Vol. 40:ARVO E‐Abstract 1529. ">McColgin 1999</a>; <a href="./references#CD010516-bbs2-0026" title="MiyakeK , NishimuraK , HarinoS , OtaI , AsanoS , KondoN , et al. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation. Investigative Ophthalmology &amp; Visual Science2007;48(12):5647‐52. ">Miyake 2007</a>; <a href="./references#CD010516-bbs2-0028" title="MiyanagaM , MiyaiT , NejimaR , MaruyamaY , MiyataK , KatoS . Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. Acta Ophthalmologica2009;87(3):300‐5. ">Miyanaga 2009</a>; <a href="./references#CD010516-bbs2-0029" title="MoschosMM , ChatziralliIP , PantazisP , RouvasAA , SergentanisTN . Is topical diclofenac essential before and after uneventful phacoemulsification cataract surgery?. Journal of Ocular Pharmacology and Therapeutics2012;28(4):335‐9. ">Moschos 2012</a>; <a href="./references#CD010516-bbs2-0030" title="MuletME , AlioJL , AyalaMJ , De laHozF , BedaJL . Efficacy of 0.5% ketorolac (Acular™) as an anti‐inflammatory treatment after cataract surgery. Investigative Ophthalmology &amp; Visual Science2001;42:ARVO E‐Abstract 66. ">Mulet 2001</a>; <a href="./references#CD010516-bbs2-0033" title="RodríguezYR , PereraIIYM , HernándezIM , ÁvilaIIRI , Hernández SilvaJR , OchoaMJ . Diclofenac sodium eyedrops in cataract's surgery by phacoemulsification [Colirio de diclofenaco sódico en cirugía de catarata por facoemulsificación]. Revista Cubana de Oftalmología2011;24(1):46‐54. ">Ruiz Rodríguez 2011</a>; <a href="./references#CD010516-bbs2-0034" title="SahuS , RamJ , BansalR , PandavSS , GuptaA . Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification. Journal of Cataract and Refractive Surgery2015;41(10):2043‐8. ">Sahu 2015</a>; <a href="./references#CD010516-bbs2-0036" title="ShimazakiJ , FujishimaH , YagiY , TsubotaK . Effects of diclofenac eye drops on corneal epithelial structure and function after small‐incision cataract surgery. Ophthalmology1996;103(1):50‐7. ">Shimazaki 1996</a>; <a href="./references#CD010516-bbs2-0039" title="TiclyFG , LiraRP , ZanettiFR , MachadoMC , RodriguesGB , ArietaCE . Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial. Journal of Ocular Pharmacology and Therapeutics2014;30(6):495‐501. ">Ticly 2014</a>; <a href="./references#CD010516-bbs2-0040" title="TrinavaratA , AtchaneeyasakulL , SurachatkumtonekulT , KosrirukvongsP . Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification. Journal of the Medical Association of Thailand2003;86(2):143‐50. ">Trinavarat 2003</a>; <a href="./references#CD010516-bbs2-0042" title="VoudouriA , ZafirakisP , Livir‐RallatosG , Livir‐RallatosC , CanakisC , MarkomichelakisN . Diclofenac versus prednisolone post phacoemulsification treatment: a randomized clinical trial. Investigative Ophthalmology &amp; Visual Science2002; Vol. 43:ARVO E‐Abstract 373. ">Voudouri 2002</a>; <a href="./references#CD010516-bbs2-0044" title="WittpennJR , SilversteinS , HeierJ , KenyonKR , HunkelerJD , EarlM , et al. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low‐risk cataract surgery patients. American Journal of Ophthalmology2008;146(4):554‐60. ">Wittpenn 2008</a>). We judged some of these studies to have unclear risk of bias also because some participants had both eyes enrolled and randomized, but it was unclear whether the authors had taken into account the non‐independence of eyes in the analysis. We judged four studies to have a high risk of bias because the authors were employees or consultants to the pharmaceutical company that manufactured one of the study medications, or the company provided the medications used in the study (<a href="./references#CD010516-bbs2-0018" title="HessemerV , SchartnerH . Low influence of anti‐inflammatory therapy on intraocular inflammation following minimally invasive phacoemulsification [Geringer Einfluß antiinflammatorischer Therapie auf den intraokularen Reizzustand nach minimal invasiver Phakoemulsifikation]. Der Ophthalmologe1997;94(1):30‐2. HessemerV , SchmidtK , SchartnerH . Minimally inflammatory cataract surgery [Minimal inflammatorische Kataraktchirurgie (MIK)]. Klinische Montasblätter für Augenheilkunde1996;209(6):331‐9. ">Hessemer 1996</a>; <a href="./references#CD010516-bbs2-0027" title="MiyakeK , OtaI , MiyakeG , NumagaJ . Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. Journal of Cataract and Refractive Surgery2011;37(9):1581‐8. ">Miyake 2011</a>; <a href="./references#CD010516-bbs2-0037" title="SinghR , AlpernL , JaffeGJ , LehmannRP , LimJ , ReiserHJ , et al. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clinical Ophthalmology2012;2012(6):1259‐69. ">Singh 2012</a>; <a href="./references#CD010516-bbs2-0046" title="ZaczekA , ArtzenD , LaurellCG , SteneviU , MontanP . Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery. Journal of Cataract and Refractive Surgery2014;40(9):1498‐505. ">Zaczek 2014</a>). Five studies were judged to have unclear risk of bias because although it was reported that funding was provided by a pharmaceutical company that manufactured that study drug, the authors were not employees or consultants of the companies and reported no conflicts of interest (<a href="./references#CD010516-bbs2-0010" title="DemcoTA . Topical diclofenac versus prednisolone acetate in control of inflammation after phacoemulsification. American Academy of Ophthalmology1995:150. DemcoTA , SuttonH , DemcoCJ , RajPS . Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification‐lens implant surgery. European Journal of Ophthalmology1997;7(3):236‐40. ">Demco 1997</a>; <a href="./references#CD010516-bbs2-0013" title="el‐HaraziSM , RuizRS , FeldmanRM , VillanuevaG , ChuangAZ . A randomized double‐masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post‐phacoemulsification flare and cells. Ophthalmic Surgery and Lasers1998;29(7):539‐44. ">el‐Harazi 1998</a>; <a href="./references#CD010516-bbs2-0019" title="HolzerMP , SolomonKD , SandovalHP , VromanDT . Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification. Journal of Cataract and Refractive Surgery2002;28(1):93‐9. ">Holzer 2002</a>; <a href="./references#CD010516-bbs2-0032" title="BrennanKM , BrownRM , RobertsCW . A comparison of topical non‐steroidal anti‐inflammatory drugs to steroids for control of post cataract inflammation. Journal of the American Society of Ophthalmic Registered Nurses1993;18(1):8‐11. BrownRM , RobertsCW . Preoperative and postoperative use of nonsteroidal antiinflammatory drugs in cataract surgery. Journal of the American Society of Ophthalmic Registered Nurses1996;21(1):13‐6. RobertsCW . A comparison of non‐steroidal anti‐inflammatory drug to steroids for postoperative inflammation. American Academy of Ophthalmology1992; Vol. 22. RobertsCW , BrennanKM . A comparison on topical diclofenac with prednisolone for postcataract inflammation. Archives of Ophthalmology1995;113(6):725‐7. ">Roberts 1995</a>; <a href="./references#CD010516-bbs2-0038" title="SolomonKD , VromanDT , BarkerD , GehlkenJ . Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Journal of Cataract and Refractive Surgery2001;27(8):1232‐7. ">Solomon 2001</a>). We judged two studies to have a high risk of bias because of unusual protocols when treatment with the assigned study drug appeared not to work. In <a href="./references#CD010516-bbs2-0012" title="DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Acta Ophthalmologica2015;93(4):e314‐5. DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Asia‐Pacific Journal of Ophthalmology2014;3(4):220‐5. ">Duong 2014</a>, participants who did not respond to the study drug were given a "rescue medication" of the other medication class. <a href="./references#CD010516-bbs2-0016" title="EntezariM , RamezaniA , NikkhahH , YaseriM . The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial. International Ophthalmology2017;37(1):13‐8. [DOI: 10.1007/s10792‐016‐0209‐4] ">Entezari 2016</a> reported that "the frequency of the corticosteroid drops was adjusted for each eye." </p> </section> </section> <section id="CD010516-sec-0069"> <h3 class="title" id="CD010516-sec-0069">Effects of interventions</h3> <p>See: <a href="./full#CD010516-tbl-0001"><b>Summary of findings for the main comparison</b> Summary of findings for NSAIDs versus corticosteroids</a>; <a href="./full#CD010516-tbl-0002"><b>Summary of findings 2</b> Summary of findings for NSAIDs plus corticosteroids versus corticosteroids alone</a> </p> <section id="CD010516-sec-0070"> <h4 class="title">NSAIDs versus corticosteroids</h4> <section id="CD010516-sec-0071"> <h5 class="title">Primary outcomes</h5> <section id="CD010516-sec-0072"> <h6 class="title">Intraocular inflammation at one week after surgery</h6> <section id="CD010516-sec-0073"> <p><b>Inflammation measured by anterior chamber cell and flare</b></p> <p>None of the included studies that compared treatment with an NSAID to treatment with a corticosteroid reported inflammation as a dichotomous outcome in the format of the percentage with anterior chamber cell and flare classifications of 1 or higher according to the SUN working group criteria (<a href="./references#CD010516-bbs2-0123" title="JabsDA , NussenblattRB , RosenbaumJT , Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. American Journal of Ophthalmology2005;140(3):509‐16. ">Jabs 2005</a>). However, several of the included studies reported mean cell and flare measurements. As a modification to the published protocol, we performed a meta‐analysis on the mean cell values at one week (<a href="./references#CD010516-fig-0007" title="">Analysis 1.1</a>, <a href="#CD010516-fig-0004">Figure 4</a>) and the mean flare values at one week (<a href="./references#CD010516-fig-0008" title="">Analysis 1.2</a>, <a href="#CD010516-fig-0005">Figure 5</a>), though we noted that the data for these outcomes were skewed, which may affect our analysis and interpretation of the data. Three studies reported the mean cell data measured using a cell meter (<a href="./references#CD010516-bbs2-0005" title="BucciFA , MattaAZ . An objective comparison of acular vs vexol to control inflammation following phacoemulsification. American Academy of Ophthalmology; 2001 Nov 11‐14; New Orleans (LA). 2001:117. ">Bucci 2001</a>; <a href="./references#CD010516-bbs2-0019" title="HolzerMP , SolomonKD , SandovalHP , VromanDT . Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification. Journal of Cataract and Refractive Surgery2002;28(1):93‐9. ">Holzer 2002</a>; <a href="./references#CD010516-bbs2-0032" title="BrennanKM , BrownRM , RobertsCW . A comparison of topical non‐steroidal anti‐inflammatory drugs to steroids for control of post cataract inflammation. Journal of the American Society of Ophthalmic Registered Nurses1993;18(1):8‐11. BrownRM , RobertsCW . Preoperative and postoperative use of nonsteroidal antiinflammatory drugs in cataract surgery. Journal of the American Society of Ophthalmic Registered Nurses1996;21(1):13‐6. RobertsCW . A comparison of non‐steroidal anti‐inflammatory drug to steroids for postoperative inflammation. American Academy of Ophthalmology1992; Vol. 22. RobertsCW , BrennanKM . A comparison on topical diclofenac with prednisolone for postcataract inflammation. Archives of Ophthalmology1995;113(6):725‐7. ">Roberts 1995</a>). There was uncertainty as to whether treatment with an NSAID or treatment with a corticosteroid resulted in less inflammation marked by fewer cells in the anterior chamber (MD ‐0.60, 95% CI ‐2.19 to 0.99). We downgraded the certainty of the evidence for this outcome once and judged it to be moderate due to risk of bias because the included studies were all poorly reported. We did not downgrade for imprecision because a difference of approximately two cells in the anterior chamber is not clinically significant. Two other studies reported on mean cell data measured using a slit lamp rather than the cell and flare meter, however they used different scales to grade the number of cells and could not be combined in a meta‐analysis (<a href="./references#CD010516-bbs2-0017" title="GuzeyM , KaradedeZ , DoganZ , SaticiA . Ketorolac‐tobramycin combination vs fluorometholone‐tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision. Ophthalmic Surgery and Lasers2000;31(6):451‐6. ">Guzey 2000</a>; <a href="./references#CD010516-bbs2-0019" title="HolzerMP , SolomonKD , SandovalHP , VromanDT . Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification. Journal of Cataract and Refractive Surgery2002;28(1):93‐9. ">Holzer 2002</a>). Five studies reported the mean flare data obtained from a flare meter (in photons/millisecond) at one week postoperatively (<a href="./references#CD010516-bbs2-0004" title="AsanoS , MiyakeK , OtaI , SugitaG , KimuraW , SakkaY , et al. Reducing angiographic cystoid macular edema and blood‐aqueous barrier disruption after small‐incision phacoemulsification and foldable intraocular lens implantation. Multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasonone 0.1%. Journal of Cataract and Refractive Surgery2008;31(1):57‐63. ">Asano 2008</a>; <a href="./references#CD010516-bbs2-0005" title="BucciFA , MattaAZ . An objective comparison of acular vs vexol to control inflammation following phacoemulsification. American Academy of Ophthalmology; 2001 Nov 11‐14; New Orleans (LA). 2001:117. ">Bucci 2001</a>; <a href="./references#CD010516-bbs2-0026" title="MiyakeK , NishimuraK , HarinoS , OtaI , AsanoS , KondoN , et al. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation. Investigative Ophthalmology &amp; Visual Science2007;48(12):5647‐52. ">Miyake 2007</a>; <a href="./references#CD010516-bbs2-0027" title="MiyakeK , OtaI , MiyakeG , NumagaJ . Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. Journal of Cataract and Refractive Surgery2011;37(9):1581‐8. ">Miyake 2011</a>; <a href="./references#CD010516-bbs2-0032" title="BrennanKM , BrownRM , RobertsCW . A comparison of topical non‐steroidal anti‐inflammatory drugs to steroids for control of post cataract inflammation. Journal of the American Society of Ophthalmic Registered Nurses1993;18(1):8‐11. BrownRM , RobertsCW . Preoperative and postoperative use of nonsteroidal antiinflammatory drugs in cataract surgery. Journal of the American Society of Ophthalmic Registered Nurses1996;21(1):13‐6. RobertsCW . A comparison of non‐steroidal anti‐inflammatory drug to steroids for postoperative inflammation. American Academy of Ophthalmology1992; Vol. 22. RobertsCW , BrennanKM . A comparison on topical diclofenac with prednisolone for postcataract inflammation. Archives of Ophthalmology1995;113(6):725‐7. ">Roberts 1995</a>). The meta‐analysis showed that the mean flare was 13.74 photons/ms lower in the NSAID group compared with the corticosteroid group (MD ‐13.74, 95% CI ‐21.47 to ‐6.00), indicating less intraocular inflammation for those who received NSAIDs, but we noted that very high statistical heterogeneity among the studies included in this analysis (I<sup>2</sup> = 92%). We judged the certainty of the evidence for this outcome to be low; we downgraded for this inconsistency and because of potential risk of bias due to poor reporting of the studies included in this meta‐analysis. As with the cell measurements, the same studies also reported mean flare value measured using a slit lamp rather than a flare meter (<a href="./references#CD010516-bbs2-0017" title="GuzeyM , KaradedeZ , DoganZ , SaticiA . Ketorolac‐tobramycin combination vs fluorometholone‐tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision. Ophthalmic Surgery and Lasers2000;31(6):451‐6. ">Guzey 2000</a>; <a href="./references#CD010516-bbs2-0019" title="HolzerMP , SolomonKD , SandovalHP , VromanDT . Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification. Journal of Cataract and Refractive Surgery2002;28(1):93‐9. ">Holzer 2002</a>), but we again did not combine these in a meta‐analysis. <a href="./references#CD010516-bbs2-0019" title="HolzerMP , SolomonKD , SandovalHP , VromanDT . Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification. Journal of Cataract and Refractive Surgery2002;28(1):93‐9. ">Holzer 2002</a> reported on the mean flare data recorded by a flare meter as well, but the scale used to report the outcome was unclear. Three studies reported on the sum of cells and flare, but because one used its own scale (<a href="./references#CD010516-bbs2-0010" title="DemcoTA . Topical diclofenac versus prednisolone acetate in control of inflammation after phacoemulsification. American Academy of Ophthalmology1995:150. DemcoTA , SuttonH , DemcoCJ , RajPS . Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification‐lens implant surgery. European Journal of Ophthalmology1997;7(3):236‐40. ">Demco 1997</a>), and one did not report standard deviations (<a href="./references#CD010516-bbs2-0012" title="DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Acta Ophthalmologica2015;93(4):e314‐5. DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Asia‐Pacific Journal of Ophthalmology2014;3(4):220‐5. ">Duong 2014</a>), the data could not be analyzed with the third study (<a href="./references#CD010516-bbs2-0032" title="BrennanKM , BrownRM , RobertsCW . A comparison of topical non‐steroidal anti‐inflammatory drugs to steroids for control of post cataract inflammation. Journal of the American Society of Ophthalmic Registered Nurses1993;18(1):8‐11. BrownRM , RobertsCW . Preoperative and postoperative use of nonsteroidal antiinflammatory drugs in cataract surgery. Journal of the American Society of Ophthalmic Registered Nurses1996;21(1):13‐6. RobertsCW . A comparison of non‐steroidal anti‐inflammatory drug to steroids for postoperative inflammation. American Academy of Ophthalmology1992; Vol. 22. RobertsCW , BrennanKM . A comparison on topical diclofenac with prednisolone for postcataract inflammation. Archives of Ophthalmology1995;113(6):725‐7. ">Roberts 1995</a>). </p> <div class="figure" id="CD010516-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 NSAIDs versus corticosteroids, outcome: 1.1 Mean cell values at one week." data-id="CD010516-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 NSAIDs versus corticosteroids, outcome: 1.1 Mean cell values at one week. </p> </div> </div> </div> <div class="figure" id="CD010516-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 NSAIDs versus corticosteroids, outcome: 1.2 Mean flare values at one week." data-id="CD010516-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 NSAIDs versus corticosteroids, outcome: 1.2 Mean flare values at one week. </p> </div> </div> </div> </section> <section id="CD010516-sec-0074"> <p><b>Inflammation defined by presence of corneal edema</b></p> <p>Only one study that compared an NSAID with a corticosteroid reported on the presence of corneal edema at one week. In the NSAID group, 4 of 39 participants (10.3%) and, in the corticosteroid group, 10 out of 75 participants (13.3%) showed signs of corneal edema (<a href="./references#CD010516-bbs2-0040" title="TrinavaratA , AtchaneeyasakulL , SurachatkumtonekulT , KosrirukvongsP . Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification. Journal of the Medical Association of Thailand2003;86(2):143‐50. ">Trinavarat 2003</a>). There was insufficient evidence to conclude that one treatment group had a lower proportion of corneal edema at one week post‐surgery than the other (RR 0.77, 95% CI 0.26 to 2.29). We judged the certainty of the evidence for this outcome to be low, downgraded one level each due to imprecision and high risk of performance and detection bias; this was reported as an unmasked study. </p> </section> </section> <section id="CD010516-sec-0075"> <h6 class="title">BCVA of 20/40 or better at one week after surgery</h6> <p>Though some included studies that compared treatment with an NSAID with treatment with a corticosteroid reported the mean BCVA for treatment groups at one week follow‐up, none of the included studies reported BCVA as a dichotomous variable that reported on the proportion of participants with BCVA of 20/40 or better at one‐week after surgery. </p> </section> </section> <section id="CD010516-sec-0076"> <h5 class="title">Secondary outcomes</h5> <section id="CD010516-sec-0077"> <h6 class="title">Cystoid macular edema at one week after surgery</h6> <p>None of the included studies reported the presence of CME at one week after surgery, but several studies reported this outcome at other time points up to one month postoperatively. <a href="./references#CD010516-bbs2-0026" title="MiyakeK , NishimuraK , HarinoS , OtaI , AsanoS , KondoN , et al. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation. Investigative Ophthalmology &amp; Visual Science2007;48(12):5647‐52. ">Miyake 2007</a> reported that at two weeks' post‐cataract surgery none of the participants who had received an NSAID had CME, while four participants who had received a corticosteroid had CME (0% versus 16%). However, this study was relatively small, and there was statistical uncertainty as to whether the NSAID treatment was favored (RR 0.11, 95% CI 0.01 to 1.96). Another study reported on the proportion of participants that had a CME during the trial follow‐up period, but did not report the time point at which the outcome was observed (<a href="./references#CD010516-bbs2-0043" title="WangQW , YaoK , XuW , ChenPQ , ShentuXC , XieX , et al. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification. Ophthalmologica2013;229(4):187‐94. ">Wang 2013</a>). In this study, none of the participants in the NSAID group had CME, while seven in the corticosteroid group had CME. This study showed that participants who received an NSAID had a lower risk of developing CME, but the 95% confidence interval crossed the null value and there was uncertainty in the measurement (RR 0.07, 95% CI 0.00 to 1.16). </p> <p>We included four studies in our meta‐analysis of the proportion of participants with CME by one month postoperatively. <a href="./references#CD010516-bbs2-0004" title="AsanoS , MiyakeK , OtaI , SugitaG , KimuraW , SakkaY , et al. Reducing angiographic cystoid macular edema and blood‐aqueous barrier disruption after small‐incision phacoemulsification and foldable intraocular lens implantation. Multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasonone 0.1%. Journal of Cataract and Refractive Surgery2008;31(1):57‐63. ">Asano 2008</a>, <a href="./references#CD010516-bbs2-0026" title="MiyakeK , NishimuraK , HarinoS , OtaI , AsanoS , KondoN , et al. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation. Investigative Ophthalmology &amp; Visual Science2007;48(12):5647‐52. ">Miyake 2007</a>, and <a href="./references#CD010516-bbs2-0027" title="MiyakeK , OtaI , MiyakeG , NumagaJ . Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. Journal of Cataract and Refractive Surgery2011;37(9):1581‐8. ">Miyake 2011</a> reported this outcome at five weeks' postoperatively, while <a href="./references#CD010516-bbs2-0028" title="MiyanagaM , MiyaiT , NejimaR , MaruyamaY , MiyataK , KatoS . Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. Acta Ophthalmologica2009;87(3):300‐5. ">Miyanaga 2009</a> reported at one month postoperatively. Participants who were treated with an NSAID had a lower risk of CME at one month compared with participants who were treated with a corticosteroid (RR 0.26, 95% CI 0.17 to 0.41; <a href="./references#CD010516-fig-0009" title="">Analysis 1.3</a>). Another study with three arms that compared two different NSAIDs with a corticosteroid reported that no participants had CME at one month postoperatively. We performed a sensitivity analysis removing one study (<a href="./references#CD010516-bbs2-0027" title="MiyakeK , OtaI , MiyakeG , NumagaJ . Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. Journal of Cataract and Refractive Surgery2011;37(9):1581‐8. ">Miyake 2011</a>) in which the authors were paid consultants the manufacturer one the study drugs. Removing this data from the meta‐analysis did not change the conclusions; participants treated with an NSAID had less risk of developing CME compared with participants treated with a corticosteroid (RR 0.30, 95% CI 0.18 to 0.49). Based on our sensitivity analysis, we did not downgrade the certainty of the evidence based on the potential risk of bias from the influence of the manufacturer of the study drugs, however we did downgrade based on risk of bias for the studies in this analysis, as they were poorly reported, details of masking and analysis were unclear, and in one there was a high risk of attrition bias. We also downgraded the evidence one level due to indirectness, because our outcome of interest was CME at one week, and the data we were able to combine was for one month. Additionally, two of the studies included in the meta‐analysis used fluorometholone as the corticosteroid in the comparison, which is a very weak corticosteroid and therefore a weak comparator. These two studies contributed 30% of the weight of the meta‐analysis, which also contributed to our decision to downgrade for indirectness. The certainty of the evidence for the outcome of CME at one month postoperatively was low. </p> </section> <section id="CD010516-sec-0078"> <h6 class="title">Time to cessation of treatment</h6> <p>None of the included studies that compared an NSAID with a corticosteroid reported on the time to cessation of treatment. </p> </section> </section> <section id="CD010516-sec-0079"> <h5 class="title">Adverse events</h5> <p>None of the studies in this comparison reported on adverse events.</p> </section> <section id="CD010516-sec-0080"> <h5 class="title">Economic outcomes</h5> <p>None of the studies in this comparison reported on economic outcomes.</p> </section> </section> <section id="CD010516-sec-0081"> <h4 class="title">Combination of NSAIDs plus corticosteroids versus corticosteroids alone</h4> <section id="CD010516-sec-0082"> <h5 class="title">Primary outcomes</h5> <section id="CD010516-sec-0083"> <h6 class="title">Intraocular inflammation at one week after surgery</h6> <section id="CD010516-sec-0084"> <p><b>Inflammation measured by anterior chamber cell and flare</b></p> <p>None of the included studies that compared a combination of NSAID plus a corticosteroid with a corticosteroid alone reported inflammation by anterior chamber cell and flare as a dichotomous outcome. There was not enough continuous data for anterior chamber cell and flare to perform a meta‐analysis. </p> </section> <section id="CD010516-sec-0085"> <p><b>Inflammation defined by presence of corneal edema</b></p> <p>Only one study that compared the combination of an NSAID plus a corticosteroid versus a corticosteroid alone reported on the proportion of participants with corneal edema each week up to one month postoperatively (<a href="./references#CD010516-bbs2-0007" title="ChatziralliIP , PapazisisL , SergentanisTN . Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial. Ophthalmologica2011;225(2):89‐94. ChatziralliIP , SergentanisTN , ParikakisEA , PapazisisLE , MitropoulosP , MoschosMM . The impact of non‐steroidal anti‐inflammatory agents after phacoemulsification on quality of life: a randomized study. Ophthalmology and Therapy2017;6(1):133‐40. ">Chatziralli 2011</a>). At each of the four time points, there was statistical uncertainty as to which group had a lower risk of developing corneal edema (RR 1.07, 95% CI 0.98 to 1.16 at one week; RR 0.52, 95% CI 0.24 to 1.14 at two weeks; RR 0.97, 95% CI 0.20 to 4.65 at three weeks; and RR 2.92, 95% CI 0.12 to 70.35 at four weeks). We reported the one‐week data in our <a href="./full#CD010516-tbl-0002">summary of findings Table 2</a>, and downgraded one level to moderate due to concerns about reporting bias: the study investigators said they collected data at certain postoperative time points, but no all results were reported. Another study reported that no participant in either the NSAID plus corticosteroid group or the corticosteroid‐alone group presented with corneal edema at four weeks (<a href="./references#CD010516-bbs2-0029" title="MoschosMM , ChatziralliIP , PantazisP , RouvasAA , SergentanisTN . Is topical diclofenac essential before and after uneventful phacoemulsification cataract surgery?. Journal of Ocular Pharmacology and Therapeutics2012;28(4):335‐9. ">Moschos 2012</a>). </p> </section> </section> <section id="CD010516-sec-0086"> <h6 class="title">BCVA of 20/40 or better at one week after surgery</h6> <p>None of the included studies that compared a combination of an NSAID plus a corticosteroid with a corticosteroid alone reported on the proportion of participants that had BCVA of 20/40 or better one week after surgery. Some included studies did report the mean BCVA for each treatment group at one week after surgery; however, this was not an outcome of interest for this review. </p> </section> </section> <section id="CD010516-sec-0087"> <h5 class="title">Secondary outcomes</h5> <section id="CD010516-sec-0088"> <h6 class="title">Cystoid macular edema at one week after surgery</h6> <p>Only one of the included studies reported presence of CME at one week after surgery (<a href="./references#CD010516-bbs2-0008" title="ChenJ , WangGQ . Clinical observation of bromfenac sodium 0.1% eye drops on cataract surgery. International Eye Science2015;15(12):2102‐4. ">Chen 2015</a>), but several studies reported this outcome at later follow‐up time points. One study reported on the incidence of CME at two weeks after surgery (<a href="./references#CD010516-bbs2-0011" title="DonnenfeldED , PerryHD , WittpennJR , SolomonR , NattisA , ChouT . Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic‐response curve. Journal of Cataract and Refractive Surgery2006;32(9):1474‐82. ">Donnenfeld 2006</a>). We combined the one‐week data from <a href="./references#CD010516-bbs2-0008" title="ChenJ , WangGQ . Clinical observation of bromfenac sodium 0.1% eye drops on cataract surgery. International Eye Science2015;15(12):2102‐4. ">Chen 2015</a> with the two‐week data from <a href="./references#CD010516-bbs2-0011" title="DonnenfeldED , PerryHD , WittpennJR , SolomonR , NattisA , ChouT . Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic‐response curve. Journal of Cataract and Refractive Surgery2006;32(9):1474‐82. ">Donnenfeld 2006</a>; the combined estimates favored the combination of NSAID plus corticosteroid over corticosteroid alone (RR 0.17, 95% CI 0.03 to 0.97; <a href="#CD010516-fig-0006">Figure 6</a>, <a href="./references#CD010516-fig-0010" title="">Analysis 2.1</a>). We graded the certainty of the evidence for this outcome as low; we downgraded one level each for inconsistency and imprecision. We included seven studies in the meta‐analysis for the proportion of participants who had CME at one month postoperatively (<a href="./references#CD010516-bbs2-0020" title="JungJW , ChungBH , KimEK , SeoKY , KimTI . The effects of two non‐steroidal anti‐inflammatory drugs, bromfenac 0.1% and ketorolac 0.45%, on cataract surgery. Yonsei Medical Journal2015;56(6):1671‐7. ">Jung 2015</a>; <a href="./references#CD010516-bbs2-0023" title="LiMC , YangXR , LiuF , ShaoDP , LiYB . Effect of topical NSAIDs in preventing macular edema after phacoemulsification in diabetes. International Journal of Ophthalmology2011;11(9):1614‐6. ">Li 2011</a>; <a href="./references#CD010516-bbs2-0028" title="MiyanagaM , MiyaiT , NejimaR , MaruyamaY , MiyataK , KatoS . Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. Acta Ophthalmologica2009;87(3):300‐5. ">Miyanaga 2009</a>; <a href="./references#CD010516-bbs2-0029" title="MoschosMM , ChatziralliIP , PantazisP , RouvasAA , SergentanisTN . Is topical diclofenac essential before and after uneventful phacoemulsification cataract surgery?. Journal of Ocular Pharmacology and Therapeutics2012;28(4):335‐9. ">Moschos 2012</a>; <a href="./references#CD010516-bbs2-0039" title="TiclyFG , LiraRP , ZanettiFR , MachadoMC , RodriguesGB , ArietaCE . Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial. Journal of Ocular Pharmacology and Therapeutics2014;30(6):495‐501. ">Ticly 2014</a>; <a href="./references#CD010516-bbs2-0044" title="WittpennJR , SilversteinS , HeierJ , KenyonKR , HunkelerJD , EarlM , et al. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low‐risk cataract surgery patients. American Journal of Ophthalmology2008;146(4):554‐60. ">Wittpenn 2008</a>; <a href="./references#CD010516-bbs2-0046" title="ZaczekA , ArtzenD , LaurellCG , SteneviU , MontanP . Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery. Journal of Cataract and Refractive Surgery2014;40(9):1498‐505. ">Zaczek 2014</a>), including one study that reported cystoid macular edema at a three‐week examination and another study that reported at five weeks post‐operatively (<a href="./references#CD010516-bbs2-0046" title="ZaczekA , ArtzenD , LaurellCG , SteneviU , MontanP . Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery. Journal of Cataract and Refractive Surgery2014;40(9):1498‐505. ">Zaczek 2014</a> and <a href="./references#CD010516-bbs2-0039" title="TiclyFG , LiraRP , ZanettiFR , MachadoMC , RodriguesGB , ArietaCE . Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial. Journal of Ocular Pharmacology and Therapeutics2014;30(6):495‐501. ">Ticly 2014</a>, respectively). This analysis favored the combination of an NSAID plus a corticosteroid over a corticosteroid alone for an approximately 50% lower risk of CME present at one month after surgery; however there was statistical uncertainty (RR 0.50, 95% CI 0.23 to 1.06; <a href="./references#CD010516-fig-0011" title="">Analysis 2.2</a>). Two of the studies included in the analysis reported that no participant in either study arm had CME at one month after surgery. </p> <div class="figure" id="CD010516-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 NSAIDs plus corticosteroids versus corticosteroids alone, outcome: 2.1 Proportion of participants with cystoid macular edema at one week." data-id="CD010516-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 NSAIDs plus corticosteroids versus corticosteroids alone, outcome: 2.1 Proportion of participants with cystoid macular edema at one week. </p> </div> </div> </div> </section> <section id="CD010516-sec-0089"> <h6 class="title">Time to cessation of treatment</h6> <p>None of the included studies that compared a combination of an NSAID plus a corticosteroid with a corticosteroid alone reported time to cessation of treatment. </p> </section> </section> <section id="CD010516-sec-0090"> <h5 class="title">Adverse events</h5> <p>Only a few of the studies in this comparison reported adverse events associated with the eye drops used after cataract surgery. <a href="./references#CD010516-bbs2-0034" title="SahuS , RamJ , BansalR , PandavSS , GuptaA . Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification. Journal of Cataract and Refractive Surgery2015;41(10):2043‐8. ">Sahu 2015</a> reported that no participants in that study reported any adverse effects related to topical NSAID use and that the only clinically significant adverse event was associated with a complication of the surgery rather than the NSAID eye drops. This participant affected had a heterogeneous retinal detachment at four weeks that subsequently was managed with pars plana vitrectomy. An epiretinal membrane was detected at four weeks after surgery in another participant. <a href="./references#CD010516-bbs2-0003" title="AlmeidaDR , KhanZ , XingL , BakarSN , RahimK , UrtonT , et al. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. Journal of Cataract and Refractive Surgery2012;38(9):1537‐43. ">Almeida 2012</a> used the Comparison of Ophthalmic Medications for Tolerability Questionnaire (COMTOL) to ascertain the frequency and severity of side effects. The investigators reported that there was no significant difference between the three study groups for all side effects, and presented only the overall number of participants with selected adverse events. Three of the five most commonly reported side effects were markers of ocular discomfort: burning (29%), redness (18%), and blurred vision (12%). </p> </section> <section id="CD010516-sec-0091"> <h5 class="title">Economic outcomes</h5> <p>None of the studies in this comparison reported on economic outcomes.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010516-sec-0092" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010516-sec-0092"></div> <section id="CD010516-sec-0093"> <h3 class="title" id="CD010516-sec-0093">Summary of main results</h3> <section id="CD010516-sec-0094"> <h4 class="title">NSAIDs alone versus corticosteroids alone</h4> <p>Though we had pre‐specified the use of dichotomous outcomes, none of the included studies that compared NSAIDs alone with corticosteroids alone reported postoperative ocular inflammation in terms of cells and flare as a dichotomous variables; to make use of data provided in the included studies, we examined data for cell and flare measurements that had been reported as continuous measures. Only one study reported the other indicator of intraocular inflammation, presence of corneal edema at one week postoperatively: no statistically significant difference was found between the NSAID group and the corticosteroid group. None of the included studies reported BCVA after phacoemulsification or time to cessation of treatment of inflammation. None of the included studies reported on the proportion of eyes with CME at one week postoperatively; however, six studies reported the presence of CME at other time points, including four RCTs involving a total of 291 participants that reported CME at one month. We found low‐certainty evidence that participants treated with an NSAID had a lower risk of CME compared with those treated with a corticosteroid (RR 0.26, 95% CI 0.17 to 0.41). One of the studies had authors who were paid consultants of the company that manufactured the study drugs. We performed a sensitivity analysis to examine the effect of this potential risk of bias on the outcome estimate. Excluding data from this study did not change the conclusions: participants treated with an NSAID still had a lower risk of developing CME compared with participants treated with a corticosteroid (RR 0.30, 95% CI 0.18 to 0.49). None of the studies in this comparison reported on adverse events or economic outcomes. A variety of NSAIDs were used in these studies including diclofenac, nepafenac, and bromfenac. The studies also varied in the corticosteroid that was used and in their dosing schedules. Follow‐up after phacoemulsification ranged from five to eight weeks. In general, the studies were poorly reported so that many of the 'Risk of bias' domains were judged to be unclear. Only one included study was judged to be at low risk of bias in all domains. </p> </section> <section id="CD010516-sec-0095"> <h4 class="title">NSAIDs plus corticosteroids versus corticosteroids alone</h4> <p>Again, ocular inflammation in terms of cells and flare were not reported as a dichotomous variable in the studies that compared a combination of an NSAID plus a corticosteroid with a corticosteroid alone. One study with high risk of reporting bias reported corneal edema at various postoperative time points. At each time point, neither treatment with a combination of NSAID plus corticosteroid nor corticosteroid alone was favored. No study reported on BCVA at one week postoperatively or time to cessation of treatment. Only one included study reported on the presence of CME at one week after surgery, and another study reported CME at two weeks after surgery. The combined analysis included 220 participants and estimated a lower risk of CME in the group receiving NSAIDs plus corticosteroids (RR 0.17, 95% CI 0.03 to 0.97), however we found this to be weak evidence based on inconsistency and imprecision of the estimate. At one‐month follow‐up, seven RCTs reported the proportion of participants with CME; the combined data did not support a significant risk reduction (RR 0.50, 95% CI 0.23 to 1.06). In general, the studies were poorly reported. Two studies in this comparison reported adverse events: one noted that adverse events were complications of surgery rather than a result of study treatments, and the other found ocular side effects such as burning, redness, and blurred vision that occurred at about the same rates in each study arm. None of the studies in this comparison reported on economic outcomes. None of the studies were judged to be at low risk of bias in all domains. </p> </section> </section> <section id="CD010516-sec-0096"> <h3 class="title" id="CD010516-sec-0096">Overall completeness and applicability of evidence</h3> <p>We included a relatively large number of studies in both intervention comparisons examined in this review; the studies have a wide global range. </p> <p>The included studies compared NSAIDs and corticosteroids after uncomplicated phacoemulsification. The results of this review may therefore be less applicable in parts of the world where other cataract surgery techniques, including manual extracapsular cataract extraction, are more commonly utilized. </p> <p>The primary aim of this review was to assess the effectiveness of topical NSAIDs, alone or in combination with topical corticosteroids, versus topical corticosteroids alone, in controlling intraocular inflammation after uncomplicated phacoemulsification. No studies reported anterior chamber inflammation as a dichotomous variable, therefore no conclusion can be made about this topic. We were able to perform meta‐analysis of continuous cell and flare data for the comparison of NSAIDs versus corticosteroids, however, we noted that the data was skewed. The evidence was also sparse for corneal edema, however there did not appear to be any significant effect of NSAIDs this outcome. There have been more reports of the proportion of eyes with postoperative CME, mainly at time points beyond two weeks after surgery. However, due to the heterogeneity of types, doses, and regimens of NSAIDs and corticosteroids used in the studies, we could only make moderate‐certainty conclusions. </p> <p>In order to perform meta‐analyses for this review, we chose to combine data from different time points, such as outcomes reported at "one month" with outcomes reported at 5 weeks. It is possible that extra days of treatment in one study compared with fewer days in another (for example, 35 days [5 weeks] of treatment versus 28‐31 days [one month] of treatment) may be significant, especially given that the presence or absence of some of our outcomes may be dose‐dependent and differ based on the amount of medication to which each eye was exposed. </p> <p>This review included studies that used a variety of NSAIDs and corticosteroids. Fluorometholone is a low potency corticosteroid that was used in two studies that contributed to our meta‐analyses. This is a weak comparator and though it contributed about 30% of the weight of the data for our meta‐analysis on the risk of CME at one month postoperatively, the effect estimates may have been different had a stronger corticosteroid been used. In terms of the secondary objectives of this review, BCVA, patient‐reported discomfort, complications such as elevation of IOP, and cost‐effectiveness were rarely or never reported; no conclusions could be drawn regarding these topics. </p> </section> <section id="CD010516-sec-0097"> <h3 class="title" id="CD010516-sec-0097">Quality of the evidence</h3> <p>In general, we graded the evidence as being of low and moderate‐certainty. The reasons for downgrades included imprecision and heterogeneity in factors such as study design, medications used, and regimens studied. The outcome of mean anterior chamber flare was downgraded due to suspected publication bias. We suspected it may be possible that smaller studies that did not have statistically significant effects may never have been submitted for publication. Many of the included studies were also poorly reported, so that it was difficult to judge the degree of bias likely present in the various domains. In our certainty estimates, we downgraded for risk of bias when the analysis included poorly‐reported studies. </p> </section> <section id="CD010516-sec-0098"> <h3 class="title" id="CD010516-sec-0098">Potential biases in the review process</h3> <p>Due to the nature of the research question we posed in the review, and our goal of exploring the proportion of participants with anterior chamber inflammation at one week postoperative (cell or flare) as a dichotomous variable, the data regarding anterior chamber inflammation in all RCTs were not applicable. Defining the primary outcome as intraocular inflammation at one week of follow‐up also limited the applicability of data regarding CME, which were mostly reported at later time points. </p> </section> <section id="CD010516-sec-0099"> <h3 class="title" id="CD010516-sec-0099">Agreements and disagreements with other studies or reviews</h3> <p>A recent Cochrane review (<a href="./references#CD010516-bbs2-0127" title="LimBX , LimCHL , LimDK , EvansJR , BunceC , WormaldR . Prophylactic non‐steroidal anti‐inflammatory drugs for the prevention of macular oedema after cataract surgery. Cochrane Database of Systematic Reviews2016, Issue 11. [DOI: 10.1002/14651858.CD006683.pub3] ">Lim 2016</a>) evaluated the proportion of people with a poor vision outcome due to CME at three months after cataract surgery, with poor vision defined as 6/9 or worse attributed to a diagnosis of CME. That study found low‐certainty evidence that people who received topical NSAIDs in combination with steroid may have had a lower risk of poor vision due to macular edema at three months after cataract surgery compared to those taking corticosteroids alone (RR 0.40, 95% CI 0.27 to 0.61). In that study, cataract surgery included manual extracapsular cataract extraction, manual small‐incision cataract surgery, phacoemulsification cataract surgery, and intracapsular cataract extraction. </p> <p>Another review by <a href="./references#CD010516-bbs2-0138" title="WieldersLH , LambermontVA , SchoutenJS , van denBiggelaarFJ , WorthyG , SimmonsRW , et al. Prevention of cystoid macular edema after cataract surgery in nondiabetic and diabetic patients: a systematic review and meta‐analysis. American Journal of Ophthalmology2016;160(5):968‐81. ">Wielders 2015</a> reported a similar effect, though they reported odds ratios rather than risk ratios. The authors did not comment on the quality of the evidence in their conclusions. </p> <p>A report by the American Academy of Ophthalmology (<a href="./references#CD010516-bbs2-0125" title="KimSJ , SchoenbergerSD , ThorneJE , EhlersJP , YehS , BakriSJ . Topical nonsteroidal anti‐inflammatory drugs and cataract surgery: a report by the American Academy of Ophthalmology. Ophthalmology2015;122(11):2159‐68. ">Kim 2015</a>) concluded that NSAIDs reduced the incidence of CME, and may increase visual recovery, but found that the use of NSAIDs did not alter long‐term (three‐month) visual outcomes. </p> <p>One review published in 2014 evaluated the incidence of CME after phacoemulsification alone and compared NSAIDs with corticosteroids alone (<a href="./references#CD010516-bbs2-0124" title="KesselL , TendalB , JorgensenKJ , ErngaardD , FlesnerP , AndresenJL , et al. Post‐cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti‐inflammatory eye drops: a systematic review. Ophthalmology2014;121(10):1915‐24. ">Kessel 2014</a>). They evaluated inflammation within one week of surgery and macular edema at any time point. The authors reported greater risk of CME in the corticosteroid group when compared with the NSAID group as we do in this review, but with a stronger effect (RR 5.35, 95% CI 2.94 to 9.76). <a href="./references#CD010516-bbs2-0124" title="KesselL , TendalB , JorgensenKJ , ErngaardD , FlesnerP , AndresenJL , et al. Post‐cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti‐inflammatory eye drops: a systematic review. Ophthalmology2014;121(10):1915‐24. ">Kessel 2014</a> considered the evidence in their review to be of high‐certainty. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010516-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/urn:x-wiley:14651858:media:CD010516:CD010516-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_t/tCD010516-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010516-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010516-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/urn:x-wiley:14651858:media:CD010516:CD010516-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_t/tCD010516-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010516-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010516-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/urn:x-wiley:14651858:media:CD010516:CD010516-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_t/tCD010516-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010516-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010516-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/urn:x-wiley:14651858:media:CD010516:CD010516-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_t/tCD010516-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 NSAIDs versus corticosteroids, outcome: 1.1 Mean cell values at one week." data-id="CD010516-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 NSAIDs versus corticosteroids, outcome: 1.1 Mean cell values at one week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010516-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/urn:x-wiley:14651858:media:CD010516:CD010516-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_t/tCD010516-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 NSAIDs versus corticosteroids, outcome: 1.2 Mean flare values at one week." data-id="CD010516-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 NSAIDs versus corticosteroids, outcome: 1.2 Mean flare values at one week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010516-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/urn:x-wiley:14651858:media:CD010516:CD010516-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_t/tCD010516-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 NSAIDs plus corticosteroids versus corticosteroids alone, outcome: 2.1 Proportion of participants with cystoid macular edema at one week." data-id="CD010516-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 NSAIDs plus corticosteroids versus corticosteroids alone, outcome: 2.1 Proportion of participants with cystoid macular edema at one week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010516-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/urn:x-wiley:14651858:media:CD010516:CD010516-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_t/tCD010516-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs versus corticosteroids, Outcome 1 Mean cell values at one week." data-id="CD010516-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs versus corticosteroids, Outcome 1 Mean cell values at one week.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/references#CD010516-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010516-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/urn:x-wiley:14651858:media:CD010516:CD010516-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_t/tCD010516-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs versus corticosteroids, Outcome 2 Mean flare values at one week." data-id="CD010516-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs versus corticosteroids, Outcome 2 Mean flare values at one week.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/references#CD010516-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010516-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/urn:x-wiley:14651858:media:CD010516:CD010516-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_t/tCD010516-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs versus corticosteroids, Outcome 3 Proportion of participants with cystoid macular edema one month postoperative." data-id="CD010516-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs versus corticosteroids, Outcome 3 Proportion of participants with cystoid macular edema one month postoperative. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/references#CD010516-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010516-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/urn:x-wiley:14651858:media:CD010516:CD010516-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_t/tCD010516-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 NSAIDs plus corticosteroids versus corticosteroids alone, Outcome 1 Proportion of participants with cystoid macular edema at one week." data-id="CD010516-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 NSAIDs plus corticosteroids versus corticosteroids alone, Outcome 1 Proportion of participants with cystoid macular edema at one week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/references#CD010516-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010516-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/urn:x-wiley:14651858:media:CD010516:CD010516-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_t/tCD010516-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 NSAIDs plus corticosteroids versus corticosteroids alone, Outcome 2 Proportion of participants with cystoid macular edema at one month." data-id="CD010516-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 NSAIDs plus corticosteroids versus corticosteroids alone, Outcome 2 Proportion of participants with cystoid macular edema at one month. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/references#CD010516-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/media/CDSR/CD010516/image_n/nCD010516-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010516-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings for NSAIDs versus corticosteroids</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>NSAIDs compared with corticosteroids for controlling inflammation after uncomplicated cataract surgery</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people who received phacoemulsification </p> <p><b>Intervention:</b> NSAID </p> <p><b>Comparison:</b> corticosteroid </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corticosteroid</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NSAID</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Intraocular inflammation measured by anterior chamber cell and flare</b> </p> <p>1 week</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Cell values</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>174</p> <p>(3 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<sup>1</sup> <br/> <b>moderate</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The cell values presented were measured using a Kowa cell meter. 2 additional studies measured cells using a slit lamp, but we were unable to combine these data as the studies used different scales to report the number of cells. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean cell value ranged from 3.7 to 5.8.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean cell value was<b>0.24 cells lower</b> (1.65 lower to 1.16 higher). </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Flare values</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>365</p> <p>(5 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<sup>1,2</sup> <br/> <b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The flare values presented were measured using a Kowa cell meter. There was high statistical heterogeneity among the included studies (I<sup>2</sup> = 92%). </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean flare ranged from 15.65 to 48.3 photons/ms.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean flare was <b>13.74 photons/ms lower</b> (21.47 lower to 6 lower). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intraocular inflammation measured by proportion of participants with corneal edema</b> </p> <p>1 week</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>133 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>103 per 1000</b> </p> <p>(35 to 305)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.77</b> (0.26 to 2.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>3,4</sup> <br/> <b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proportion of participants with best‐corrected visual acuity of 20/40</b> </p> <p>1 week</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>None of the included studies reported on this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proportion of participants with cystoid macular edema</b> </p> <p>1 week</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>521 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>135 per 1000</b> </p> <p>(89 to 214)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.26</b> (0.17 to 0.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>291<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>1,5</sup> <br/> <b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None of the included studies reported the proportion of participants with cystoid macular edema at 1 week, our intended outcome of interest. <b>The data shown here are for 4 studies that reported on the presence of macular edema at 1 month.</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to cessation of treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>None of the included studies reported on this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>None of the included studies reported on this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Economic outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>None of the included studies reported on this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High‐certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate‐certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low‐certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low‐certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded the evidence due to risk of bias: the studies included in this meta‐analysis were poorly reported.<br/> <sup>2</sup>We downgraded the certainty of the evidence due to inconsistency: the I<sup>2</sup> for this estimate was 92%.<br/> <sup>3</sup>We downgraded the certainty of the evidence because the study was unmasked: participants and outcome assessor were not masked, and there was high risk of performance and detection bias.<br/> <sup>4</sup>We downgraded the certainty of the evidence due to imprecision.<br/> <sup>5</sup>We downgraded the certainty of the evidence due to indirectness: the time point at which the study data were reported was one month rather than one week, and two of the studies, which made up 30% of the weight, used a weak corticosteroid in their comparison. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings for NSAIDs versus corticosteroids</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010516-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings for NSAIDs plus corticosteroids versus corticosteroids alone</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>NSAIDs plus corticosteroids compared with corticosteroids alone for controlling inflammation after uncomplicated cataract surgery</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people who received phacoemulsification </p> <p><b>Intervention:</b> NSAID plus corticosteroid </p> <p><b>Comparison:</b> corticosteroid alone </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corticosteroid alone</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NSAID plus corticosteroid</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intraocular inflammation measured by anterior chamber cell and flare</b> </p> <p>1 week</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>None of the included studies reported on this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intraocular inflammation measured by proportion of participants with corneal edema</b> </p> <p>1 week</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>912 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>976 per 1000</b> </p> <p>(894 to 1000)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.07</b> (0.98 to 1.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>138<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>1</sup> <br/> <b>moderate</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proportion of participants with best‐corrected visual acuity of 20/40</b> </p> <p>1 week</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>None of the included studies reported on this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proportion of participants with cystoid macular edema</b> </p> <p>1 week</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>47 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>8 per 1000</b> <br/> (1 to 46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.17</b> (0.03 to 0.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>220<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>2,3</sup> <br/> <b>low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 additional studies (including 1213 participants) reported on the presence of cystoid macular edema at <b>1 month</b> postoperatively. The meta‐analysis showed that the group that received a combination of NSAID plus corticosteroid had a lower risk of macular edema at 1 month compared with the group that received a corticosteroid only, however there was uncertainty in the measurement (<b>RR 0.50, 95% CI 0.23 to 1.06</b>) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to cessation of treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>None of the included studies reported on this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 2 studies reported on adverse events. 1 reported that there were no adverse events related to NSAID use, but that 1 participant randomized to NSAIDs plus corticosteroid had heterogeneous retinal detachment as a complication of cataract surgery. Another study used the COMTOL questionnaire to ask participants about the frequency and severity of side effects; 3 of the top 5 most commonly reported side effects were markers of ocular discomfort: burning, redness, and blurred vision. The adverse events reported in this study were not separated by intervention group. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Economic outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>None of the included studies reported on this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>COMTOL:</b> Comparison of Ophthalmic Medications for Tolerability; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High‐certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate‐certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low‐certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low‐certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded the certainty of the evidence due to high risk of reporting bias: the study reported collecting data for certain time points, but results were not reported.<br/> <sup>2</sup>We downgraded the certainty of the evidence due to inconsistency based on the heterogeneity of types, doses, and regimens of NSAIDs and corticosteroids used.<br/> <sup>3</sup>We downgraded the certainty of the evidence due to imprecision: there was a small number of events for this outcome. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings for NSAIDs plus corticosteroids versus corticosteroids alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010516-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">The SUN Working Group Grading Scheme for Anterior Chamber Cells</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cells/Grade</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cells per field</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Less than 1</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.5+</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 to 5 cells</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1+</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 to 15 cells</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2+</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16 to 25 cells</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3+</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26 to 50 cells</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4+</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>More than 50 cells</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">The SUN Working Group Grading Scheme for Anterior Chamber Cells</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010516-tbl-0004"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">The SUN Working Group Grading Scheme for Anterior Chamber Flare</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Flare/Grade</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Description</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None to trace</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Faint</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate (iris and lens details clear)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Marked (iris and lens details hazy)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intense (fibrin or plastic aqueous)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">The SUN Working Group Grading Scheme for Anterior Chamber Flare</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010516-tbl-0005"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Rating scale to determine the degree of ocular discomfort</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Grade</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Degree of ocular discomfort</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Description</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absent</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mild</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>You experience ocular discomfort, but it does not interfere at all with your completion of daily tasks. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>You experience ocular discomfort and it slows you down, but you are able to carry out work of a light or sedentary nature (e.g. light house work, office work). </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Severe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Your experience of ocular discomfort makes you completely unable to carry out any work activities. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Rating scale to determine the degree of ocular discomfort</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010516-tbl-0006"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Outcomes in included studies: Expected outcomes compared with reported outcomes</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Primary Outcomes</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Secondary outcomes</b> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expected outcome: Proportion of participants with corneal edema &gt;grade 0</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expected outcome: Proportion of participants with anterior chamber cells and flare &gt;grade 1</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported outcome: Cells and flare as a continuous measure</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expected outcome: Proportion of participants with BCVA of 20/40 or better</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported outcome: Visual acuity as a continuous measure</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expected outcome: Proportion of participants with CME</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported outcome: OCT outcomes or FFA outcomes measured continuously (macular thickness, total macular volume, macular cube volume, fluorescein leakage,etc)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expected outcome: Time to cessation of treatment for inflammation</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expected outcome: Adverse events</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expected outcome: Economic outcomes (cost)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Studies comparing an NSAID to a corticosteroid</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0004" title="AsanoS , MiyakeK , OtaI , SugitaG , KimuraW , SakkaY , et al. Reducing angiographic cystoid macular edema and blood‐aqueous barrier disruption after small‐incision phacoemulsification and foldable intraocular lens implantation. Multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasonone 0.1%. Journal of Cataract and Refractive Surgery2008;31(1):57‐63. ">Asano 2008</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0005" title="BucciFA , MattaAZ . An objective comparison of acular vs vexol to control inflammation following phacoemulsification. American Academy of Ophthalmology; 2001 Nov 11‐14; New Orleans (LA). 2001:117. ">Bucci 2001</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0010" title="DemcoTA . Topical diclofenac versus prednisolone acetate in control of inflammation after phacoemulsification. American Academy of Ophthalmology1995:150. DemcoTA , SuttonH , DemcoCJ , RajPS . Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification‐lens implant surgery. European Journal of Ophthalmology1997;7(3):236‐40. ">Demco 1997</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0012" title="DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Acta Ophthalmologica2015;93(4):e314‐5. DuongHV , WestfieldKC , SingletonIC . Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Asia‐Pacific Journal of Ophthalmology2014;3(4):220‐5. ">Duong 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0015" title="EndoN , KatoS , HaruyamaK , ShojiM , KitanoS . Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes. Acta Ophthalmologica2010;88(8):896‐900. KitanoS , EndoN , ShojiM , HaruyamaK , KatoS . Effect of bromfenac sodium ophthalmic solution on preventing cystoids macular edema and inflammation after phacoemulsification and implantation of intraocular lens in diabetic patients. Investigative Ophthalmology &amp; Visual Science2008; Vol. 49:ARVO E‐Abstract 3470. ">Endo 2010</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data in figure only</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0017" title="GuzeyM , KaradedeZ , DoganZ , SaticiA . Ketorolac‐tobramycin combination vs fluorometholone‐tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision. Ophthalmic Surgery and Lasers2000;31(6):451‐6. ">Guzey 2000</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0019" title="HolzerMP , SolomonKD , SandovalHP , VromanDT . Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification. Journal of Cataract and Refractive Surgery2002;28(1):93‐9. ">Holzer 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0021" title="KatoS , BokuC , OnishiT , KoikeM , KageyamaT , NishiharaH , et al. Comparison of postoperative inflammation with two types of intraocular lense and anti‐inflammatory agents. Folia Ophthalmologica Japonica1998;49:286‐9. ">Kato 1998</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Partial</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0022" title="LaurellCG , ZetterströmC . Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery. British Journal of Ophthalmology2002;86(12):1380‐4. ">Laurell 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0026" title="MiyakeK , NishimuraK , HarinoS , OtaI , AsanoS , KondoN , et al. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation. Investigative Ophthalmology &amp; Visual Science2007;48(12):5647‐52. ">Miyake 2007</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0027" title="MiyakeK , OtaI , MiyakeG , NumagaJ . Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. Journal of Cataract and Refractive Surgery2011;37(9):1581‐8. ">Miyake 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0032" title="BrennanKM , BrownRM , RobertsCW . A comparison of topical non‐steroidal anti‐inflammatory drugs to steroids for control of post cataract inflammation. Journal of the American Society of Ophthalmic Registered Nurses1993;18(1):8‐11. BrownRM , RobertsCW . Preoperative and postoperative use of nonsteroidal antiinflammatory drugs in cataract surgery. Journal of the American Society of Ophthalmic Registered Nurses1996;21(1):13‐6. RobertsCW . A comparison of non‐steroidal anti‐inflammatory drug to steroids for postoperative inflammation. American Academy of Ophthalmology1992; Vol. 22. RobertsCW , BrennanKM . A comparison on topical diclofenac with prednisolone for postcataract inflammation. Archives of Ophthalmology1995;113(6):725‐7. ">Roberts 1995</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0038" title="SolomonKD , VromanDT , BarkerD , GehlkenJ . Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Journal of Cataract and Refractive Surgery2001;27(8):1232‐7. ">Solomon 2001</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0042" title="VoudouriA , ZafirakisP , Livir‐RallatosG , Livir‐RallatosC , CanakisC , MarkomichelakisN . Diclofenac versus prednisolone post phacoemulsification treatment: a randomized clinical trial. Investigative Ophthalmology &amp; Visual Science2002; Vol. 43:ARVO E‐Abstract 373. ">Voudouri 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0043" title="WangQW , YaoK , XuW , ChenPQ , ShentuXC , XieX , et al. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification. Ophthalmologica2013;229(4):187‐94. ">Wang 2013</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Studies comparing an NSAID plus a corticosteroid to a corticosteroid alone</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0001" title="AdamR , RodallecT , NordmannJP . Indometacine and macular thickness undergoing cataract surgery: a prospective randomized study. Investigative Ophthalmology &amp; Visual Science2005; Vol. 46:E‐Abstract 787. ">Adam 2005</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0002" title="AlmeidaDR , JohnsonD , HollandsH , SmallmanD , BaxterS , EngKT , et al. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. Journal of Cataract and Refractive Surgery2008;34(1):64‐9. ">Almeida 2008</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0006" title="Cervantes‐CosteG , Sánchez‐CastroY , Orozco‐CarrollM , Mendoza‐SchusterE , Velasco‐BaronaC . Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac. Clinical Ophthalmology2009;3(1):219‐26. ">Cervantes‐Coste 2009</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0007" title="ChatziralliIP , PapazisisL , SergentanisTN . Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial. Ophthalmologica2011;225(2):89‐94. ChatziralliIP , SergentanisTN , ParikakisEA , PapazisisLE , MitropoulosP , MoschosMM . The impact of non‐steroidal anti‐inflammatory agents after phacoemulsification on quality of life: a randomized study. Ophthalmology and Therapy2017;6(1):133‐40. ">Chatziralli 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data in figure only</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0008" title="ChenJ , WangGQ . Clinical observation of bromfenac sodium 0.1% eye drops on cataract surgery. International Eye Science2015;15(12):2102‐4. ">Chen 2015</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0009" title="DalD , SaraçO , TokluY , CakmakHB , GungorED . Efficacy of topical ketoroloc on macular thickness in patients undergoing cataract surgery. Ophthalmologica2014;232(Suppl 2):43. ">Dal 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0014" title="ElsawyMF , BadawiN , KhairyHA . Prophylactic postoperative ketorolac improves outcomes in diabetic patients assigned for cataract surgery. Clinical Ophthalmology2013;7:1245‐9. ">Elsawy 2013</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0016" title="EntezariM , RamezaniA , NikkhahH , YaseriM . The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial. International Ophthalmology2017;37(1):13‐8. [DOI: 10.1007/s10792‐016‐0209‐4] ">Entezari 2016</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0023" title="LiMC , YangXR , LiuF , ShaoDP , LiYB . Effect of topical NSAIDs in preventing macular edema after phacoemulsification in diabetes. International Journal of Ophthalmology2011;11(9):1614‐6. ">Li 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0024" title="AschbrennerMW , MathysKC , CohenKL . Do biological parameters and phaco metrics affect OCT measured CMT with and without nepafenac 0.1% treatment?. Investigative Ophthalmology &amp; Visual Science2008;49(13):389. MathysKC , CohenKL . Effect of nepafenac on macular thickness following uncomplicated cataract surgery. Investigative Ophthalmology &amp; Visual Science2008; Vol. 49:ARVO E‐Abstract 5674. MathysKC , CohenKL . Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema. Eye2010;24(1):90‐6. ">Mathys 2010</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0025" title="McColginAZ , RaizmanMB . Efficacy of topical voltaren in reducing the incidence of postoperative cystoid macular edema. Investigative Ophthalmology &amp; Visual Science1999; Vol. 40:ARVO E‐Abstract 1529. ">McColgin 1999</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0029" title="MoschosMM , ChatziralliIP , PantazisP , RouvasAA , SergentanisTN . Is topical diclofenac essential before and after uneventful phacoemulsification cataract surgery?. Journal of Ocular Pharmacology and Therapeutics2012;28(4):335‐9. ">Moschos 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0033" title="RodríguezYR , PereraIIYM , HernándezIM , ÁvilaIIRI , Hernández SilvaJR , OchoaMJ . Diclofenac sodium eyedrops in cataract's surgery by phacoemulsification [Colirio de diclofenaco sódico en cirugía de catarata por facoemulsificación]. Revista Cubana de Oftalmología2011;24(1):46‐54. ">Ruiz Rodríguez 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Partial</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0036" title="ShimazakiJ , FujishimaH , YagiY , TsubotaK . Effects of diclofenac eye drops on corneal epithelial structure and function after small‐incision cataract surgery. Ophthalmology1996;103(1):50‐7. ">Shimazaki 1996</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data in figure only</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0037" title="SinghR , AlpernL , JaffeGJ , LehmannRP , LimJ , ReiserHJ , et al. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clinical Ophthalmology2012;2012(6):1259‐69. ">Singh 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Partial</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0039" title="TiclyFG , LiraRP , ZanettiFR , MachadoMC , RodriguesGB , ArietaCE . Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial. Journal of Ocular Pharmacology and Therapeutics2014;30(6):495‐501. ">Ticly 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0044" title="WittpennJR , SilversteinS , HeierJ , KenyonKR , HunkelerJD , EarlM , et al. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low‐risk cataract surgery patients. American Journal of Ophthalmology2008;146(4):554‐60. ">Wittpenn 2008</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0046" title="ZaczekA , ArtzenD , LaurellCG , SteneviU , MontanP . Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery. Journal of Cataract and Refractive Surgery2014;40(9):1498‐505. ">Zaczek 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data in figure only</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0048" title="ZhangHY , ZhuSQ . Clinical study of pranoprofen eyedrops on prophylaxis of cystoids macular edema after cataract surgery. International Journal of Ophthalmology2008;8(7):1370‐2. ">Zhang 2008</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Studies with other combinations of NSAIDs and corticosteroids</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0003" title="AlmeidaDR , KhanZ , XingL , BakarSN , RahimK , UrtonT , et al. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. Journal of Cataract and Refractive Surgery2012;38(9):1537‐43. ">Almeida 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0011" title="DonnenfeldED , PerryHD , WittpennJR , SolomonR , NattisA , ChouT . Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic‐response curve. Journal of Cataract and Refractive Surgery2006;32(9):1474‐82. ">Donnenfeld 2006</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0013" title="el‐HaraziSM , RuizRS , FeldmanRM , VillanuevaG , ChuangAZ . A randomized double‐masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post‐phacoemulsification flare and cells. Ophthalmic Surgery and Lasers1998;29(7):539‐44. ">el‐Harazi 1998</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0018" title="HessemerV , SchartnerH . Low influence of anti‐inflammatory therapy on intraocular inflammation following minimally invasive phacoemulsification [Geringer Einfluß antiinflammatorischer Therapie auf den intraokularen Reizzustand nach minimal invasiver Phakoemulsifikation]. Der Ophthalmologe1997;94(1):30‐2. HessemerV , SchmidtK , SchartnerH . Minimally inflammatory cataract surgery [Minimal inflammatorische Kataraktchirurgie (MIK)]. Klinische Montasblätter für Augenheilkunde1996;209(6):331‐9. ">Hessemer 1996</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data in figure only</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0020" title="JungJW , ChungBH , KimEK , SeoKY , KimTI . The effects of two non‐steroidal anti‐inflammatory drugs, bromfenac 0.1% and ketorolac 0.45%, on cataract surgery. Yonsei Medical Journal2015;56(6):1671‐7. ">Jung 2015</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0028" title="MiyanagaM , MiyaiT , NejimaR , MaruyamaY , MiyataK , KatoS . Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. Acta Ophthalmologica2009;87(3):300‐5. ">Miyanaga 2009</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0030" title="MuletME , AlioJL , AyalaMJ , De laHozF , BedaJL . Efficacy of 0.5% ketorolac (Acular™) as an anti‐inflammatory treatment after cataract surgery. Investigative Ophthalmology &amp; Visual Science2001;42:ARVO E‐Abstract 66. ">Mulet 2001</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0031" title="OstrovCS , SirkinSR , DeutschWE , MasiRJ , ChandlerJW , LindquistTD . Ketorolac, prednisolone, and dexamethasone for postoperative inflammation. Clinical Therapeutics1997;19(2):259‐72. ">Ostrov 1997</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0034" title="SahuS , RamJ , BansalR , PandavSS , GuptaA . Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification. Journal of Cataract and Refractive Surgery2015;41(10):2043‐8. ">Sahu 2015</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0035" title="SchmittTH . Anti‐inflammatory therapy after cataract surgery — a laser‐flare‐cell photometer controlled study [Zur antiinflammatorischen therapie nach kataraktchirurigie. Eine kontrollierte studie mittels Laser‐Flare‐Cell‐Photometrie]. Aktuelle Augenheilkunde1995;20(5):263‐8. ">Schmitt 1995</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data in figure only</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0040" title="TrinavaratA , AtchaneeyasakulL , SurachatkumtonekulT , KosrirukvongsP . Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification. Journal of the Medical Association of Thailand2003;86(2):143‐50. ">Trinavarat 2003</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0041" title="TzelikisPF , VieiraM , HidaWT , MottaAF , NakanoCT , NakanoEM , et al. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo‐controlled randomised study. British Journal of Ophthalmology2015;99(5):654‐8. ">Tzelikis 2015</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0045" title="YavasGF , OztürkF , KüsbeciT . Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema. Journal of Cataract and Refractive Surgery2007;33(5):804‐7. ">Yavas 2007</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010516-bbs2-0047" title="ZanettiFR , FulcoEA , ChavesFR , daCosta PintoAP , ArietaCE , LiraRP . Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on maintenance of intraoperative mydriasis during cataract surgery: a randomized trial. Indian Journal of Ophthalmology2012;60(4):277‐81. ">Zanetti 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> <tfoot> <tr> <td colspan="11"> <div class="table-footnote"> <p>Partial refers to studies missing data or not reporting all data needed to perform a meta‐analysis (such as reporting means without standard deviations) and studies reporting data at time points that were not of interest for this review. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Outcomes in included studies: Expected outcomes compared with reported outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/full#CD010516-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010516-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">NSAIDs versus corticosteroids</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean cell values at one week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Measured with cell meter (cells per 0.075 mm3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐2.19, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mean flare values at one week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Measured with flare meter (photons/milisecond)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.74 [‐21.45, ‐6.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Proportion of participants with cystoid macular edema one month postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>291</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.17, 0.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">NSAIDs versus corticosteroids</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/references#CD010516-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010516-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">NSAIDs plus corticosteroids versus corticosteroids alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Proportion of participants with cystoid macular edema at one week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.03, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Proportion of participants with cystoid macular edema at one month <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.23, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">NSAIDs plus corticosteroids versus corticosteroids alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010516.pub2/references#CD010516-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010516.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010516-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010516-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD010516-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD010516-note-0002">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD010516-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010516-note-0013">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010516\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010516\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010516\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010516\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010516\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010516\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010516\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010516\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010516\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010516\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010516\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010516\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010516\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010516\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010516\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010516\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010516\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010516\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=dLyXbLct&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010516.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010516.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010516.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010516.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010516.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718661085"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010516.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718661089"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010516.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dd5c6cc02f47a',t:'MTc0MDcxODY2MS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 